Acerola powder for use as a substitute for ascorbic acid in the agri-food field

The invention concerns a powder consisting of 0.5 to 8% by weight of water and a dry material consisting of 88 to 95% by weight of an acerola fruit dry extract and 5 to 12% by weight of magnesium, calcium, zinc, sodium or potassium hydroxide or carbonate, the method of preparing same and the applications thereof for replacing ascorbic acid and/or the derivatives of same in food products.

UTILIZATION OF PHOSPHATIDYLSERINE IN THE TREATMENT OF ATTENTION DEFICIT SYNDROME (ADHS)

The invention relates to the utilization of phosphatidylserine (PS), lysophosphatidylserine and/or a physiologically acceptable salt thereof in the treatment of attention deficit syndrome (ADHS) in small daily doses over an extended period and in high doses over a short period and in combination with appropriate additives selected from the group consisting of antioxidants, essential fatty acids, mineral substances, amino acids, antidepressants and/or phospholipids. It is preferably administered to probands in the 2 to 20 years age group, preferably in the 3 to 10 years age group, wherein the phosphatidylserine and the additives can be used both in solid or liquid formulations. Phosphatidylserine is particularly suitable as therapeutic agent or diet supplement in connection with ADHS due to its positive properties. The good compatibility of phosphatidylserine even in high doses and over extended supplementation periods and its excellent compliance should also be stressed.

COMPOSITIONS AND METHODS FOR NUTRITION SUPPLEMENTATION

NUTRITIONAL SUPPLEMENT

DIETARY SUPPLEMENT

A dietary supplement for treating or preventing prostate disease and/or vascular disease including saw palmetto, d-alpha tocopherol, d-gamma tocopherol, d- delta tocopherol, d-beta tocopherol, selenium, lycopene, zinc, folic acid, vitamin B12, and vitamin B6, each in a therapeutically effective amount.

MINERAL FORTIFICATION SYSTEMS FOR ADDING MINERALS TO BOTTLED, POTABLE LIQUIDS

A mineral-fortification system that has a bottle cap, a pouch and a pouch opener. A powder is contained within the pouch, and the powder contains at least one mineral and a redox modulating compound. When the cap is secured onto the opening of a bottle containing a liquid and when the pouch opener is activated, the powder is released from the pouch and mixes with the liquid to form a mineral fortified liquid composition that is fortified with at least one mineral and has a pH between about 2.5 and 9.5. Moreover, the mineral fortified liquid composition has a redox potential that satisfies the following equation:0 ~ RP - (A - B*pH). In this equation RP is the redox potential in millivolts of the mineral-containing liquid composition, pH is the pH of the mineral-containing liquid composition, A is 400 and B is 20. The mineral is preferably selected from calcium, iron, zinc, copper, manganese, iodine, magnesium, and mixtures of these. Moreover, the mineral-fortified liquid composition may ...

COMPOSITION IMPROVING AGE-RELATED PHYSIOLOGICAL DEFICITS AND INCREASING LONGEVITY

A food composition intended to prevent or restore age-related functional deficits in mammals. The food composition can mimic the effects of caloric restriction on gene expression, which can include at least one molecule that stimulates energy metabolism of the cell and at least one oxidant.

FORMULATION FOR MENOPAUSAL WOMEN

The present disclosure relates to novel compositions which provide improved nutritional support for premenopausal and menopausal women and/or relief from symptoms associated with menopause, as well as prophylactic effects, and methods for using same.

COMPOSITION CONTAINING OMEGA-3 FATTY ACIDS AND OMEGA-6 FATTY ACIDS

... ²²²The invention relates to a composition containing omega-3 fatty acids and ²omega-6 fatty acids, which comprises zinc compounds, preferably in the form of ²zinc sulfate, especially for use in the treatment of dry eye symptom.² ...

ANTIOXIDATIVE COMPOSITIONS

This invention relates to a composition that contains quercetin, vitamin B1, viamin B2, vitamin B3, vitamin B6, vitamin C, caffeine, epigallocatechin gallate, epicatechin, epicatechin gallate, epigallocatechin, and polypheron E.

NUTRITIONAL COMPOSITIONS

The present inventors discovered that the onset of galactosamine hepatopathy is suppressed by nutritional compositions comprising as essential ingredients: whey protein hydrolysates; lecithin and oils and fats high in oleic acid, which are able to improve the lipid metabolism; and palatinose having an insulin-sparing effect. Furthermore, the whey protein hydrolysate included in the nutritional compositions was found to suppress endotoxin-induced TNF-a and interleukin 6 (IL-6) production in macrophages.

PRODUCT AND METHOD TO REDUCE STRESS INDUCED IMMUNE SUPPRESSION

In its broadest aspect, the present invention is directed to the discovery of immunonutritional products that are useful in reducing the immunological system suppression that results from stress. The stress may be in the form of physical exertion, mental exhaustion, disease states and the like. In one embodiment, the invention relates to a nutritional composition comprising a structured glyceride component and an antioxidant system. This nutritional composition has been shown to be highly effective in reducing immune system down regulation or dysregulation as a result of stress.

COMPOSITION FOR ENHANCING PHYSICAL PERFORMANCE

... ²²²A composition that contains (1) quercetin and vitamin B3, or (2) quercetin and ²vitamin C. Also disclosed is a method of using the composition for enhancing ²physical performance.² ...

PHARMACEUTICAL COMPOSITION FOR MUSCULAR ANABOLISM

A pharmaceutical composition suitable for enhancing muscular anabolism contains, per daily dose, at least 5 mg of anabolic initiators comprising anabolic growth factors, at least 0.12 g of protein equivalents of anabolic substrates and at least 3 g of anabolic facilitators comprising at least 1 g of creatine or its functional equivalent. The anabolic initiators may be derived from a non-denatured animal protein, non-denaturated being defined as having a F0 of less than 3.0.

COMPOSITION FOR MODERATING ALCOHOL METABOLISM AND FOR REDUCING THE RISK OF ALCOHOL INDUCED DISEASES

The present invention is directed to a composition of matter, in particular a food composition, dietary or food supplementation, and pharmaceutical composition, respectively. The composition of matter reduces the risk of neuropathy, neurodegenerative diseases including late-onset Alzheimer~s disease, and cancer, in particular of pancreatic, esophageal, oropharyngolaryngeal, liver, colorectal, lung and/or breast cancer, in particular the drug and/or alcohol induced risk of said diseases. In this respect, the present invention is also directed to a composition of matter, in particular a food composition, dietary or food supplementation, and pharmaceutical composition, respectively, which supports and/or moderates the alcohol degradation process within the human body.

METHOD FOR THE PRODUCTION OF RIBOFLAVIN OF MODIFICATION B/C IN GRANULAR FORM

The invention relates to an improved method for producing pure riboflavin (vitamin B2) of modification B/C in granular form. Also disclosed is pure riboflavin in granular form, said pure riboflavin being provided with a bulk density of 0.45 to 0.7 g/ml, which is to be determined according to DIN 53468, and dissolution kinetics of at least 80 percent after being tableted.

TRANSPARENT LIQUID COMPOSITION

A transparent liquid composition which comprises water, an oil-soluble ingredient, and a surfactant. Specifically, the transparent liquid composition comprises at least 50 wt.% water, up to 30 wt.% oil-soluble ingredient, and up to 20 wt.% surfactant, wherein the content of the surfactant is lower than that of the oil-soluble ingredient.

NUTRITIONAL SUPPLEMENT FOR ADOLESCENTS

A multinutrient nutritional supplement is provided that is designed to be most effective in optimizing health, increasing the immunity and decreasing the instances and severity of infection particularly among adolescents.

INFANT FORMULA CONTAINING PARTIALLY HYDROLYZED ISOLATED SOY PROTEIN WITH A REDUCED PHYTATE CONTENT

Nutritional formulas are provided which comprise isolated soy protein wherein the isolated soy protein has a phytate content of 100 mg per liter or less; and the isolated soy protein has a degree of hydrolysis between 5 and 20%.

AIDING OF COGNITIVE FUNCTION

The invention provides the use of a bioavailable iron compound and a bioavailable zinc compound in a weight ratio of at least 2:1, and at least one B vitamin, in the manufacture of an edible composition, for use in aiding the cognitive development or cognitive performance of humans having an age of up to 18 years.

CARBOHYDRATE MODIFYING AGENT AND DRINKS CONTAINING THE MODIFYING AGENT

The present invention provides a composition that modulates the rate of sugar absorption and/or metabolism in a subject to whom the composition is administered. The composition includes active soluble fiber, one or more polyphenolic compounds, and a source of amino acids. The composition may be used dry in formulating foodstuffs and beverages. In a preferred embodiment, the composition is a component of a finished beverage, such as a carbonated soft drink.

NUTRITIONAL COMPOSITION AND METHOD FOR IMPROVING PROTEIN DEPOSITION

Compositions and methods that stimulate body protein synthesis and can improve muscle mass maintenance and recovery are provided. The composition comprises (i) a protein source which provides at least about 8 % total calories of the composition and which includes at least about 50 % by weight of whey protein; (ii) a lipid source having an omega 3:6 fatty acid ratio of about 5:1 to about 10:1 and which provides at least about 18 % total calories of the composition; (iii) a carbohydrate source; and (iv) a balanced macronutrient profile comprising at least vitamin E and vitamin C.

COMPOSITION CONTAINING OMEGA-3 FATTY ACIDS AND OMEGA-6 FATTY ACIDS

DUAL VISCOSITY FIBER SYSTEM AND USES THEREOF

The present invention relates generally to a method of blunting the postprandial glycemic response to a meal by feeding a dual induced viscosity fiber system. The first component of the induced viscosity fiber system is soluble fiber. The second component of the induced viscosity fiber system is water-insoluble, acid-soluble multivalent cations. The third component of the induced viscosity fiber system in lightly hydrolyzed starch. The fiber system will typically be incorporated into a meal replacement nutritional. The present invention also refers to a method of delivering soluble fiber to diabetics and to persons needing to lose weight. Additionally, the invention refers to a method of promoting the feeling of fullness and satiety by feeding a nutritional product containing the induced viscosity fiber system.

MULTIVITAMIN SYRUP FOR CHILDREN OR YOUNG ADULTS

FAT BASED FOOD PRODUCTS

The invention concerns a fat based food product comprising natural fat components which have a blood cholesterol lowering effect in amounts sufficient to obtain a blood cholesterol lowering effect if the food product is used according to the common needs and customs of the consumer, wherein at least one compound of tocotrienol, oryzanol and phytosterol is present, and preferably at least one compound of oryzanol and phytosterol. In a further preferred embodiment the fat in the product comprises at least 30 wt.%, preferably at least 45 wt.% of pufa-triglycerides. By the regular consumption of the now found fat based food products a positive contribution to health in general, and in particular to the lowering of the blood cholesterol level can be found.

NUTRITIONALLY COMPLETE LOW PH ENTERAL FORMULA

This invention is directed to a low pH nutritional formula that contains high levels of macronutrients, vitamins and minerals. The pH of the enteral formula is from about 3.0-4.6 and delivers at least 25 % of the RDI for selected vitamins and minerals in a 237 ml. serving. The enteral formula uses a stabilizing system comprising a high methoxy pectin to stabilize the protein and a unique process to produce the formula.

PREPARATION FOR THE PREVENTION AND/OR TREATMENT OF VASCULAR DISORDERS

The present invention relates to a preparation suitable for the prevention and/or treatment of vascular disorders, comprising the following fractions: fraction a) long chain polyunsaturated fatty acids; fraction b) phospholipids, which fraction contains at least two different phospholipids selected from the group consisting of phosphatidylserine; phosphatidylinositol, phosphatidylcholine and phosphatidylethanolamine. fraction c) compounds which are a factor in methionine metabolism, which fraction contains at least one member selected from the group consisting of folic acid, vitamin B12, vitamin B6, magnesium and zinc.

TOCOPHERYL POLYETHYLENE GLYCOL SUCCINATE ARTICLES AND PROCESS FOR PREPARING TPGS ARTICLES

The present invention relates to a tocopheryl polyethylene glycol succinate (TPGS) article having a weight no greater than 1 gram and a tackiness no greater than about 1550 grams. In addition, the present invention relates to a process for producing said TPGS articles, comprising the step of forming the article at a temperature below 31 ~C.

DIRECT DISSOLUTION

... ²²²The present invention describes a method for the continuous dissolution of ²e.g. crystalline astaxanthin or canthaxanthin suspension in oil, by applying ²heat for a predetermined period using an in-line or optionally batch wise-²process, followed by cooling the heated solution with an oil phase or heat ²exchanger. The resulting oil solution may be used as such or added directly to ²feed components which are turned into feed compositions by extrusion, ²compaction or granulation. Alternatively the oil solution is spray coated or ²directly loaded to extruded or compacted pellets and granulates. The invention ²avoids using formulated carotenoids prepared by known multi-step production ²methods requiring solvents, solvent removal, cooling and emulsification with ²an aqueous phase or precipitation and recovery steps. Thus the present ²invention is a more economical, efficient and environmentally friendly method ²to add nutrients and colorants to feed compositions instead of using colloid ²dispersed ...

POLYMER CONTROLLED INDUCED VISCOSITY FIBER SYSTEM AND USES THEREOF

The present invention relates generally to a method of blunting the postprandial glycemic response in a human by feeding an induced viscosity fiber system together with lightly hydrolyzed starch. The invention also relates to an induced viscosity fiber system and the liquid products that incorporate the induced viscosity fiber system. Further, the invention relates to a method of incorporating soluble fiber into a liquid product without the typical negative organoleptic or physical stability issues. The invention also relates to a method of inducing the feeling of fullness and satiety by feeding the induced viscosity fiber system.

NUTRITIONALLY COMPLETE LOW PH ENTERAL FORMULA

This invention is directed to a low pH nutritional formula that contains high levels of macronutrients, vitamins and minerals. The pH of the enteral formula is from about 3.0-4.6 and delivers at least 25 % of the RDI for selected vitamins and minerals in a 237 ml. serving. The enteral formula uses a stabilizing system comprising a high methoxy pectin to stabilize the protein and a unique process to produce the formula.

ANTI-PROLIFERATIVE COMPOSITION

Non-estrogen-dependent hyperproliferation of cells in animals or humans can be prevented or treated by means of a pharmaceutical or nutritional composition containing a combination of at least three components from: a) two or more inhibitors of the G1/S phase of the cell cycle; and b) two or more inhibitors of the G2/M phase of the cell cycle; and c) two or more inhibitors of protein tyrosine kinase activity. Especially, component a) comprises two or more compounds selected from flavanolignans, carotenoids and isoflavone; component b) comprises two or more compounds selected from flavanolignans, hydroxylated stilbenes, isoflavones and apigenin; and component c) comprises two or more compounds selected from flavanolignans and isoflavones.

СОСТАВ, СОДЕРЖАЩИЙ ПРОИЗВОДНОЕ ВИТАМИНА K3 И НЕСТЕРОИДНЫЙ ПРОТИВОВОСПАЛИТЕЛЬНЫЙ ПРЕПАРАТ

В заявке описаны высоко стабилизированные частицы, содержащие никотинамид (НА) и производное витамина K3, при этом никотинамид образует физический защитный слой (как непрерывный, так и прерывистый), обеспечивающий высокую стабильность частиц производного витамина K3, а также способ его получения.

ПОКРЫТЫЕ ПЛЕНОЧНЫМ ПОКРЫТИЕМ И/ИЛИ ГРАНУЛИРОВАННЫЕ КАЛЬЦИЙСОДЕРЖАЩИЕ СОЕДИНЕНИЯ И ИХ ПРИМЕНЕНИЕ В ФАРМАЦЕВТИЧЕСКИХ КОМПОЗИЦИЯХ

Раскрываются кальцийсодержащие соединения, которые были, по крайней мере, частично покрыты пленочным покрытием и/или гранулированы водорастворимым веществом и водорастворимым полимерным веществом, и использование таких покрытых соединений в фармацевтических композициях. Оказалось, что, по крайней мере, частично покрытые пленочным покрытием и/или гранулированные кальцийсодержащие соединения являются подходящими для получения таблеток, имеющих очень высокую загрузку элементарного кальция и удобный маленький размер. Согласно изобретению получают таблетки с загрузкой лекарственного средства примерно 90% или более, и эти таблетки имеют достаточные механические и органолептические свойства.

ВОЛОКНА ЦИТРУСОВОГО ФРУКТА В ЭМУЛЬСИЯХ

Изобретение касается композиции, содержащей пищевую жидкость, волокна цитрусового фрукта в количестве от 0,001 до 5 % и гидрофобный витамин, причем весовое соотношение волокон цитрусового фрукта к гидрофобному витамину составляет от 1:0,1 до 1:20. Кроме того, данное изобретение касается способа получения такой композиции, ее применения и напитка, содержащего указанную композицию.

СПОСОБЫ И КОМПОЗИЦИИ ДЛЯ ЛЕЧЕНИЯ ЗАБОЛЕВАНИЙ КОСТЕЙ

Настоящее изобретение относится к способам и композициям для лечения заболеваний костей, в частности потери костной массы, такой как остеопороз. В частности, настоящее изобретение относится к питательным композициям на основе молока, в которые предпочтительно добавлены пребиотики и отдельный источник витамина K2, и способам применения таких питательных композиций для лечения или профилактики заболевания костей, в частности потери костной массы, такой как остеопороз. Композиция по настоящему изобретению включает одну или более фракций и/или компонентов молока; предпочтительно один или более пребиотиков; предпочтительно одну или более солей кальция и/или магния и витамин K2 (менахинон), включающий от 7 до 13 (от МК-7 до МК-13) изопропеноидных остатков.

КОМПОЗИЦИЯ, СДЕРЖИВАЮЩАЯ АЛКОГОЛЬНЫЙ ОБМЕН ВЕЩЕСТВ

Данное изобретение относится к композиции, в частности к пищевой композиции или диететической добавке, которая обладает активностью в отношении сдерживания процесса алкогольной деградации в организме человека. Данное изобретение в особенности касается проблемы быстрой алкогольной деградации, то есть алкогольного обмена веществ, который может происходить у большинства людей с генетической структурой неевропейского типа. В этом отношении целью данного изобретения является достижение решений, которые обеспечивают уменьшение физиологического стресса, связанного с потреблением алкоголя, в особенности у людей с предрасположением к быстрой алкогольной деградации. В данном изобретении эта цель достигается с помощью пищевой композиции или диететической добавки, включающей следующие вещества: декстрозу, витамин С, L-глутамин, цистеин, рибофлавин, янтарную кислоту, фумаровую кислоту и коэнзим Q10, причем все вещества включаются в физиологически значимых дозах, в частности, указанных здесь.

ПИЩЕВАЯ ДОБАВКА, КОТОРАЯ ТОРМОЗИТ МЕТАБОЛИЗМ АЛКОГОЛЯ

Пищевая добавка, которая тормозит процесс метаболизма алкоголя в организме человека и которая содержит в расчете на массы тела декстроза в количестве от 7,2 до 12,8 мг, витамин С в количестве от 0,78 до , L-глютамин в количестве от 1,23 до , цистеин в количестве от 460 до 540 мг, рибофлавин в количестве от 32 до 48 мг, янтарную кислоту в количестве от 90 до 110 мг, фумаровую кислоту в количестве от 90 до 110 мг и кофермент Q10 в количестве от 50 до 70 мг.

КАПСУЛЫ, КОТОРЫЕ СОДЕРЖАТ ПЕЛЕТЫ С ДЕЙСТВУЮЩИМИ ВЕЩЕСТВАМИ, КОТОРЫЕ ОТЛИЧАЮТСЯ МЕЖДУ СОБОЙ ПРОФИЛЕМ ВЫСВОБОЖДЕНИЯ ИЗ НИХ ДЕЙСТВУЮЩИХ ВЕЩЕСТВ

Изобретение касается капсулы, которая содержит пелеты по крайней мере трех групп с тем же профилем высвобождения действующих веществ в каждой из них с действующими веществами, которые отличаются между собой профилем высвобождения из них действующих веществ в желудочно-кишечном тракте и которые содержат по крайней мере два разных действующих вещества, выбранных из группы витаминов, минеральных веществ, микроэлементов, ненасыщенных жирных кислот, аминокислот и/или растительных экстрактов и веществ, при этом высвобождение соответствующих действующих веществ происходит на всем участке всасывания в желудочно-кишечном тракте (группа І), в двенадцатиперстной кишке или в двенадцатиперстной кишке и в пустой кишке (группа II), соответственно в пустой кишке, в пустой кишке и подвздошной кишке или в подвздошной кишке (группа III).

ПРИМЕНЕНИЕ КОМПОЗИЦИИ, КОТОРАЯ СОДЕРЖИТ ЭКСТРАКТЫ РАСТЕНИЙ PANAX GINSENG И PAULLINIA CUPANA

Изобретение относится к применению композиции, содержащей экстракты растений Panax ginseng (женьшень) и Paullinia cupana (гуарана) для изготовления пищевой добавки для улучшения когнитивных способностей субъекта. Также заявленная композиция дополнительно включает провитамин А, витамин В1, витамин В2, витамин В6, витамин В12, витамин С, витамин D3, d,l-альфа-токоферолацетат, фолиевую кислоту, биотин и витамин РР и медь, кальций, железо, цинк, селен, фосфор и магний. Кроме того, заявленная композиция заключена в капсулу с мягкой оболочкой или таблетку.

ПРИМЕНЕНИЕ ЖИДКОЙ КОМПОЗИЦИИ НА ОСНОВЕ ГУАНИДИНУКСУСНОЙ КИСЛОТЫ И ГОТОВЫЙ ПИТЬЕВОЙ ПРОДУКТ, СОДЕРЖАЩИЙ ЕЕ

Данное изобретение касается жидкой композиции для питания людей и животных, которая состоит из водного раствора компонента, содержащего гуанидинуксусную кислоту, и по крайней мере одного донора метильной группы из ряда холина, метионина и бетаина. Кроме свободной гуанидинуксусной кислоты в качестве компонента, содержащего гуанидинуксусную кислоту, можно применять соли, аддукты и/или комплексные соединения, которые при этом можно комбинировать с дополнительными физиологически активными соединениями. Поскольку компонент, содержащий гуанидинуксусную кислоту, присутствует в растворенной форме, предлагаются, в частности, композиции в форме минеральной воды, лимонада, алкогольных напитков и композиций на основе питьевой воды. Неожиданно оказалось, что содержащий гуанидинуксусную кислоту компонент в составе этой жидкой композиции имеет очень высокую стабильность и очень быстро превращается в креатин в организме.

КОМПОЗИЦИИ, КОТОРЫЕ СОДЕРЖАТ ВИТАМИН, И ИХ ПРИМЕНЕНИЕ ДЛЯ ПОЛУЧЕНИЯ ОБОГАЩЕННЫХ КОРМОВЫХ ПРОДУКТОВ И КОМПОЗИЦИЙ ДЛЯ ЛИЧНОЙ ГИГИЕНЫ

Изобретение касается водных композиций, которые содержат алкоксилированное касторовое масло с 15-25 моль этиленоксидных единиц и витамин, преимущественно, жирорастворимый витамин, который используется в способах введения витамина животному, или применения витаминосодержащих композиций для получения композиций для личной гигиены.

КОМПОЗИЦИЯ, КОТОРАЯ СОДЕРЖИТ ОМЕГА-3-ЖИРНЫЕ КИСЛОТЫ И ОМЕГА-6-ЖИРНЫЕ КИСЛОТЫ, ДЛЯ ЛЕЧЕНИЯ СИНДРОМА СУХОГО ГЛАЗА

Данное изобретение касается композиции, которая содержит омега-3-жирные кислоты и омега-6-жирные кислоты и соединение цинка для лечения синдрома сухого глаза.

КОМПОЗИЦИЯ ДЛЯ ПОДАВЛЕНИЯ СИМПТОМОВ АБСТИНЕНЦИИ И ТЯГИ К АЛКОГОЛЮ У АЛКОГОЛИКОВ И ПРОФИЛАКТИКИ ЗЛОУПОТРЕБЛЕНИЯ АЛКОГОЛЕМ У ЗДОРОВЫХ ЛЮДЕЙ

... 1. Перорально или парентерально вводимая композиция, содержащая смесь L-карнитина, ацетил-L-карнитина и пропионил-L-карнитина или их фармакологически приемлемых солей. 2. Композиция по п.1 в качестве лекарственного средства для подавления симптомов абстиненции и тяги к алкоголю у алкоголиков. 3. Композиция по п.1 в качестве пищевой добавки или пищевых продуктов для профилактики злоупотребления алкоголем у практически здоровых людей. 4. Композиция по пп.1, 2 или 3, где молярное отношение L-карнитин:ацетил-L-карнитин:пропионил-L-карнитин или их фармакологически приемлемых солей находятся в интервале от 6:4:1 до 3:2:1. 5. Композиция по п.4, в которой указанное отношение составляет 5:4:1. 6. Композиция по п.4 или 5 в единичной дозированной форме, содержащей от 0,44 до 0,66 г внутренней соли L-карнитина; от 0,44 до 0,66 г внутренней соли ацетил-L-карнитина, от 0,12 до 0,18 г внутренней соли пропионил-L-карнитина или эквимолярного количества их фармакологически приемлемых солей. 7. Композиция ...

СИРОП ДЛЯ ДІТЕЙ АБО ПІДЛІТКІВ, ЯКИЙ МІСТИТЬ ПОЛІВІТАМІНИ

Винахід стосується живильної композиції у формі водного сиропу, 1 мл якої по суті містить: (а) від 0,1 до 0,3 мг вітаміну В1,від 0,1 до 0,3 мг вітаміну В2, від 0,2 до 0,6 мг вітаміну В6, від 10 до 40 МО вітаміну D3, від 0,5 до 1,5 мг вітаміну Е, від 0,2 до 1,0 мг декспантенолу та від 0,7 до 2,0 мг нікотинаміду, (б) від 20 до 150 мг лактату кальцію, (в) від 5 до 15 мг аргініну та від 10 до 30 мг гідрохлориду (L)-лізину, (г) від 5 до 15 мг таурину, (д) принаймні один амфіфільний солюбілізатор, молекула якого має принаймні одну гідрофобну або одну гідрофільну частину, (е) принаймні один додатковий агент, вибраний з групи, яка включає підсолоджувальні речовини, коригенти, інтенсифікатори смаку та запаху, консерванти, антиоксиданти, співрозчинники, та (ж) воду.

КОМПОЗИЦИЯ ДЛЯ РЕГУЛИРОВАНИЯ МЕТАБОЛИЗМА ЛИПИДОВ

Настоящее изобретение относится к композиции для регулирования метаболизма липидов и способам, которые можно применять в пищевой промышленности, а также в нутрицевтической и терапевтической областях. В частности, настоящее изобретение относится к пищевым и питательным добавкам или добавкам, композиции, содержащей их, и их применению, в частности, для восстановления метаболизма субъекта, в частности метаболизма людей.

СПОСОБЫ И КОМПОЗИЦИИ ДЛЯ ЛЕЧЕНИЯ ЗАБОЛЕВАНИЙ КОСТЕЙ

Настоящее изобретение относится к способам и композициям для лечения заболеваний костей, в частности потери костной массы, такой как остеопороз. В частности настоящее изобретение относится к питательным композициям на основе молока, в которые предпочтительно добавлены пребиотики и отдельный источник витамина K2, и способам применения таких питательных композиций для лечения или профилактики заболевания костей, в частности потери костной массы, такой как остеопороз. Композиция по настоящему изобретению включает одну или более фракцию и/или компонент молока; предпочтительно один или более пребиотик; предпочтительно одну или более соль кальция и/или магния и витамин K2 (менахинон), включающий от 7 до 13 (от MK-7 до MK-13) изопропеноидных остатков.

Method for prevention of formation of abnormal odor in beverage composition

Nutritional compositions

The invention relates to compositions comprising novel blends of nutritional ingredients and solid, semi-solid and beverage compositions comprising such blends. In particular, this invention relates to rehydration, energy and recovery beverages (e.g. sports drinks), compositions for support of weight management, as well as digestive, bone, cognitive and heart health.

Microbially-stable Vitamin E solutions

The present application discloses microbially-stable solutions of water-solubilized lipophilic vitamins, such as Vitamin E. These solutions contain from about 0.5% to about 30% of a salt selected from potassium chloride, magnesium chloride, calcium chloride, potassium phosphate, calcium phosphate, potassium sulfate, calcium phosphate, magnesium phosphate, magnesium sulfate, potassium iodide, and mixtures of these salts. The method of providing microbially-stable solutions of such water-solubilized lipophilic vitamins, as well as food and beverage products containing those microbially-stabilized water-solubilized lipophilic vitamins, are also disclosed.

碳水化合物改良剂和含该改良剂的饮料

... 本发明提供了一种组合物，它调节被施用该组合物的受试验者中的糖吸收和/或代谢的速率。所述组合物包含：活性可溶性纤维，一种或多种多酚化合物，以及一种氨基酸来源。所述组合物可呈干形式用于食料和饮料的配制中。在一个优选的实施方案中，所述组合物是成品饮料(例如，充气软饮料)的一种组分。 ...

Nutritional supplement which can be taken orally, intended for promoting the elimination of fats and the restoration of balanced nutritional behaviour

Complément nutritionnel absorbable, pour favoriser l'élimination des graisses et le rééquilibrage du comportement alimentaire, caractérisé en ce qu'il contient en association de la tyrosine, de la vitamine C, de la vitamine E, du magnésium et un excipient.

Nutritional supplement which can be taken orally to improve and optimise individuals' levels of physical and mental activity

Complément nutritionnel absorbable pour améliorer les niveaux d'activité physique et cérébrale, caractérisé en ce qu'il contient du magnésium, une association de vitamines C et B1 et un excipient.

BASED FOOD SUPPLEMENT OF B VITAMINS, [...]-CELL AND FATTY ACIDS W-3 AND/OR W-6 AND USE OF THE DIETARY SUPPLEMENT IN SIMULTANEOUS TREATMENT OF CELLULITE AND LOCALIZED SLACKENING OF THE SKIN

NEW COMPOSITIONS HAS SYNERGISTIC EFFECT BETWEEN MICRONUTRIMENTS ETSUBSTANCES Of ALIVE ORIGIN

FOOD COMPLEMENT INCLUDING/UNDERSTANDING an ASSOCIATION Of ANTIOXYDANT AGENTS AND CARNITINE, OBTAINED BY ENDOGENOUS OR EXOGENIC SYNTHESIS, LIKE HELPS WITH the FERTILITY AT the MAN AND the WOMAN

Food composition, useful to prevent/limit loss of muscle mass, loss of bone mineral density and cognitive decline, comprises pea/milk protein, potassium, calcium, selenium, vitamins D3, E, C, B2, B6, B9, and B12, choline and polyphenol

Composition alimentaire pour prévenir et limiter la perte de masse musculaire, la perte de densité minérale osseuse et le déclin cognitif, en particulier chez les personnes âgées de 50 ans et plus, caractérisée en ce que ladite composition comporte les constituants essentiels suivants exprimés en pourcentages en poids par rapport au poids sec de ladite composition : Protéines de pois ou de lait (lactosérum) 45 à 67 % Potassium 1,45 à 1,95 % Calcium 0,64 à 1 % Sélénium 0,000061 à 0,00013 % Vitamine D3 0,000011 à 0,000021 % Vitamine E 0,027 à 0,066 % Vitamine C 0,048 à 0,1 % Vitamine B2 0,0046 à 0,0066 % Vitamine B6 0,0048 à 0,011 % Vitamine B9 0,00037 % à 0,00086 % Vitamine B12 0,00008 % à 0,000013 % Choline 0,274 à 0,73 % Polyphénols 0,091 à 0,16 % ...

NEW PHARMACEUTICAL AND/OR DIETETIC COMPOSITIONS AGAINST THE STRESS

La présente invention se rapporte au domaine de la chimie et plus particulièrement au domaine de la chimie thérapeutique. Elle a pour objet de nouvelles compositions pharmaceutiques et/ou diététiques caractérisées en ce qu'elles renferment un ou plusieurs sels de magnésium avec un acide organique, liposolubles, des aminoacides choisis parmi la Taurine et l'Arginine et une ou des vitamines du groupe B, associées ou en mélange avec un excipient ou un véhicule inerte, non-toxique, pharmaceutiquement-acceptable. Utilisation pour la réalisation de formulations destinées à l'alimentation, à la diététique, à la thérapeutique ainsi qu'aux compléments alimentaires afin de compenser les effets du stress.

USE Of an PLANT OIL CONCENTREE IN SA FRACTION INSAPONIFIABLE AS a FOOD INGREDIENT, PROCEEDED OF PREPARATION OF THIS OIL, COMPOSITION OR FOOD COMPLEMENT the CONTAINER

La présente invention concerne l'utilisation d'une huile végétale concentrée en insaponifiable en tant qu'ingrédient alimentaire tel que la teneur en fraction insaponifiable de cette huile est de 3 à 50%, de préférence 3 à 15%, et de façon encore plus préférée 5 à 12% m/ m. De préférence, l'huile végétale est choisie dans le groupe formé par les huiles d'avocat stérolique, de tournesol, de lupin, de colza, de maïs, d'olive, de palme, de palmiste, de germe de blé, de sésame, de son de riz, de bourrache, d'onagre, ainsi que les huiles de poisson. Selon l'invention, la présente invention concerne encore un procédé de préparation de l'huile végétale concentrée comprenant au moins une étape de distillation moléculaire de l'huile végétale avant concentration dans les conditions suivantes : - température de 200°C à 280°C, - pression de 10-3 à 10-2 mmHg, ainsi qu'une composition ou un complément alimentaire contenant cette huile concentrée en insaponifiable.

Nutritional supplement for protection against premenstrual symptoms, menopausal problems, osteoporosis, and cancers comprises evening primrose and borage oils

La présente invention se rapporte au domaine de la diététique et plus particulièrement au domaine de la supplémentation alimentaire. Elle concerne une formulation renfermant une source végétale d'huiles apportant l'acide gamma linolénique, du lycopène de tomate. Elle peut être utilisée aussi bien par la femme pré ménopausée que par celle en période de ménopause afin d'éviter les troubles pré menstruels et d'apporter un confort et une prévention. Le complexe vitaminique C, B3 et B6 permet à l'organisme carencé de synthétiser facilement les prostaglandines à partir de l'acide gamma linolénique apporté par ce supplément. Enfin le lycopène de tomate est un actif protecteur contre les syndromes malins. L'addition de vitamine D, permet d'apporter une synergie et une action contre la prolifération des cellules malignes. Cette action est renforcée par la présence de curcuma. Emploi en supplémentation alimentaire sous diverses formes galéniques.

COMPOSITION CONTAINING OF POLYPHENOLS OF GRENADE, THE VITAMIN D AND THE OLIGOELEMENTS.

METHOD FOR REALIZATION OF FOOD PRODUCTS CONTAINING FLOWERS OF PLANTS OF KIND HIBISCUS

APPLICATION Of an EXTRACT TITRATES IN ROSAVIN ASSOCIATES HAS a BIOLOGICAL PRINCIPLE OF the HYDRO TYPEVITAMINE AND SOLUBLE LIPO, TRACE ELEMENTS AND PARAVITAMINES

Preparing syrupy product containing vitamins used to treat hypovitaminosis, comprises inerting apparatus, introducing sugar syrup and vitamins, adding dehydrated and deoxygenated glucose syrup, deoxygenating syrupy product, and packaging

La présente invention porte sur un procédé de préparation d'un produit sirupeux comprenant des vitamines, ledit procédé comprenant les étapes suivantes : a) l'inertage de tous les appareillages mis en œuvre dans le procédé b) l'introduction dans lesdits appareillages, d'un sirop de sucre et l'introduction des vitamines sous atmosphère inerte ; c) l'ajout de glucose déshydraté et désoxygéné sous atmosphère inerte ; d) la désoxygénation du produit sirupeux ainsi formé ; e) le conditionnement sous atmosphère inerte du produit sirupeux.

NUTRITIONAL COMPOSITION FOR PREGNANT WOMAN

La présente invention concerne une composition nutritionnelle pour femme enceinte permettant à la fois de répondre aux besoins nutritifs liés à l'état de grossesse et de soulager le phénomène de nausée. A cet effet, l'invention concerne une composition nutritive comprenant une fraction protéique, une fraction glucidique, une fraction lipidique comprenant au moins un acide gras du groupe des omégas 3, au moins un élément minéral dont le fer, au moins une vitamine dont la vitamine B6, ainsi que la combinaison d'une poudre de gingembre et d'un extrait d'artichaut.

Orally-absorbable nutritional supplement for daily admin. to females

Complément nutritionnel absorbable per-os à base de sels minéraux et de vitamines, pour assurer l'apport quotidien en micronutriments, caractérisé en ce qu'il comprend : - du glycérophosphate de magnésium ; - du carbonate de calcium ; - du citrate de zinc ; - du bétacarotène ; - un mélange de vitamines B1, B2, B5, B6, B8, B9, B12 et PP ; - de la vitamine C ; - de la vitamine E ; - et un excipient.

Antioxidant nutritional supplement, comprises tea flavonoids together with isoflavones, gamma-linolenic acid, carotenoids and/or vitamin E

Un complément alimentaire comprend une présentation orale contenant une quantité antioxydante efficace d'un mélange de flavonoïdes de thé et d'un ou de plusieurs antioxydants choisis parmi les isoflavones, l'acide gamma-linolénique, les caroténoïdes et la vitamine E.

Food supplement which can relieve both menstrual and prostate disorders contains e.g. evening primrose and marrow seed oils and tomato lycopene

La présente invention se rapporte au domaine de la diététique et plus particulièrement au domaine de la supplémentation alimentaire. Elle concerne une formulation renfermant une source végétale d'huiles apportant l'acide gamma linolénique, du lycopène de tomate, de l'huile de graine de courge. Elle peut être utilisée aussi bien par la femme que par l'homme afin d'éviter aux uns les troubles menstruels et d'apporter un confort urinaire dû aux troubles de la prostate aux autres. Enfin le lycopène de tomate est un actif protecteur contre les syndromes malins. Il est bénéfique pour les deux sexes. Emploi en supplémentation alimentaire.

NОUVЕLLЕS СОМРОSIТIОNS А ЕFFЕТ SYNЕRGIQUЕ ЕNТRЕ МIСRОNUТRIМЕNТS ЕТ SUВSТАNСЕS D'ОRIGINЕ VIVАNТЕ

NEW PHARMACEUTICAL COMPOSITIONS IN PARTICULAR FOR CARDIOVASCULAR PREVENTION DESPATHOLOGIES

NEW PHARMACEUTICAL COMPOSITIONS IN PARTICULAR FOR CARDIOVASCULAR PREVENTION DESPATHOLOGIES

NEW PHARMACEUTICAL COMPOSITIONS IN PARTICULAR FOR CARDIOVASCULAR PREVENTION DESPATHOLOGIES

NEW PHARMACEUTICAL COMPOSITIONS IN PARTICULAR FOR CARDIOVASCULAR PREVENTION DESPATHOLOGIES

NEW PHARMACEUTICAL COMPOSITIONS IN PARTICULAR FOR CARDIOVASCULAR PREVENTION DESPATHOLOGIES

Composition comprising the extract of Loranthus yadoriki SIEB. having monoamine oxidase-inhibiting activity

２―Ｏ―（β―Ｄ―GLUCOPYRANOSYL)ASCORBIC ACID, PROCESS FOR ITS PRODUCTION, AND FOODS AND COSMETICS CONTAINING COMPOSITIONS COMPRISING IT

PROCESS FOR PRODUCING COLLAGEN PRODUCTION ENHANCERS AND USE THEREOF

Concerning foods, drinks, cosmetics, drugs, feeds and so on, it is intended to prevent the skin from aging and maintaining and improving health. More specifically speaking, the technical feature resides in preparing a TGF-β production/collagen production enhancer containing as the active ingredients royal jelly and L-ascorbic acid or a TGF-β production enhancer containing as the active ingredient royal jelly alone, orally or percutaneously administering the former to fibroblasts or the latter to keratinocytes, thus enhancing the production of TGF-β in fibroblasts/keratinocytes of the subject animal to thereby enhance the production of collagen in fibroblasts or promote the proliferation of keratinocytes. Thus, the production of collagen, which is a major constituent of derm, tissues and organs, can be enhanced or fibroblasts occurring in derm constituting the skin or keratinocytes occurring in epiderm can be activated. © KIPO & WIPO 2007 ...

LIQUID FORMULATION BASED ON A GUANIDINOACETIC ACID COMPONENT

The present invention relates to a liquid formulation for human and animal nutrition, consisting of an aqueous solution, a guanidinoacetic acid component and at least one methyl group donor from the group of choline, methionine and betaine. In addition to the free guanidinoacetic acid, it is also possible to use salts, adducts and/or complexes as the guanidinoacetic acid component, which can additionally be combined with further physiologically active compounds. Since the guanidinoacetic acid component is present in dissolved form, formulations including those in the form of mineral water, lemonade, alcoholic drinks and drinking water formulations are envisaged. It has been found that, surprisingly, the guanidinoacetic acid component present in this liquid formulation has very good stability and is converted very rapidly to creatine in the body. © KIPO & WIPO 2008 ...

2?O?(ß?D?GLUCOPYRANOSYL)ASCORBIC ACID, PROCESS FOR ITS PRODUCTION, AND FOODS AND COSMETICS CONTAINING COMPOSITIONS COMPRISING IT

The present invention provides a novel ascorbic acid derivative as a provitamin C with improved stability in the body and prolonged life in the body compared to conventionally known 2-O-(α-D-glucopyranosyl) ascorbic acid. The composition comprising the novel compound 2-O-(β- D-glucopyranosyl)ascorbic acid has been extracted from plants such as from Ningxia Lycium barbarum L. and/or Lycium chinense Mill. The compositions comprising 2-O-(β-D-glucopyranosyl)ascorbic acid may be enzymatically synthesized using β-D-glucosyltransferase. Pure 2-O-β-D-glucopyranosyl)ascorbic acid may be produced from such compositions. Alternatively, 2-O-(β-D-glucopyranosyl)ascorbic acid may be produced by chemical synthesis. The 2-O-(β-D-glucopyranosyl) ascorbic acid results in higher stability and a prolonged life of vitamin C when ingested in the body compared to the corresponding α-D- glucopyranosyl derivative, and is therefore highly suitable as a provitamin C to be used in cosmetics and foods. COPYRIGHT KIPO ...

CEREAL-BASED FORTIFIIED FOOD PRODUCTS AND PROCESS FOR THEIR PREPARATION

A process for manufacturing a cereal-based fortified food product comprises the steps of (A) comminuting cereal raw material to obtain a comminuted cereal-based material; (B) hydrothermally-mechanically treating the comminuted cereal-based material until a cereal-based matrix material is obtained by at least partial gelatinization of the comminuted cereal-based material; (C) forming the at least partially gelatinized cereal-based matrix material by pressing and portioning in order to obtain cereal-based food articles; (D) drying the cereal-based food articles to obtain the final product in the form of reconstituted cereal-based food articles. At least one micronutrient is added to the comminuted cereal-based material during steps A) and/or B). Also, at least one further feature is added to the final product during any one of steps A) through D); said at least one further feature corresponding to the at least one micronutrient in the final product; and said at least one further feature being ...

DIETARY SUPPLEMENT

The present invention has as an object a food supplement based on a multicomponent formulation, and its use to improve the functionality of the human body, in particular its use In arterial blood pressure regulation.

LONG-TERM FEED - CANCER PATIENT

Pursuant to the present invention, methods and compositions are provided for providing long-term tube-fed nutrition. More specifically, pursuant to the present invention, methods and compositions are provided for providing long-term tube-fed nutrition to cancer patients.

RECONSTITUTED GRAIN OF RICE AND CORRESPONDING MANUFACTURING PROCESS

The invention relates to a reconstituted grain of rice obtained from a mixture comprising a flour composed of at least one gluten-free cereal, said reconstituted grain of rice being characterized in that it comprises at least one food substance that has a nutritional and/or organoleptic function, in that it has an appearance substantially identical to that of a natural grain of rice and a substantially smooth outer surface. Treatment of grains of rice.

EDIBLE WAFER-TYPE PRODUCT FOR DELIVERY OF NUTRACEUTICALS AND PHARMACEUTICALS

A food product for carrying and delivery nutraceutical or pharmaceutical or both is provided. The food product may be an edible wafer-based outer layer and an inner layer of an edible filling comprising the nutraceutical or pharmaceutical or both.

COMPOSITION HAVING A BENEFICIAL EFFECT ON THE CARDIOVASCULAR SYSTEM, COMPRISING MONACOLIN K, LYCOPENE AND VITAMIN D3

The present invention is in the field of medical treatment and relates to a formulation for oral administration, such as for instance in the form of tablets or of a powder, which is able to exert a beneficial effect on the cardiovascular system. More in particular, the invention provides a composition for oral administration having a beneficial effect on the cardiovascular system, comprising as active ingredients a mixture of monacolin K, lycopene and vitamin D3.

DIETARY SUPPLEMENT COMPOSITIONS WITH ENHANCED DELIVERY MATRIX, AND METHODS OF MAKING THE SAME

A method of making dietary supplement compositions includes generating an aqueous phase, generating an oil phase, performing a first homogenizing step by mixing the aqueous and oil phases, adding reduced glutathione to the aqueous-oil composition and performing a second homogenizing step by mixing the aqueous-oil composition and reduced glutathione, adding a first flavor to the aqueous-oil-glutathione composition, performing a third homogenizing step by mixing the aqueous-oil-glutathione composition and the first flavor, adding xanthan gum dispersed with glycerin to the aqueous-oil-glutathione-first-flavor composition and performing a fourth homogenizing step by mixing the aqueous-oil-glutathione-first-flavor composition and xanthan gum; adding a second flavor to the aqueous-oil-glutathione-firsf-flavor-xanthan composition and performing a fifth homogenizing step by mixing the aqueous-oil-glutathione-first-flavor-xanthan composition and the second flavor so as to form a dietary supplement ...

LONG-CHAIN POLYUNSATURATED FATTY ACIDS (LC-PUFA) IN MATERNAL NUTRITION DURING PREGNANCY AND LACTATION

The present invention relates in general to maternal food compositions. In particular, the present invention relates to maternal food compositions comprising LC-PUFA and their uses. Embodiments of the present invention relate to maternal food compositions comprising a source of lipids, wherein the source of lipids includes at least one LC-PUFA in the form selected from the group consisting of phospholipids (PL), phosphotidylcholine (PC), phosphatidylethanolamine (PE), N-Acylphosphatidylethanolamine (NAPE), phosphatidylinositol (Pl), phosphatidylserine (PS) or their lyso derivatives and their uses in brain development and eye development of neonates.

COMBINATION OF COMPONENTS FOR THE PREVENTION AND TREATMENT OF FRAILTY

Composition comprising at least two components, more preferably at least three com- ponents, more preferably at least four components, selected from the group of (i) a nu- cleoside equivalent, (ii) an ω-3 polyunsaturated fatty acid selected from the group of DHA, DPA and EPA, (iii) a vitamin B, (iv) a phospholipid, (v) an antioxidant and (vi) a choline, with the proviso that at least component (i) or (iii) is present, for use in the prevention or treatment of frailty in a mammal, wherein frailty is determined by com- pliance with at least 2 criterions, preferably 3 criterions, selected from the group of muscle weakness, excessive feelings of exhaustion or fatigue, abnormally low physical activity, slow or unsteady gait, weight loss, and neurological dysfunction.

METHODS AND COMPOSITIONS FOR STIMULATING BENEFICIAL BACTERIA IN THE GASTROINTESTINAL TRACT

The invention relates to supporting the growth or maintenance of oxygen-sensitive bacteria in the gastrointestinal tract of an animal. Provided is the use of riboflavin, riboflavin phosphate or a salt thereof, for the manufacture of a food composition, pharmaceutical composition, food or dietary supplement, for the selective stimulation of Faecalibacterium prausnitzii in the gastrointestinal tract. Also provided is a synbiotic composition comprising living beneficial butyrate- producing anaerobic bacteria formulated with riboflavin, riboflavin phosphate or a salt thereof, and cysteine.

A UBIQUINONE COMPOSITION AND A CONTAINER FOR ITS CONVENIENT TRANSPORT AND STORAGE

The present invention relates to a combination of a hermetically sealed, substantially air-tight container, and a quinone-containing composition disposed therein. The container of the present invention is adapted for the convenient transport, and storage of an effective amount of an active ingredient, for example, ubiquinone, ubiquinol or a mixture thereof, and at least one pharmaceutically acceptable excipient. In another aspect the invention relates to a hermitically sealed container comprising an composition containing a single daily dose of ubiquinone, ubiquinol or both.

WEIGHT REGULATING METHOD BY RESTORING GUSTATORY FUNCTION

The invention concerns a nutritional method for regulating weight by restoring the gustatory function. Said restoration consists in activating the taste receptors. Said activation causes a neurohormone cascade effect which enables to trigger the satiety signal at the time when the organism has ingested what it needs, enabling good assimilation of what it needs and elimination of what is useless. The invention also concerns a kit for implementing said weight regulating method by restoring the gustatory function.

METHOD FOR PRODUCING PELLETIZED FUZZY COTTONSEED

The invention is a method for producing pelletized whole fuzzy cottonseed (10). The method (10) comprises means for selectively delivering a measured amount of linted cottonseed (18) to a screw extruder (20). The screw extruder (20) having a bore and screw that decreases in diameter from one distal end to the other. Thereby, the linted cottonseed is subjected to predetermined increases in pressure and ground to a pasty oatmeal-like consistency before being extruded at the output end to a delivery system (22) feeding the pellet forming mechanism (24) having as its output pelletized linted cottonseed.

PREPARATION OF MICROBIAL POLYUNSATURATED FATTY ACID CONTAINING OIL FROM PASTEURISED BIOMASS

The present invention discloses a microbial polyunsaturated fatty acid(PUFA)-containing oil with a high triglyceride content and a high oxidative stability. In addition, a method is described for the recovery of such oil from a microbial biomass derived from a pasteurised fermentation broth, wherein the microbial biomass is subjected to extrusion to form granular particles, dried and the oil then extracted from the dried granules using an appropriate solvent.

PROCESS FOR THE PREPARATION OF A GRANULAR MICROBIAL BIOMASS AND ISOLATION OF VALUABLE COMPOUNDS THEREFROM

A process for the isolation of desired compound(s) from a microbial biomass is diclosed, wherein the microbial biomass (which, if necessary, is pretreated to give a dry matter content of from 25 to 80 %) is granulated (e.g. by extrusion) and then dried to a dry matter content of at least 80 %. The granulation of the biomass to granules significantly eases subsequent drying of the biomass (which can be stored as dried granules) and gives higher yields on extraction of the compound(s).

BEVERAGES FOR TREATMENT OF GLUCOSE METABOLISM DISORDERS

Compositions and methods of using the same for the treatment of diabetes and other disorders of glucose metabolism are provided. Compositions may include one or more of a bioavailable source of chromium and vanadium, and may be in the form of liquid beverages, or powders or concentrates for preparing such beverages.

USE OF A COMBINATION OF VITAMINS B AND PHYTOSTEROLS FOR LOWERING BLOOD PRESSURE

Use of a combination of at least one B vitamin and at least one phytosterol or analogue or derivative thereof, for lowering blood pressure in a mammal.

METHODS OF TREATING OR AMELIORATING DISEASES AND ENHANCING PERFORMANCE COMPRISING THE USE OF A MAGNETIC DIPOLE STABILIZED SOLUTION

The present invention is directed to methods for treating or ameliorating skin conditions, diabetic conditions, cardiovascular conditions, cancer, infections or metal poisoning, enhancing performance, or providing nutritional support, comprising administering to a subject in need thereof compositions comprising a magnetic dipole stabilized solution (MDSS). The MDSS solution may include additional components and can be provided in a kit.

FLAVONOL CONTAINING FOOD SUPPLEMENTS

Disclosed is a plant-derived flavonol-containing dry composition suitable for human consumption, wherein at least 25 % of the plant-derived material in the composition comprises polyphenols, together with uses thereof.

ANTIOXIDANT, CYTOSTATIC AND SUSTAINED ENERGY COMPOSITION WHICH AMELIORATES THE METABOLIC UTILIZATION OF GLUCOSE COMPRISING ACETYL-L-CARNITINE AND A CATECHIN

L'invention concerne une composition, destinée à la prévention et/ou au traitement thérapeutique de diverses altérations et pathologies induites par des radicaux libres, pouvant prendre la forme d'un complément alimentaire, d'un support diététique ou d'un médicament véritable, et comprenant en tant que principes actifs caractéristiques de l'acétyl-L-carnitine et au moins l'une des catéchines que l'on peut extraire du thé vert (par exemple le gallate d'épigallocatéchine).

COMPOSITIONS FOR MASKING THE FLAVOR OF NUTRIENTS AND METHODS FOR MAKING SAME

Nutritional compositions and methods of making and using the nutritional compositions are provided. In a general embodiment, the present disclosure provides nutritional compositions having whey protein micelles and leucine. The nutritional compositions provide a sufficient amount of leucine to improve protein synthesis in humans, while also maintaining a low-viscosity fluid matrix and acceptable organoleptic properties. 1. A nutritional composition comprising: whey protein powder comprising whey protein micelles and leucine , wherein the total amount of leucine in the composition is between about 20% and about 40% by weight dry matter.2. The composition according to claim 1 , wherein the whey protein powder comprises at least about 20% to at least about 80% whey protein micelles.3. The composition according to claim 1 , wherein the whey protein powder comprises at least about 50% whey protein micelles.4. The composition according to claim 1 , wherein the whey protein powder has a water binding capacity of at least about 50% to about 100%.5. The composition according to claim 1 , wherein the whey protein micelles and leucine are present in a weight ratio of about 30:1 to about 1:100.6. The composition according to claim 1 , wherein the dry weight ratio of added leucine to whey protein micelles is from about 1:2 to about 1:3.7. The composition according to claim 1 , wherein the whey protein powder is obtained by a process selected from the group consisting of spray-drying and freeze-drying claim 1 , that is performed with the whey protein micelles and leucine.8. The composition according to comprising at least one ingredient selected from the group consisting of antioxidants claim 1 , vitamins claim 1 , minerals claim 1 , phytonutrients claim 1 , prebiotics claim 1 , and probiotics.9. The composition according to claim 1 , wherein the composition is a liquid and the total amount of leucine in the composition is less than about 2.5 g per 100 g of the liquid claim 1 , ...

Reconstituted nut and/or carob ingredient

The present invention describes a reconstituted food ingredient comprising a nut, a carob, a derivative thereof or their mixtures having a low fat content, or a low sugar content, or low fat and sugar content, characterized in that it is enriched with phenolic compounds, and/or sterols and tocopherols originating from nut or carob. The invention also describes a method for preparing said reconstituted food ingredient, as well as its use in the treatment and/or prevention of cardiovascular diseases, vascular diseases, neuronal diseases, neurodegenerative diseases, cancer, inflammatory processes, metabolic syndrome diseases, etc., by means of using this ingredient in the diet. The use of said ingredient in preparing a food composition and various food compositions for human or animal consumption is also described.

NOVEL STABLE BEADLETS OF LIPOPHILIC NUTRIENTS

The invention disclosed in this application relates to novel stable beadlets of lipophilic nutrients comprising an inert core having a coating of stabilizing antioxidants, lipophilic nutrients, or mixtures thereof. The beadlets may be coated with one or more coatings to protect the lipophilic ingredients from the atmosphere, specifically the coatings can be used to protect against moisture and/or oxygen. The invention also relates to a process for the preparation of the stable beadlets. The beadlets can be used in medicines and dietary supplements intended to facilitate the reduced risk of macular degeneration, cataract, and several forms of cancer. 147-. (canceled)48. A tablet product , comprising:a tablet matrix;beadlets within the tablet matrix, the beadlets being intact within the tablet matrix,the beadlets comprise an inert generally spherical core and a coating comprising a stabilizing antioxidant and a lipophilic nutrient, andthe beadlets having an angle of repose between about 22 degrees to about 27 degrees.49. The tablet product of claim 48 , wherein the lipophilic nutrient comprises one or more carotenoids.50. The tablet product of claim 49 , wherein the one or more carotenoids is selected from at least one from the group consisting of lutein claim 49 , lutein esters claim 49 , alpha-carotene claim 49 , beta-carotene claim 49 , zeaxanthin claim 49 , zeaxanthin esters claim 49 , astaxanthin claim 49 , lycopene claim 49 , and mixtures thereof.51. The tablet product of claim 48 , wherein the coating comprises a binding agent claim 48 , the coating being applied on the inert generally spherical core as a colloidal suspension that is formed by a solution of the stabilizing antioxidant and the lipophilic nutrient that is first dispersed in a non-polar solvent claim 48 , and then with addition of a polar solvent claim 48 , and the colloidal suspension is mixed with the binding agent claim 48 , the coating being applied by a bottom-spray fluidizing-bed system.52. ...

Food Supplement

The invention discloses a food supplement, which includes at least the following components: omega-3 fatty acids; natural carotenoids; natural tocopherol; and tocotrienol. The carotenoids include carotenes. The carotenoids and tocotroniel are obtained from a Carotino mixed concentrate. The Carotino mixed concentrate is a natural tocotrienol (Vitamin E) and carotene oil complex derived from palm fruits. 1. A food supplement , which includes at least the following components:(a) omega-3 fatty acids;(b) natural carotenoids;(c) natural tocopherol; and(d) tocotrienol.2. A food supplement as claimed in claim 1 , which includes no synthetic ingredients.3. A food supplement as claimed in claim 1 , in which the components are of natural origin and of high purity.4. A food supplement as claimed in ; in which the carotenoids include carotenes.5. A food supplement as claimed in claim 1 , in which the carotenoids and tocotroniel are obtained from a Carotino mixed concentrate.6. A food supplement as claimed in claim 5 , in which the Carotino mixed concentrate is a natural tocotrienol (Vitamin E) and carotene oil complex derived from palm fruits.7. A food supplement as claimed in claim 5 , in which the Carotino mixed concentrate includes tocotrienols consisting of alpha- claim 5 , beta- claim 5 , gamma- and delta-tocotrienols.8. A food supplement as claimed in claim 5 , in which the Carotino mixed concentrate includes a spectrum of carotenes claim 5 , but consists predominantly of alpha- and beta-carotenes.9. A food supplement as claimed in claim 5 , in which the Carotino mixed concentrate includes the following percentages:(a) at least 2.7% carotenoid composition;(b) at least 9.3% tocopherol and tocotrienol; and(c) at least 53% palm oil.14. A food supplement as claimed in claim 5 , in which the Carotino mixed concentrate includes substantially the following micro-biological purity: Total plate count claim 5 , yeast and mold less than 10 cfu/g.15. A food supplement as claimed in ...

ARRAY OF COMPLEMENTARY INFANT/YOUNG CHILD NUTRITIONAL COMPOSITIONS

The present invention relates to infant/young child nutrition. A set of nutritional compositions having beneficial effects to infants/young children is disclosed. The set of nutritional compositions comprises at least two compositions with varying amounts of components which impart a beneficial effect to the infants young/children. A nutrition kit for infants/young children comprising the set of nutritional compositions is also disclosed as well as a method for manufacturing the set of nutritional components. A dosage regimen is also disclosed. 1. A set of nutritional compositions comprising at least two compositions , wherein a composition of each one of the compositions is selected to complement the other composition to provide an intended beneficial effect.2. The set of nutritional compositions according to claim 1 , wherein the two compositions differ from each other in a nature and/or an amount of at least one component.3. The set of nutritional compositions according to claim 2 , wherein the at least one component is selected from the group consisting of vitamins claim 2 , minerals claim 2 , trace elements claim 2 , nucleosides claim 2 , nucleotides claim 2 , prebiotics claim 2 , probiotics claim 2 , lactoferrin claim 2 , fatty acids claim 2 , fat claim 2 , carbohydrate claim 2 , protein claim 2 , growth factors claim 2 , immunoglobulins claim 2 , MFGM components claim 2 , and oligosaccharides.4Lactobacillus rhamnosus, Lactobacillus rhamnosusLactobacillus paracasei, Lactobacillus reuteri, Lactobacillus reuteri, Bifidobacterium lactis, Bifidobacterium longum, Lactobacillus helveticus, Bifidobacterium longum, Bifidobacterium breve, Lacococcus lactis, Lactobacillus paracasei, Streptococcus salivariusStreptococcus thermophilus, Lactobacillus johnsoniiLactobacillus fermentumLactobacillus acidophilus. The set of nutritional compositions according to claim 3 , wherein the probiotics are selected from the group consisting of ATCC 53103CGMCC 1.3724 claim 3 , CNCM 1- ...

Composition Comprising OPC and Omega-3 for Preventing and/or Inhibiting the Development of Diabetic Retinopathy

This invention relates to a composition comprising oligoproanthocyanidins (OPC) and omega-3 fatty acids, for use in preventing or stabilizing the development and/or the progression of a diabetes-related eye condition in a subject; this invention includes a functional food, a nutraceutical composition or a food or dietary supplement comprising said composition; this invention also relates to a pharmaceutical composition or a veterinarian product comprising oligoproanthocyanidins (OPC) and omega-3 fatty acids. 119.-. (canceled)21. The method of claim 20 , wherein the OPC and omega-3 fatty acid are comprised in a composition prior to administration.22. The method of claim 20 , further comprising administering at least one vitamin or inorganic compound to the subject.23. The method of claim 22 , further comprising administering at least one B vitamin to the subject.24. The method of claim 22 , further comprising administering at least one mineral to the subject.25. The method of claim 20 , further comprising administering at least one of vitamin B1 claim 20 , vitamin B6 claim 20 , chromium claim 20 , or magnesium to the subject.26. The method of claim 25 , wherein vitamin B1 is administered as at least one of thiamin or benfotiamin.27. The method of claim 25 , wherein vitamin B6 is administered as at least one of pyridoxamine claim 25 , pyridoxal claim 25 , or pyridoxine.28. The method of claim 25 , wherein chromium is administered as at least one of chromium picolinate claim 25 , chromium chloride claim 25 , chromium GTF® claim 25 , or chromium polynicotinate.29. The method of claim 25 , wherein magnesium is administered as at least one of magnesium gluconate claim 25 , magnesium citrate claim 25 , magnesium chloride claim 25 , magnesium malate claim 25 , magnesium orotate claim 25 , or magnesium from the sea.30. The method of claim 25 , further comprising administering OPC claim 25 , omega-3 fatty acids claim 25 , vitamin B1 claim 25 , vitamin B6 claim 25 , chromium ...

NUTRITIONAL FOOD PRODUCT AND METHOD OF PRODUCING A NUTRITIONAL FOOD PRODUCT

A procedure for making a food product includes preparing a first mixture of dry ingredients including vitamins, proteins and additives; preparing a second mixture of liquid ingredients including water and a monosaccharide; preparing a third mixture in which a fat component is melted and is mixed with an emulsifier and a flavoring agent; preparing a fourth coating mixture that is solid at room temperature and includes fat components, vitamins, emulsifiers, and preservatives. The fourth coating mixture is melted to make a coating bath and the first, second and third mixtures are mixed to obtain a dough. The fourth coating mixture is poured over the mixture of the first, second and third mixtures. 1. A method of producing a food product having a core with an outer coating , the method comprising:producing a first mixture of dry ingredients comprising a source of proteins, a source of hydrocarbons, a nutritional supplement and additives, wherein the first mixture of drying ingredients includes at least one ingredient that is able to reduce water activity;producing a second mixture of liquid ingredients that has a single phase, the second mixture of liquid ingredients comprising water and a monosaccharide;producing a third mixture by melting at a predetermined temperature a source of fat matter and mixing with at least an emulsifier/stabilizer and a flavoring agent;producing a fourth coating mixture which is solid at room temperature and which comprises components including a source of fat matter, a source of proteins, a source of hydrocarbons, a nutritional supplement, vitamins, an emulsifier/stabilizer and a preservative, wherein at least one of the components is able to reduce water activity;subjecting the fourth mixture to heat so as to melt the fourth mixture to produce a coating bath;mixing the first mixture of solid ingredients, the second mixture of liquid ingredients, the third mixture, and a substitute of fats and sugars which reduces water activity and gives ...

DIETARY SUPPLEMENT CONTAINING ALKALINE ELECTROLYTE BUFFERS

An improved dietary and/or therapeutic supplement composition comprising a quantity of a dietary and/or therapeutic supplement agent having a pH that upon ingestion with food or a beverage would limit the effectiveness of the agent and a sufficient amount of an alkaline electrolyte additive is provided in combination with the agent to raise the pH of the composition to a level of from about 8 to about 12.5 to increase the effectiveness and functional utilization of the agent while the composition is in the person's stomach. 1. A method of improving uptake of a dry dietary supplement comprising:a) providing the supplement;b) providing an alkaline electrolyte agent comprising electrolytes selected from the group consisting of magnesium, calcium, potassium, sodium electrolytes and mixes thereof;c) mixing the supplement and agent to from a mixture, wherein the agent is provided in sufficient amount such that the pH of the resulting mixture is in the range from 8.5 to 12.5, andd) feeding the mixture to a person.2. The method according to wherein the supplement is selected from the group consisting of Vitamins A claim 1 , B1 claim 1 , B2 claim 1 , B3 claim 1 , B5 claim 1 , B6 claim 1 , B12 claim 1 , D3 claim 1 , E claim 1 , folic acid claim 1 , biotin claim 1 , inositol claim 1 , phosphate claim 1 , zinc claim 1 , manganese claim 1 , copper claim 1 , selenium claim 1 , amino acids claim 1 , glucosamine claim 1 , choline claim 1 , chondroitin claim 1 , bioflavonoids claim 1 , MSM claim 1 , kelp claim 1 , ginseng claim 1 , gingko biloba extract claim 1 , fruit blends claim 1 , rose hips claim 1 , acerola and mixes thereof.3. The method according to wherein the supplement is selected from the group consisting of hawthorne berry extract claim 1 , astaxanthin extract claim 1 , coenzyme Q-10 claim 1 , borage extract claim 1 , DHA/EPA and mixes thereof.4. A dry mixture adapted for consumption by a person and having a pH in the range of 8.5 to 12.5 after consumption wherein the ...

NUTRITIONAL COMPOSITION

A nutritional composition is provided which has an effective prophylactic and/or improving effect for various symptoms of muscle mass decrease, decreased basal metabolism, low body temperature, suppression of obesity, suppression of visceral fat accumulation, hyperglycemia, hyperlipidemia and the like in elderly people. The nutritional composition can include n-3 fatty acid and one or more of free lysine, dipeptides containing lysine, and lysine salts, wherein the content of free lysine, dipeptides containing lysine, and/or lysine salts is 0.1 g-10.0 g per 100 kcal of the composition, and the content of the total amount of n-3 fatty acid is 0.17 g-5.00 g per 100 kcal of the composition. 1. A nutritional composition comprising:i) n-3 fatty acid, andii) an ingredient selected from the group consisting of free lysine, dipeptides containing lysine and lysine salts, and combinations thereof;wherein the ingredient is present in the composition in an amount of 0.1 g-10.0 g per 100 kcal of the composition, andwherein the n-3 fatty acid is present in the composition in an amount of 0.17 g-5.00 g per 100 kcal of the composition.2. The nutritional composition according to claim 1 , further comprising a branched chain amino acid selected from the group consisting of valine claim 1 , leucine claim 1 , isoleucine claim 1 , and combinations thereof.3. The nutritional composition according to claim 2 , wherein the branched chain amino acid is present in the composition in an amount of 1.0 g-20 g per 100 kcal of the composition.4. The nutritional composition according to claim 2 , wherein the branched chain amino acid in a free form is present in the composition in an amount of 0.1 g-15 g per 100 kcal of the composition.5. The nutritional composition according to claim 1 , wherein the n-3 fatty acid is selected from the group consisting of eicosapentaenoic acid claim 1 , docosapentaenoic acid claim 1 , docosahexaenoic acid claim 1 , and combinations thereof.6. The nutritional ...

POWDEROUS VITAMIN E FORMULATIONS

The present invention relates to improved vitamin E formulations, as well as to the production of such formulations. 1. A powderous formulation comprising(i) at least 50 wt-%, based on the total weight of the powderous formulation, of vitamin E and/or vitamin E derivates, and(ii) 0.5 wt-%-8 wt-%, based on the total weight of the powderous formulation, of at least one auxiliary compound selected from the group consisting of aluminium ammonium sulphate, aluminium potassium sulfate, ammonium acetate, ammonium bisulphite, ammonium carbonate, ammonium chloride, ammonium dihydrogen phosphate, ammonium hydrogen carbonate, bentonite, montmorillonite, calcium aluminates, calcium carbonate, calcium silicate, synthetic calcium sulphate di-hydrate, calcium sulfate, kaolinitic clays (such as Kaolin), diatoma-ceous earth, perlite, potassium bisulphite, potassium hydrogen carbonate, potassium sulphate, potassium carbonate, sepiolitic clays, silicic acid, synthetic sodium aluminosilicate, sodium aluminosulfate, sodium bisulphate, sodium carbonate, sodium chloride, sodium hydrogen carbonate, sodium sulphate, vermiculite, calcium carbonate, magnesium carbonate, calcareous marine algae, magnesium oxide, magnesium sulphate, dicalcium phosphate, tri-calcium phosphate, mono-dicalcium phosphate, defluorinated rock-phosphate, monocalcium phosphate, calcium-magnesium phosphate, mono-ammonium phosphate, magnesium phosphate, sodium-calcium-magnesium phosphate, mono-sodium phosphate, glycerol, propylene glycol (E 1520), glyceryl triacetate (E1518), sorbitol (E420), polydextrose, lactic acid and urea, and(iii) at least 40 wt-%, based on the total weight of the powderous formulation, of a carrier material.2. A powderous formulation according to further comprising(iv) 0 to 5 wt-%, based on the total weight of the powderous formulation, of water.3. A powderous formulation according to claim 1 , wherein the carrier material is chosen from the group consisting of synthetically produced precipitated ...

FOOD COMPOSITION CONTAINING AMINO ACIDS AND COCOA

A food composition described herein contains a protein hydrolysate from a legume and cocoa. The food composition may be in a solid or powder composition, and it may also contain creatine, especially creatine monohydrate. The food composition may also contain at least one B vitamin and/or a zinc compound. 1. Food composition containing:a) a protein hydrolysate from a legume selected from peas, beans and lentils; andb) cocoa.2. Food composition according to claim 1 , which also contains creatine.3. Food composition according to or claim 1 , which also contains at least one B vitamin and/or a zinc compound.4. Food composition according to any one of the preceding claims claim 1 , wherein the protein hydrolysate from a legume is a pea protein hydrolysate.5. Food composition containing:a) hydrolysed pea protein; andb) cocoa.6. Food composition according to claim 5 , which also contains creatine.7. Food composition according to or claim 5 , which also contains at least one B vitamin and/or a zinc compound.8. Food composition claim 5 , especially a drink powder claim 5 , containing:a) 40-80% by weight hydrolysed pea protein;b) 20-50% by weight cocoa. The present invention relates to a food composition that contains a protein hydrolysate from a legume and cocoa.Preferably, the food composition according to the invention, especially when it is a solid or powder-form food composition, also contains creatine, especially creatine monohydrate, more especially Creapure©.More preferably, the food composition according to the invention contains at least one B vitamin and/or a zinc compound.More preferably, the food composition according to the invention contains all 20 standard amino acids in the form of the free amino acid and/or in the form of peptides.In the context of the present invention, the term legume relates to beans, lentils and peas, with preference being given to peas. In the context of the present invention, the term legume does not relate to soya or soybeans, that is ...

FOOD COMPOSITION

A food composition comprising astaxanthin (A), a powder (B) of a sucrose fatty acid ester that is powdery at 25° C. and has an HLB value of 10 or more, and an oil (C) that is a liquid at 25° C., wherein the powder (B) is dispersed in a dispersion medium comprising the oil (C). 1. A food composition comprising astaxanthin (A) , a powder (B) of a sucrose fatty acid ester that is powdery at 25° C. and has an HLB value of 10 or more , and an oil (C) that is a liquid at 25° C. ,wherein the powder (B) is dispersed in a dispersion medium comprising the oil (C).2. The food composition according to claim 1 , further comprising a polyoxyethylene sorbitan fatty ester (D) having an HLB value of 10 or more.3. The food composition according to claim 2 , wherein the polyoxyethylene sorbitan fatty ester (D) is polyoxyethylene sorbitan monolaurate.4. The food composition according to claim 1 , wherein the powder (B) is a powder of sucrose laurate.5. The food composition according to claim 2 , wherein the powder (B) is a powder of sucrose laurate.6. The food composition according to claim 3 , wherein the powder (B) is a powder of sucrose laurate.7. The food composition according to claim 1 , further comprising crocetin.8. The food composition according to claim 2 , further comprising crocetin.9. The food composition according to claim 3 , further comprising crocetin.10. The food composition according to claim 4 , further comprising crocetin.11. The food composition according to claim 1 , wherein a dosage form of the food composition is a soft capsule. This application is based on and claims priority under 35 USC 119 from Japanese Patent Application No. 2015-131090, filed on Jun. 30, 2015. The entire disclosure of the above application is incorporated herein by reference.Technical FieldThe present invention relates to a food composition.Related ArtAstaxanthin has attracted attention as a component having ‘anti-oxidant action’ for eliminating active oxygen. Astaxanthin is known to have ...

PARTICLES COMPRISING A RELEASABLE DOPANT THEREIN

A process for making particles comprising a hydrophobic dopant for subsequent release therefrom is disclosed. The process comprises providing an emulsion comprising a hydrophilic phase and a hydrophobic phase dispersed in the hydrophilic phase, and reacting the precursor material to form the particles comprising the dopant therein. The hydrophobic phase comprises a precursor material and the dopant. 125.-. (canceled)26. A process for making particles comprising a hydrophobic dopant therein said dopant being releasable from the particles , the process comprising:forming an emulsion comprising a hydrophilic phase and a hydrophobic phase dispersed in the hydrophilic phase, said hydrophobic phase comprising a precursor material and the dopant;adding an aminofunctional silane catalyst to the emulsion, whereby the catalyst penetrates into the hydrophobic phase; andreacting the precursor material in the presence of the catalyst to form the particles comprising the dopant therein,wherein (i) each of the particles is a porous solid particle and (ii) the dopant is distributed substantially homogeneously within and is releasable by diffusion from each particle.27. The process of claim 26 , wherein said hydrophobic phase additionally comprises a solvent.28. The process of claim 26 , wherein said precursor material is selected from the group consisting of hydrolysable organosilica precursors claim 26 , organotitania precursors claim 26 , organoalumina precursors claim 26 , organozirconia precursors claim 26 , and a mixture of any two or more thereof.29. The process of claim 26 , wherein the precursor material comprises an organosilane.30. The process of claim 29 , wherein the organosilane is an organotrialkoxysilane.31. The process of claim 30 , wherein the organotrialkoxysilane is selected from the group consisting of ethyltrimethoxysilane claim 30 , vinyltrimethoxysilane claim 30 , phenyltrimethoxysilane claim 30 , isopropyltrimethoxysilane claim 30 , benzyltrimethoxysilane ...

DIETARY SUPPLEMENTS CONTAINING CAFFEINE AND NIACIN

Dietary supplements that can provide energy to a user are described herein. The dietary supplements can contain a delivery matrix suitable for being added to a foodstuff, caffeine and niacin. The dietary supplements can be odorless and flavorless. The caffeine can be provided by green coffee bean extract. Other components, including green tea extract, can also be present. 1. A dietary supplement comprising:a delivery matrix suitable for being added to a foodstuff;niacin; and 'wherein the dietary supplement is odorless and flavorless.', 'caffeine;'}2. The dietary supplement of claim 1 , wherein the dietary supplement is substantially calorie-free.3. The dietary supplement of claim 1 , wherein the delivery matrix comprises a liquid matrix.4. The dietary supplement of claim 3 , wherein the liquid matrix comprises water.5. The dietary supplement of claim 1 , further comprising:pyroxidine hydrochloride, cyanocobalamin, pantothenic acid, any derivative thereof, or any combination thereof.6. The dietary supplement of claim 1 , further comprising:{'i': 'Hoodia gordonii', 'extract, green tea extract, green coffee bean extract, a bioavailable chromium source, one or more B vitamins, or any combination thereof.'}7. The dietary supplement of claim 1 , further comprising:green coffee bean extract, at least a portion of the caffeine being provided by the green coffee bean extract.8. The dietary supplement of claim 7 , further comprising:green tea extract.9. The dietary supplement of claim 8 , wherein an amount of green tea extract in the dietary supplement ranges between about 0.01% to about 0.03% (w/v) of the dietary supplement.10. The dietary supplement of claim 9 , wherein an amount of niacin in the dietary supplement ranges between about 0.08% to about 0.3% (w/v) of the dietary supplement claim 9 , and an amount of caffeine in the dietary supplement ranges between about 0.6% to about 3.4% (w/v) of the dietary supplement.11. The dietary supplement of claim 1 , wherein an ...

NUTRITIONAL COMPOSITIONS AND METHODS FOR PROMOTING COGNITIVE DEVELOPMENT

A method for enhancing cognitive development in a pediatric subject involving administering to the subject a nutritional composition which includes up to 7 g/100 Kcal of a fat or lipid; up to 5 g/100 Kcal of a protein or protein equivalent source; 0.06 g/100 Kcal to 1.5 g/100 Kcal of an enriched milk product; 5 mg/100 Kcal to 90 mg/100 Kcal of a source of long chain polyunsaturated fatty acid; and 0.015 g/100 Kcal to 1.5 g/100 Kcal of a prebiotic. 1. A method for enhancing cognitive development in a pediatric subject , the method comprising administering to the subject a nutritional composition comprising: up to 7 g/100 Kcal of a fat or lipid; up to 5 g/100 Kcal of a protein or protein equivalent source; 0.06 g/100 Kcal to 1.5 g/100 Kcal of enriched milk product; 5 mg/100 Kcal to 90 mg/100 Kcal of a source of long chain polyunsaturated fatty acid; and 0.015 g/100 Kcal to 1.5 g/100 Kcal of a prebiotic , wherein the enriched milk product is present at a level such that the nutritional composition comprises 6 mg/100 Kcal to 300 mg/100 Kcal of phospholipids , 1 mg/100 Kcal to 30 mg/100 Kcal of sphingomyelin , and 0.25 mg/100 Kcal to 6 mg/100 Kcal of gangliosides.2. The method of claim 1 , wherein the enriched milk product is present at a level of 0.3 g/100 Kcal to 1.4 g/100 Kcal.3. (canceled)4. The method of claim 3 , wherein the enriched milk product comprises an enriched whey protein concentrate.5. The method of claim 1 , wherein the nutritional composition further comprises lactoferrin at a level of 5 mg/100 Kcal to 300 mg/100 Kcal.6. The method of claim 5 , wherein the lactoferrin is lactoferrin from a non-human source.7. The method of claim 5 , wherein the lactoferrin has at least 48% homology with human lactoferrin.8. The method of claim 1 , wherein the source of long chain polyunsaturated fatty acids includes at least one of docosahexaenoic acid claim 1 , arachidonic acid claim 1 , and combinations thereof.9. The method of claim 8 , wherein the source of long ...

NUTRITIONAL COMPOSITIONS AND METHODS FOR PROMOTING COGNITIVE DEVELOPMENT

A method for enhancing cognitive development in a pediatric subject involving administering to the subject a nutritional composition which includes up to 7 g/100 Kcal of a fat or lipid; up to 5 g/100 Kcal of a protein or protein equivalent source; 0.25 g/100 Kcal to 16 g/100 Kcal of buttermilk; 5 mg/100 Kcal to 90 mg/100 Kcal of a source of long chain polyunsaturated fatty acid; and 0.015 g/100 Kcal to 1.5 g/100 Kcal of a prebiotic. 1. A method for enhancing cognitive development in a pediatric subject , the method comprising administering to the subject a nutritional composition comprising:up to 7 g/100 Kcal of a fat or lipid;up to 5 g/100 Kcal of a protein or protein equivalent source;0.25 g/100 Kcal to 16 g/100 Kcal of buttermilk;5 mg/100 Kcal to 90 mg/100 Kcal of a source of long chain polyunsaturated fatty acid; and0.015 g/100 Kcal to 1.5 g/100 Kcal of a prebiotic.2. The method of claim 1 , wherein the buttermilk is present at a level of 0.6 g/100 Kcal to 15 g/100 Kcal.3. The method of claim 2 , wherein the buttermilk is present at a level such that the nutritional composition comprises 6 mg/100 Kcal to 300 mg/100 Kcal of phospholipids claim 2 , 1 mg/100 Kcal to 60 mg/100 Kcal of sphingomyelin claim 2 , and 0.25 mg/100 Kcal to 7.5 mg/100 Kcal of gangliosides.4. The method of claim 1 , wherein the nutritional composition further comprises lactoferrin at a level of 5 mg/100 Kcal to 300 mg/100 Kcal.5. The method of claim 5 , wherein the lactoferrin is lactoferrin from a non-human source.6. The method of claim 5 , wherein the lactoferrin has at least 48% homology with human lactoferrin.7. The method of claim 1 , wherein the source of long chain polyunsaturated fatty acids includes at least one of docosahexaenoic acid claim 1 , arachidonic acid claim 1 , and combinations thereof.8. The method of claim 7 , wherein the source of long chain polyunsaturated fatty acids is present from about 5 mg/100 Kcal to about 75 mg/100 Kcal.9. The method of claim 8 , wherein the ...

A COMPOSITION FOR ENHANCING NEWBORN INFANT COGNITIVE, BRAIN AND/OR CNS DEVELOPMENT AND METHOD OF USING SAME

Disclosed are nutritional compositions generally, and infant formulas specifically, that include a combination of RRR-alpha tocopherol, fat, and protein. The amount of non-RRR alpha tocopherol stereoisomers in the nutritional compositions is limited Also disclosed are methods of using the compositions to improve cognitive, brain and/or central nervous system development in an individual. 1. A nutritional composition comprising:i) from about 20 to about 50 g/L fat;ii) from about 10 to about 15 g/L protein;iii) from about 5 mg/L to about 100 mg/L RRR-alpha tocopherol;iv) less than about 8 mg/L of non-RRR alpha tocopherol isomers;v) from about 60 mg/L to about 180 mg/L of DHA;vi) from about 120 mg/L to about 360 mg/L of ARA; andvii) at least about 130 mg/L of ascorbic acid;wherein the DHA to RRR-alpha tocopherol ratio is from about 7.5:1 to about 20:1 and the ARA to RRR-alpha tocopherol ratio is from about 15:1 to about 40:1.2. The nutritional composition of claim 1 , wherein the nutritional composition is substantially free of the non-RRR alpha tocopherol isomers.3. The nutritional composition of claim 1 , wherein the nutritional composition comprises less than about 0.5 mg/L of the non-RRR alpha tocopherol isomers.4. The nutritional composition of claim 1 , wherein the nutritional composition comprises less than about 5 mg/L of the non-RRR alpha tocopherol isomers.5. The nutritional composition of claim 1 , wherein the nutritional composition further comprises a carotenoid.6. The nutritional composition of claim 5 , wherein the carotenoid comprises all trans-lutein.7. The nutritional composition of claim 1 , wherein the nutritional composition is a liquid nutritional product.8. The nutritional composition of claim 1 , wherein the nutritional composition is a powdered nutritional product.9. The nutritional composition of claim 1 , wherein the nutritional composition is an infant formula.10. A method for enhancing central nervous system development in an individual ...

FORMULATIONS FOR PREVENTING AND TREATING DECREASING PLATELET CELL COUNTS

The invention provides formulations to prevent or treat decreasing platelet cell counts. The formulations essentially consist of peanut skins, papaya leaves, folic acid, vitamin B12, vitamin C, vitamin D, vitamin E, selenium, and iron. In some formulations, some vitamins are replaced by fruit or vegetable juice. 1. A formulation , which exerts to prevent or treat decreasing platelet cell counts , is comprising herbs and vitamins.2. The formulation of claiml , wherein said herbs are in the form of herbs or herb extracts.3. The formulation according to claiml , wherein said herbs comprise one or more herbs selected from the group essentially consisting of peanut skins , papaya leaves , Millettla , Polygonum cuspidatum , Agrimony , Eclipta , and Licorice.4. Each herb of claim 3 , wherein the dose for one day is 0.01-120 grams.5. The formulation according to claiml claim 3 , wherein said vitamins comprise one or more vitamins selected from a group essentially consisting of folic acid claim 3 , vitamin B12 claim 3 , vitamin C claim 3 , vitamin D claim 3 , and vitamin E.6. Vitamins of claim 5 , wherein the dosage ranges are as the following: folic acid 65-1000 micrograms/day; vitamin B12 0.4 micrograms-1 milligrams/day; vitamin C 40 mg-2000 mg/day; vitamin D 400 IU-4000IU/day; vitamin E 4 mg-1000 mg/day.7. A formulation claim 5 , which exerts to prevent and treat decreasing platelet cell counts claim 5 , is comprising herbs claim 5 , vitamins and minerals.8. The formulation of claim 7 , wherein said herbs are in the form of herbs or herb extracts.9. The formula according to claim 7 , wherein said herbs comprise one or more herbs selected from the group essentially consisting of peanut skins claim 7 , papaya leaves claim 7 , Millettla claim 7 , Polygonum cuspidatum claim 7 , Agrimony claim 7 , Eclipta claim 7 , and Licorice.10. Each herb of claim 9 , wherein the doses for one day are 0.01-120 grams.11. The formulation according to claiml claim 9 , wherein said vitamins ...

METHODS AND PRODUCTS TO PROVIDE ORAL NUTRITIONAL CARE TO SUBJECTS WITH DEMENTIA

The present invention provides food products, nutritional programs, and methods for meeting nutritional needs of subjects with dementia and related cognitive disorders. In one embodiment, the invention provides a food product comprising a reversibly sealed container and a soup, wherein the soup is in the container and comprises a total volume of 200-2000 mls, a vegetable or meat component, 300 to 2500 calories, a macronutrient caloric distribution comprising: 20-80% fat, 10-45% protein, and 10-65% carbohydrate, about 2% to about 40% medium chain triglycerides, omega 3 fatty acids in an amount of 100 to 2000 mg and less than 20 solid food particles having a volume greater than about 20 cm. Such food products, when administered to affected subjects, can positively impact (i) nutritional status; (ii) quality of life; (iii) disease course; (v) the demand for assistance from a care giver; (vi) subject compliance with a nutritional plan using the food product, and (vii) ease of monitoring compliance by the caregiver for verification. 1. A product comprising a reversibly closed container and a soup , wherein the soup is in the container and comprises:a. a total volume of 200 to 2000 ml;b. at least one of a vegetable component and a meat component;c. 300 to 2500 calories; i. 20% to 80% fat;', 'ii. 10% to 45% protein; and', 'iii. 10% to 65% carbohydrate; and', 'iv. about 2% to about 40% medium chain triglycerides,, 'd. a macronutrient caloric distribution comprisinge. optionally one or more antioxidants in a total amount of at least 100 mg equivalents of vitamin C by FRSA;f. optionally omega 3 fatty acids in an amount of at least 100 mg; andg. optionally a means for extending the stability of the product.2. The product of comprising omega 3 fatty acids in an amount of 100 to 2000 mg claim 1 , and comprising antioxidants in a total amount of 100 mg to 500 mg equivalents of vitamin C by FRSA.3. The product of wherein the product claim 1 , when provided daily to a subject with ...

COMPOSITIONS OF NUTRITION SUPPLEMENTATION FOR NUTRITIONAL DEFICIENCIES AND METHOD OF USE THEREOF

A nutritional supplement composition for treating nutritional deficiencies caused by a medical condition in subjects is disclosed. The present application further discloses a method of using a nutritional supplements composition for treating a subject with complications resulting from sickle cell anemia. The method comprises administering to a subject an effective amount of the nutritional supplement. 127.-. (canceled)28. A method for treating conditions associated with abnormally slow energy metabolism or high energy requirement , comprising:administering to a subject in need of such treatment a daily nutritional supplement having total calories of about 700-980 kcal, wherein about 10-20% of the total calories are derived from protein, about 25-40% of the total calories are derived from fat, and about 45-65% of the total calories are derived from carbohydrate.29. The method of claim 28 , wherein the conditions associated with abnormally slow energy metabolism include malnutrition claim 28 , anorexia claim 28 , cancers claim 28 , AIDS and aging.30. The method of claim 28 , wherein the conditions associated with high energy requirement include sickle cell anemia claim 28 , pregnancy claim 28 , lactation claim 28 , growth claim 28 , exercise claim 28 , infectious diseases and recovery from surgical and other injuries.31. The method of claim 30 , wherein the condition associated with high energy requirement is sickle cell anemia.32. The method of claim 28 , wherein the nutritional supplement is administered orally in the form of a snack.33. The method of claim 32 , wherein the nutritional supplement is administered orally as the last snack before sleeping.34. The method of claim 32 , wherein the nutritional supplement is administered as snacks after each meal.35. A nutritional supplement to normal diet for treating conditions associated with abnormally slow energy metabolism or high energy requirement claim 32 , comprising:protein in an amount that provides about 10-20 ...

Infant nutritional product with rrr alpha-tocopherol

This invention relates to a method of improving CNS maturation in an infant by administering a mixture of natural tocopherols, wherein the composition contains an optimum tocopherol profile similar to that found in human breast milk, and can encompass a tocopherol profile from early stage to transitional to mature human breast milk. For ease of administration and maximized efficacy, the optimized mixture of natural tocopherols are typically delivered in an oral dosage form with a limited level of non-RRR alpha-tocopherols to maximize efficacy of the RRR alpha-tocopherol on stimulating post-natal CNS development.

NUTRITIONAL SUPPLEMENT FOR GROWTH ENHANCEMENT

Provided are nutritional supplements designed for enhancing the growth, particularly the linear growth, of pre-pubertal children with a stature measure short compared to the norm. The nutritional composition includes an energy source, arginine and a combination of micronutrients. 1. A nutritional supplement in a powder form having per 100 g powder a total caloric content of from about 300 kcal to about 500 kcal comprising per 100 g powder arginine in an amount of from about 250 mg to about 1000 mg and a micronutrient combination comprising calcium in an amount of from about 250 mg to about 750 mg; vitamin C in an amount of from about 15 mg to about 350 mg; zinc in an amount of from about 2.0 mg to about 15 mg; iron in an amount of from about 2.0 mg to about 10 mg; vitamin A in an amount of from about 50 μg to about 350 μg; and vitamin D in an amount of from about 2 μg to about 10 μg.2. The nutritional supplement of claim 1 , wherein 40% to 70% of the total caloric content is carbohydrates.3. The nutritional supplement of claim 1 , wherein 10% to 40% of the total caloric content is lipids.4. The nutritional supplement of claim 1 , wherein 10% to 40% of the total caloric content is proteins.5. The nutritional supplement of claim 1 , said supplement comprises per 100 g powder arginine in an amount of from about 500 mg to about 1000 mg; calcium in an amount of from about 300 mg to about 400 mg; vitamin C in an amount of from about 15 mg to about 50 mg; zinc in an amount of from about 2.0 mg to about 5.0 mg; iron in an amount of from about 3.0 mg to about 5.0 mg; vitamin A in an amount of from about 50 μg to about 150 μg; and vitamin D in an amount of from about 2 μg to about 3.5 μg.6. The nutritional supplement of claim 1 , said composition having per 100 g powder a total caloric content of about 420 kcal; arginine in an amount of about 826-992 mg; calcium in an amount of about 413 mg; vitamin C in an amount of about 24-28 mg; zinc in an amount of from about 4 mg; iron ...

Nutritional Supplement and Method of Administering the Same

A nutritional supplement that improves energy levels in a human being and a method of administering the same to provide enhanced energy is described. The nutritional supplement comprises fat, caffeine, vitamins and minerals enveloped and surrounded in an edible protective coating. In preferred embodiments, the nutritional supplement is a composition including a fatty matrix supporting caffeine, B vitamins and vitamin D, the fatty matrix is comprised of dark chocolate and the edible protective coating is a sugar shell. The caffeine in the supplement provides for enhanced energy, vitamin D helps to maintain muscle function and strength and supports mental health, and B vitamins facilitate conversion of food or stored energy into active energy. The fatty matrix and edible protective coating cooperate to preserve the nutritional supplement without the need for artificial preservatives. The fatty matrix and edible protective coating further provide for delivery and improved bioabsorption of the caffeine and vitamins to a human ingesting the food product. The composition also may include L-Theanine to assist in tempering the anxiety-inducing effects of caffeine such as jitteriness and masking agents to mask the bitterness of the caffeine, vitamins and minerals. The method comprises administration of the nutritional supplement as described to improve energy levels in a human being. 1. A nutritional supplement having extended shelf life , comprising:a fatty matrix supporting caffeine and vitamin D;an edible protective coating enveloping the fatty matrix;the fatty matrix and edible protective coating cooperating to preserve the caffeine without artificial preservatives.2. The nutritional supplement of wherein the fatty matrix further provides for delivery of caffeine and vitamin D to a human being ingesting the food product for enhanced bioabsorption.3. The nutritional supplement of wherein the Vitamin D helps to maintain muscle function and strength and supports mental ...

EDIBLE STICKER WITH NUTRIENT

An edible sticker including an edible paper, an edible ink, and an edible compound on at least a portion of the edible paper. The edible compound includes one selected from a nutrient, a supplement, a medicine, a mineral, a flavoring, a vitamin, and combinations thereof. A method of providing nutrients to a child using the edible sticker, a method of manufacturing the edible sticker, and a system for manufacturing the edible sticker have also been disclosed. 1. An edible sticker , comprising:an edible paper;an edible indicia on a first side of the edible paper; andan edible compound on at least a portion of the edible paper, the edible compound comprising one selected from the group consisting of a nutrient, a supplement, a medicine, a mineral, a flavoring, a vitamin, and combinations thereof.2. The edible sticker of claim 1 , wherein the edible compound comprises at least one of liquid multi-vitamin and mineral claim 1 , essential fatty acids claim 1 , colostrum with probiotics claim 1 , vitamin A claim 1 , vitamin C claim 1 , vitamin D claim 1 , vitamin E claim 1 , DHA claim 1 , calcium claim 1 , magnesium claim 1 , beta carotene claim 1 , iron or combinations thereof.4. The edible sticker of claim 1 , wherein the indicia comprises a customized design claim 1 , a picture claim 1 , text claim 1 , a cartoon character claim 1 , a bar code claim 1 , or combinations thereof.5. The edible sticker of claim 1 , further comprising:a protection layer over the edible compound.6. The edible sticker of claim 1 , further comprising:a paper backing on a second side of the edible paper opposite to the first side.7. The edible sticker of claim 6 , further comprising:an edible adhesive between the edible paper and the paper backing.8. The edible sticker of claim 7 , wherein the edible adhesive is selected from the group consisting of pressure sensitive adhesive claim 7 , heat activatable adhesive claim 7 , and water activatable adhesive.9. The edible sticker of claim 8 , wherein ...

Nutraceuticals Having Sustained Release for Improved Bioavailability and Method of Production

The present disclosure describes economical processes to improve the bioavailability of nutraceuticals by formulations that induce micronization and sustained release. The inventive process can be used to increase the solubility and bioavailability of lipophilic and moderately water-soluble nutraceuticals by combining excipients that increase the solubility and induce sustained release of the active compounds. The inventive process also can be used to increase the residence time of highly water-soluble nutraceuticals that are metabolized and eliminated quickly from the body, consequently increasing the therapeutic potential. The disclosed formulations advantageously are freely flowing powders that can be used to formulate with other ingredients into tablets, capsules, or the like; or used as bulk powders. 1. A particulate nutraceutical composition , which comprise:(a) between about 1% and 60% by weight of a lipophilic nutraceutical having a particle size not substantially larger than about 10μ;(b) between about 0.5% and 20% be weight of a lipid selected from the group consisting essentially of vegetable oils, medium chain triglycerides and isopropyl or ethyl esters of fatty acids;(c) between about 10% and 30% by weight of a surfactant being one or more of a non-ionic type polysorbate, or polyglycerol esters of fatty acids with a hydrophilic-lipophilic balance (HLB) value between 8-16;(d) between about 1% and 50% by weight of a polymer being one or more of carboxymethyl cellulose, ethyl cellulose, hydroxypropyl methyl cellulose, alginic acid sodium salt, or a cyclodextrin; and(e) between about 1% and 50% by weight of an excipient being one or more of a microcrystalline cellulose, silica, maltodextrin, potato starch, bamboo silica, or rice flour;where the amount of said polymer and lipid is insufficient to coat all of the nutraceutical composition particles and where said nutraceutical composition has improved bioavailability and a combination of immediate release and ...

Natural nutritional supplements

Dietary nutritional supplements specially formulated for use by high school, college and professional athletes, especially wrestlers. The nutritional supplements build strength, endurance and stamina, replenish electrolytes lost during intense sweating, provide essential nutrients, and increase and sustain energy. The nutritional supplements can be mixed with each other in various combinations to provide athletes with essential nutrients as necessary based on the activity undertaken. While designed primarily for athletes with demanding workout routines, the nutritional supplements can benefit persons of all ages by providing essential nutrients, vitamins and minerals. Through the use of natural and nontoxic ingredients, the nutritional supplements are designed to provide beneficial vitamins and minerals without leading to violations of anti-doping regulations or causing other detrimental effects. Especially preferred formulations include the combination of various essential amino acids and vitamin B combinations that are stable and can be delivered orally as a spray. 1. A nutritional supplement comprising the combination of B-Vitamin Blend including at least B1 (Thiamine) , B2 (Riboflavin) , B3 (Niacin) , B6 (Pyridoxine) , B12 (Cobalamin) and B7 (D-Biotin) and the combination of at least 8 of the following amino acids: Glycine , L-Serine , L-Threonine , L-Valine , L-Histidine , L-Arginine , cysteine , L-Proline , L-Alanine , glutamate , glutamine , aspartae , asparagine and methionine.2. The nutritional supplement of delivered in the form of a spray.3. The nutritional supplement of in which the spray container has sufficient supplement for ten 0.2 ml sprays per day for 30 days. This application is a continuation-in-part of application Ser. No. 13/451,329, filed Apr. 19, 2012 in the name of Leroy P. Kemp, Woo Chun Paik and Mia Scheid. application Ser. No. 13/451,329 is hereby incorporated by reference in its entirety.1. Field of the InventionThis invention relates ...

SWEETENER COMPOSITIONS

A sweetener composition comprising xylose, a sugar alcohol and brown seaweed extract in solid form, preferably powdered or crystalline form. The sugar alcohol is preferably an erythritol and the brown seaweed extract is preferably obtained from Laminaria japonica. The sweetener composition can further comprise one or a combination of additional vitamins, minerals, probiotic cultures, and other plant-based extracts. 123-. (canceled)24. A sweetener composition consisting of: a xylose , an erythritol and a brown seaweed extract ,wherein the sweetener composition is provided in solid, crystalline and/or powdered form;wherein the sweetener composition is used for enhancing the flavor of foods; andwherein the relative amounts of the xylose, erythritol and brown seaweed extract are present in the sweetener composition to provide a mouth feel and taste like sucrose.25. A sweetener composition comprising: a xylose , an erythritol , and a brown seaweed extract ,wherein the sweetener composition is provided in solid, crystalline and/or powdered form;wherein the sweetener composition enhances the flavor of foods; andwherein the relative amounts of the xylose, erythritol and brown seaweed extract are present in the sweetener composition to provide a mouth feel and taste like sucrose.26. The sweetener composition of further comprising one or more vitamins selected from the group consisting of: vitamin A claim 25 , vitamin B claim 25 , vitamin B claim 25 , vitamin B claim 25 , vitamin B claim 25 , vitamin B claim 25 , vitamin B claim 25 , vitamin B claim 25 , vitamin B claim 25 , L-methyl folate claim 25 , inositol claim 25 , vitamin C claim 25 , vitamin D claim 25 , vitamin E claim 25 , vitamin K claim 25 , and CoQ10.27. The sweetener composition of claim 25 , further comprising one or more minerals selected from the group consisting of: calcium claim 25 , chromium claim 25 , copper claim 25 , iron claim 25 , magnesium claim 25 , manganese claim 25 , and zinc.28Bacillus coagulans ...

PREMIX FOR A FORTIFIED FOOD BLEND

The present invention relates to a vitamin, mineral and enzyme premix for a fortified food blend comprising an alpha-amylase and a glucoamylase to increase energy content, reduce viscosity, and improve taste of a porridge prepared from said fortified food blend. Furthermore, the invention relates to a high energy fortified food blend comprising a vitamin, mineral and enzyme premix from which a high energy, low viscosity and tasty porridge can be prepared. It also relates to a porridge prepared form the fortified food blend according to the present invention. 1. A fortified food blend for a porridge comprising a vitamin , mineral and enzyme premix , wherein the premix comprises at least an alpha-amylase and a glucoamylase having a ratio of alpha-amylase/glucoamylase enzyme units of between 1/2 and 1/75 , and wherein the porridge has an energy density of greater than 800 kcal/l , and a viscosity at 45° C. , as measured in a Bostwick test , of greater than 10 cm/30″.2. The fortified food blend according to claim 1 , wherein the fortified food blend is a corn soya blend or a wheat soya blend.3. The fortified food blend according to claim 2 , wherein the energy density of the porridge is greater than 1000 kcal/l claim 2 , and the viscosity at 45° C. claim 2 , as measured in a Bostwick test claim 2 , is greater than 10 cm/30″.4. The fortified food blend according to claim 1 , wherein the energy density of the porridge is greater than 1200 kcal/l claim 1 , and the viscosity at 45° claim 1 , as measured in a Bostwick test claim 1 , is greater than 10 cm/30″.5. The fortified food blend according to claim 1 , wherein the energy density of the porridge is greater than 1000 kcal/l claim 1 , and the viscosity at 45° C. claim 1 , as measured in a Bostwick test claim 1 , is greater than 12 cm/30″.6. A porridge prepared from a fortified food blend comprising a vitamin claim 1 , mineral and enzyme premix claim 1 , wherein the premix comprises at least an alpha-amylase and a ...

EFFERVESCENT MULTI-VITAMIN/MINERAL ADDITIVE FOR COFFEE AND TEA

A water soluble micronutrient composition that infuses vitamins and minerals into coffee and tea designed to maximize bio-absorption in consideration of pH levels, temperature and caffeine. The composition contains water-soluble and oil-soluble vitamins and minerals in bioavailable forms contained in a composition consisting of -% of a vitamin blend with -% of one or more minerals selected from the group consisting of calcium, magnesium, iron, zinc, copper and manganese, -% citric acid, -% of one or more alkali or alkaline earth metal bicarbonates or carbonates, -% flavoring agent, -% of a sweetening agent. When dissolved in liquid a specific amount of micronutrients are infused into the drink by way of a soluble, bioavailable form in the amount of approximately -% of the US RDA of multiple vitamins and trace minerals along with a desired flavor to enhance the coffee, tea or other liquid. 1. A water soluble micronutrient (vitamin and/or mineral) composition for direct use as an additive in coffee and tea , comprising:at least one of a vitamin additive, a literal additive and a flavor additive;at least one pH stabilizing agent that stabilizes a pH of the liquid into which the tablet is to be placed;at least one effervescence agent having sufficient effervescence to separate the tablet or powder upon placement in the coffee and tea; andat least one solubility agent that facilitates expeditious dissolution of the composition in the coffee and tea into which it is placed; wherein a percentage of components in the tablet are in a range of:Vitamin additive 1-5%;Mineral additive 5-15%;Flavor additive 10-20%;Base Reactor(s) 15-30% Acid Reactor(s) 10-30%;Binding Agent 10-30%;Lubricant(s) 5-10%.2. The effervescent vitamin and mineral composition of wherein the composition comprises a tablet and a dosage unit of said tablet is about two to six grams.3. The effervescent vitamin and mineral composition of wherein a dosage unit of said composition contains between about 25 and ...

COMPOSITIONS AND METHODS FOR THE TREATMENT OF NATAL AND PRE-NATAL CONDITIONS WITH ALPHA-TOCOPHEROL

The present invention provides methods, compositions, and systems for preventing or reducing an allergic condition in an offspring by administering tocopherol to a mother pregnant or nursing the offspring, where the tocopherol in the composition is 98-100% unmodified natural d-alpha tocopherol, and less than 2% gamma tocopherol (e.g., undetectable levels of gamma tocopherol). In certain embodiments, a prenatal tablet or pill is provided composed of such tocopherol compositions in combination with folic acid, iron, and calcium. 1. A method of preventing , or reducing the severity of , a condition in a neonate , infant , or child comprising:administering a composition to a mother of a neonate, infant, or child: 1) prior to birth of said neonate, infant, or child, and/or 2) during a time period wherein said mother is breast feeding said neonate, infant, or child;wherein said composition comprises at least 5 international units (IU's) of tocopherol, wherein at least 98% of all of said tocopherol in said composition is unmodified natural d-alpha-tocopherol, and wherein less than 2% of all of said tocopherol in said composition is gamma-tocopherol, andwherein said administering prevents, or reduces the severity of, an inflammatory condition in said neonate, infant, or child.2. The method of claim 1 , wherein said condition premature fetal lung disease claim 1 , full term pulmonary distress claim 1 , childhood asthma claim 1 , or an allergic condition.3. The method of claim 1 , wherein said mother has at lease one type of allergy.4. The method of claim 3 , wherein said method further comprising claim 3 , prior to said administering claim 3 , testing said mother for at lease one type of allergy.5. The method of claim 1 , wherein at least 99% of all of said tocopherol in said composition is unmodified natural d-alpha-tocopherol claim 1 , and wherein less than 1% of all of said tocopherol in said composition is gamma-tocopherol.6. The method of claim 1 , wherein at least 99.9 ...

IMPROVED COGNITIVE SUPPLEMENTS

The invention generally provides supplements and methods of using the same to improve cognitive functions such as learning, memory, concentration, focus, attention, and mood. 1. A supplement comprising:a) one or more vitamins selected from the group consisting of vitamin B and vitamin D;b) one or more alkaloids selected from the group consisting of caffeine, vinpocetine, and huperzine; and{'i': Rhodiola rosea, Bacopa monnieri, Panax ginseng', 'Gingko biloba., 'c) one or more herbs selected from the group consisting of , and'}2. The supplement of claim 1 , wherein the vitamin D is vitamin D3.3. The supplement of any one of to claim 1 , wherein the supplement comprises one or more B vitamins selected from the group consisting of vitamin B1 (thiamine) claim 1 , vitamin B5 (panthothenic acid) claim 1 , vitamin B9 (folate) claim 1 , methylcobalamin claim 1 , hydroxocobalamin claim 1 , and cyanocobalamin.4. The supplement of any one of to claim 1 , wherein the supplement comprises the B vitamins: thiamine claim 1 , panthothenic acid claim 1 , and methylcobalamin.5. The supplement of any one of to claim 1 , wherein the supplement comprises the B vitamins: thiamine claim 1 , panthothenic acid claim 1 , and hydroxocobalamin.6. The supplement of any one of to claim 1 , wherein the supplement comprises the B vitamins: thiamine claim 1 , panthothenic acid claim 1 , and cyanocobalamin.7. The supplement of any one of to claim 1 , wherein the supplement comprises folate.8. The supplement of any one of to claim 1 , wherein the supplement comprises caffeine claim 1 , vinpocetine claim 1 , and huperzine.9. The supplement of any one of to claim 1 , wherein the supplement comprises caffeine claim 1 , cyclopropylmethyl apovincaminate claim 1 , and huperzine.10. The supplement of any one of to claim 1 , wherein the supplement comprises caffeine claim 1 , cyclopropylmethyl apovincaminate claim 1 , and galantamine.11. The supplement of any one of to claim 1 , wherein the supplement ...

NUTRITIONAL SUPPLEMENT COMPRISING HERBAL GALACTAGOGUE

The present invention provides a single unit composition for lactation improvement comprising herbal galactagogue and a method for using the same. In one particular embodiment, the single unit composition of the invention comprises fenugreek and a mixture of essential minerals and vitamins. 1. A single unit nutritional supplement for breastfeeding female to enhance breast milk supply and/or lactation , said nutritional supplement comprising a postnatal vitamin , an essential mineral , and an effective amount of an herbal galactagogue.2. The single unit nutritional supplement of claim 1 , wherein said herbal galactagogue comprises fenugreek claim 1 , fennel seed claim 1 , or a combination thereof.3. The single unit nutritional supplement of claim 2 , wherein said nutritional supplement comprises at least 750 mg of effective fenugreek.4. The single unit nutritional supplement of claim 3 , wherein said nutritional supplement comprises at least 2 claim 3 ,000 mg of effective fenugreek.5. The single unit nutritional supplement of claim 1 , wherein said herbal galactagogue comprises fenugreek seed powder claim 1 , fenugreek extract claim 1 , or a combination thereof.6. The single unit nutritional supplement of claim 1 , wherein said single unit nutritional supplement comprises vitamin D claim 1 , vitamin B claim 1 , vitamin B claim 1 , chromium claim 1 , folic acid claim 1 , or a combination thereof.7. The single unit nutritional supplement of claim 6 , wherein said single unit nutritional supplement comprises vitamin D claim 6 , vitamin B claim 6 , vitamin B claim 6 , chromium claim 6 , folic acid claim 6 , fenugreek claim 6 , fennel seed claim 6 , and at least one of an additional ingredient selected from the group consisting of vitamin A claim 6 , vitamin C claim 6 , vitamin E claim 6 , vitamin K claim 6 , thiamin claim 6 , riboflavin claim 6 , niacin claim 6 , biotin claim 6 , pantothenic acid claim 6 , calcium claim 6 , iron claim 6 , iodine claim 6 , magnesium claim ...

CRYSTALS OF PYRROLOQUINOLINEQUINONE SODIUM SALTS

A crystal of pyrroloquinoline quinone disodium salt having peaks at 2θ of 9.1°, 10.3°, 13.8°, 17.7°, 18.3°, 24.0°, 27.4°, 31.2° and 39.5° (±0.2° for each) in powder X-ray diffractometry using Cu Kα radiation, or a crystal of pyrroloquinoline quinone trisodium salt having peaks at 2θ of 6.6°, 11.4°, 13.0°, 22.6°, 26.9°, 27.9°, 37.0°, 38.9° and 43.4° (±0.2° for each) in powder X-ray diffractometry using Cu Kα radiation. 1. (canceled)2. A functional food , comprising:a crystal of pyrroloquinoline quinone disodium salt having peaks at 2θ of 9.1°, 10.3°, 13.8°, 17.7°, 18.3°, 24.0°, 27.4°, 31.2° and 39.5° (±0.2° for each) in powder X-ray diffractometry using Cu Kα radiation.3. The functional food of claim 2 , wherein the crystal has a purity of 99.5% or higher as assayed by high performance liquid chromatography.4. The functional food of claim 2 , further comprising:at least one additive which includes at least one of water, sugar, oil, and a glycol.5. A functional food claim 2 , comprising:a crystal of pyrroloquinoline quinone trisodium salt having peaks at 2θ of 6.6°, 11.4°, 13.0°, 22.6°, 26.9°, 27.9°, 37.0°, 38.9° and 43.4° (±0.2° for each) in powder X-ray diffractometry using Cu Kα radiation.6. The functional food of claim 5 , further comprising:at least one additive which includes at least one of water, sugar, oil, and a glycol. The present application is a divisional of application Ser. No. 13/383,472, filed Jan. 11, 2012, the entire contents of which are incorporated herein by reference. application Ser. No. 13/383,472 is a 371 of International Application No. PCT/JP2010/059761, filed Jun. 9, 2010, which is based upon and claims the benefits of priority to Japanese Application No. 2009-168087, filed Jul. 16, 2009.The present invention relates to a novel crystal of a sodium salt of pyrroloquinoline quinone and a method for producing it.Since it has been proposed that pyrroloquinoline quinone (PQQ) may be a novel vitamin, it has drawn attention (see, for example, Non ...

FOOD SUPPLEMENT FOR PEOPLE WITH DOWN SYNDROME, AUTISM SPECTRUM DISORDER AND/OR ATTENTION DEFICIT DISORDER WITH OR WITHOUT HYPERACTIVITY

The present invention describes a food supplement comprising isomaltulose, milk serum protein concentrate, linseed, milk serum mineral complex, short chain fructooligosacharides, lactoferrin, and vitamin B6. This food supplement was developed for use as support in the nutritional therapy in people suffering from Trisomy 21, Autism Spectrum Disorders and/or Attention Deficit Disorder with or without Hyperactivity. 1. A food supplement characterized by comprising , by weight: a) from 62 to 75% isomaltulose; b) from 12 to 21% milk serum protein concentrate; c) from 2 to 8.4% linseed; d) from 1 to 4.4% milk serum mineral complex; e) from 1.6 to 6.7% short chain fructooligosacharides; f) from 0.03 to 0.09% lactoferrin; and , g) from 0.002 to 0.008% vitamin B6.2. A food supplement claim 1 , according to claim 1 , further comprising claim 1 , by weight: a) from 65 to 71% isomaltulose; b) from 14 to 17% milk serum protein concentrate; c) from 4 to 4.5% linseed; d) from 2 to 2.5% milk serum mineral complex; e) from 3 to 4% short chain fructooligosacharides; f) from 0.05 to 0.07% lactoferrin; and claim 1 , g) from 0.005 to 0.007% vitamin B6.3. A food supplement claim 1 , according to claim 1 , wherein the milk serum protein concentrate has a protein content of about 80%.4. A food supplement claim 1 , according to claim 1 , wherein the linseed has the following composition: about 41% fat claim 1 , about 28% dietetic fiber claim 1 , about 20% plant protein claim 1 , about 7% humidity claim 1 , and about 4% ashes.5. A food supplement claim 4 , according to claim 4 , wherein the linseed has a two parts of omega-6 fatty acids to three parts of omega-3 fatty acids ratio.6. A food supplement claim 5 , according to claim 5 , wherein the linseed employed is golden linseed.7. A food supplement claim 1 , according to claim 1 , wherein the milk serum mineral complex has the following composition: about 24% calcium claim 1 , about 12.50% phosphorous claim 1 , about 1.50% magnesium claim 1 ...

Preconception/Prenatal/Postnatal Optimal Nutrition System, Compositions and Kits for Use Therein, and Methods of Making and Using Same

A nutrition system for use during a preconception period, during pregnancy, during lactation, and/or during postnatal weight loss is disclosed herein. Also disclosed are compositions and kits for use therein, as well as methods of making and using same. Also disclosed are a range of preconception, prenatal, pregnancy, postnatal, and/or lactation food and/or beverage products, assemblies containing same, and methods of production and use thereof. 1. A composition , comprising at least two food and/or beverage product designed specifically for consumption during one or more periods spanning from preconception through postnatal lactation , the at least one food and/or beverage product comprising:a preconception/prenatal/postnatal fundamental nutrient bundle that comprises at least three preconception/prenatal/postnatal fundamental micronutrients;at least one macronutrient; andan metabolic health profile that includes one or more of: less than or equal to 20% calories from added sugar; less than 3 g fat; 0 g trans fat; less than 60 mg cholesterol; and less than 300 mg sodium;wherein each fundamental nutrient is present in the composition at a level in a range of from about 0.1% DV to about 100% DV; andwherein the at least one macronutrient is selected from the group consisting of protein, at least one amino acid, and carbohydrate.2. The composition of claim 1 , further defined as being sized and proportioned to serve as a complete meal claim 1 , as a meal replacement claim 1 , as an incomplete meal component claim 1 , and/or as a snack.3. The composition of claim 1 , wherein each of the at least three preconception/prenatal/postnatal fundamental micronutrients present in the preconception/prenatal/postnatal fundamental nutrient bundle is selected from the group consisting of docosahexaenoic acid (DHA) claim 1 , choline claim 1 , folic acid claim 1 , calcium claim 1 , vitamin C claim 1 , vitamin D claim 1 , vitamin E claim 1 , magnesium claim 1 , potassium claim 1 , ...

UNIFORM FILMS FOR RAPID-DISSOLVE DOSAGE FORM INCORPORATING ANTI-TACKING COMPOSITIONS

The present invention relates to water-soluble films incorporating anti-tacking agents and methods of their preparation. Anti-tacking agents may improve the flow characteristics of the compositions and thereby reduce the problem of film adhering to a user's mouth or to other units of film. In particular, the present invention relates to edible water-soluble delivery systems in the form of a film composition including a water-soluble polymer, an active component selected from cosmetic agents, pharmaceutical agents, vitamins, bioactive agents and combinations thereof and at least one anti-tacking agent. 1. An edible film for delivery of an active comprising:an edible, water-soluble polymer;at least one anti-tacking agent selected from the group consisting of lubricants, antiadherants, glidants and combinations thereof; andan active component selected from the group consisting of cosmetic agents, pharmaceutical agents, vitamins, bioactive agents and combinations thereof,wherein said film is self-supporting.2. The film of claim 1 , wherein said anti-tacking agent comprises Vitamin E TPGS.3. The film of claim 1 , wherein said anti-tacking agent comprises magnesium stearate.4. The film of claim 3 , wherein said anti-tacking agent further comprises silica.5. The film of claim 1 , wherein said anti-tacking agent is present in amounts of about 0.01% to about 20% by weight of said delivery system.6. The film of claim 1 , wherein said anti-tacking agent comprises:magnesium stearate present in amounts of about 0.1% to about 2.5% by weight of said delivery system; andsilica present in amounts of about 0.1% to about 1.5% by weight of said delivery system.7. The film of claim 1 , wherein said water-soluble polymer comprises polyethylene oxide and a cellulosic polymer.8. The film of claim 7 , wherein said cellulosic polymer comprises hydroxypropyl cellulose.9. The film of claim 7 , wherein said cellulosic polymer comprises hydroxypropylmethyl cellulose.10. The film of claim 1 , ...

Food supplement to support brain function

The present invention relates to a food supplement to support brain function, including cognitive functions such as memory. The food supplement comprises one or more active ingredients selected from the group consisting of uridine, cytidine, glutamine, pantothenic acid, iron, colostrinin and caffeine.

Anti-Inflammatory Composition for Modulating the Cell Response of Neutrophils and Eosinophils

The present invention relates to an anti-inflammatory composition intended for humans and animals for modulating the cell response of the neutrophils and of eosinophils. 1Corturnix corturnix japonica. An anti-inflammatory composition intended for humans and animals for modulating a cell response of neutrophils and eosinophils , the anti-inflammatory composition comprising: an extract from eggs of a quail of a strain B-Mina comprising an ovomucoid and a quail egg ovo-inhibitor.2. The anti-inflammatory composition according to claim 1 , further comprising: at least one vitamin selected from a group consisting of A claim 1 , B claim 1 , C claim 1 , D claim 1 , E claim 1 , F claim 1 , K and P.3. The anti-inflammatory composition according to claim 1 , further comprising: at least one mineral selected from a group consisting of Al claim 1 , Bi claim 1 , Co claim 1 , Cu claim 1 , Fe claim 1 , F claim 1 , Li claim 1 , Mg claim 1 , Ni claim 1 , P claim 1 , K claim 1 , Se claim 1 , S and Zn.4. The anti-inflammatory composition according to claim 1 , further comprising: at least one amino acid taken from a group consisting of Ile claim 1 , Leu claim 1 , Lys claim 1 , Met claim 1 , Phe claim 1 , Thr claim 1 , Trp claim 1 , Val claim 1 , Glu and Gln.5. The anti-inflammatory composition according to claim 1 , further comprising: at least one plant extract selected from a group formed by plant extracts from roots claim 1 , stems claim 1 , leaves claim 1 , flowers and fruit.6. The anti-inflammatory composition according to claim 1 , further comprising: a pharmaceutically acceptable or food-compatible excipient.7. The anti-inflammatory composition according to claim 1 , wherein the anti-inflammatory composition is packaged as one of tablets claim 1 , globules claim 1 , gelatin capsules claim 1 , granules claim 1 , powders claim 1 , fluids claim 1 , liquids claim 1 , creams and sprays.8. The anti-inflammatory composition according to claim 3 , wherein Zn is protected Zn.9. The anti- ...

Diet For Altering The Nutrient Composition Of Feeder Insects

A diet for altering the nutrient composition of a feeder insect includes a feed composition of feed material and nutrients. The diet is provided in a variety of forms, including as a powder or dry pellet. The nutrients in the diet include a carotenoid, essential fatty acid, and vitamin E in selected quantities and ratios. 1. A diet for altering the nutrient composition of a feeder insect , the diet comprising:a feed composition comprising feed material and nutrients, the nutrients comprising a carotenoid, an essential fatty acid, and vitamin E; the carotenoid is selected from the group consisting of beta-carotene in the range of 0.3 to 1,496.4 milligrams per kilogram of feed composition, lutein in the range of 58.7 to 2,310.8 milligrams per kilogram of feed composition, and zeaxanthin in the range of 58.7 to 2,310.8 milligrams per kilogram of feed composition;', 'the essential fatty acid is selected from the group consisting of eicosapentaenoic acid and docosahexaeonic acid; and', 'the vitamin E is in the range of 69 to 1,930 IU per kilogram of feed composition., 'wherein2. The diet of claim 1 , wherein the carotenoid is in the range of 155 to 1 claim 1 ,496.4 milligrams per kilogram of feed composition.3. The diet of claim 1 , wherein the carotenoid is in the range of 155 to 564 milligrams per kilogram of feed composition.4. The diet of claim 1 , wherein the nutrients further comprise vitamin A.5. The diet of claim 1 , wherein the beta-carotene is in the range of 12 claim 1 ,000 to 100 claim 1 ,000 IU per kilogram of feed composition.6. The diet of claim 1 , wherein the beta-carotene is in the range of 3 to 65 milligrams per kilogram of feed composition.7. The diet of claim 1 , wherein the beta-carotene is in the range of 68.4 to 365 milligrams per kilogram of feed composition.8. The diet of claim 1 , wherein the nutrients include between 732.7 and 1 claim 1 ,635.1 milligrams of lutein and zeaxanthin claim 1 , in combination claim 1 , per kilogram of feed ...

Machines for the preparation of beverage and liquid food products

The present disclosure relates to improvements in machines for the preparation of beverage and food products, and in particular to such a machine which utilizes a compressed tablet of food or beverage product, which is inserted into the brew chamber of the machine, into which a liquid is directed to break up or dissolve the tablet. The machine for preparing a beverage or food product from a compressed disc of at least one ingredient comprises a sealable brew chamber, and said brew chamber comprises means for mounting the disc so that it is able to spin freely around a central axis. The brew chamber further comprises and at least one nozzle having an outlet in the brew chamber located to direct a jet of liquid at a peripheral edge of the disc mounted in the brew chamber.

COMPOSITIONS OF NUTRITION SUPPLEMENTATION FOR NUTRITIONAL DEFICIENCIES AND METHOD OF USE THEREFORE

A nutritional supplement composition for treating nutritional deficiencies caused by a medical condition in subjects is disclosed. The present application further discloses a method of using a nutritional supplements composition for treating a subject with complications resulting from sickle cell anemia. The method comprises administering to a subject an effective amount of the nutritional supplement. 17-. (canceled)8. A nutritional supplement to normal diet for treating conditions associated with abnormally slow energy metabolism or high energy requirement , comprising:protein in an amount that provides about 10-20% of the total calories;fat in an amount that provides about 25-40% of the total calories; andcarbohydrate that provides about 45-65% of the total calories.9. The nutritional supplement of claim 8 , wherein the nutritional supplement comprises:protein in an amount that provides about 14% of the total calories;fat in an amount that provides about 32% of the total calories; andcarbohydrate that provides about 54% of the total calories.10. The nutritional supplement of claim 8 , wherein the nutritional supplement has a total calorie of about 700-980 kcal.11. The nutritional supplement of claim 10 , wherein the nutritional supplement comprises about 24-34 grams of protein; about 25-35 grams of fat; and about 96-135 grams of carbohydrate.12. The nutritional supplement of claim 8 , wherein the nutritional supplement further comprises at least one food grade amino acid selected from the group consisting of arginine claim 8 , histidine claim 8 , leucine claim 8 , valine claim 8 , cysteine and glutamine.13. The nutritional supplement of claim 12 , wherein the nutritional supplement comprises arginine claim 12 , histidine claim 12 , leucine claim 12 , valine claim 12 , cysteine and glutamine claim 12 , and wherein each amino acid is provided at a per diem dose range of 8-14 mg/kg body weight/day.14. The nutritional supplement of claim 12 , wherein the nutritional ...

Nutraceutical composition and method of use thereof

A nutraceutical composition comprising water having an alkaline pH and a plurality of members of the group consisting of orange extract, vanilla extract, apple honey, agave syrup, apple cider vinegar, olive oil, coconut oil, liquid multivitamin, aloe vera juice, flax seed oil, hemp oil, and elephant garlic, wherein each of the plurality of members is present in an amount effective to ameliorate the effects of inflammation and raise energy levels when administered to a mammal.

Seed butter composition and food products

An edible seed butter composition and consumable food products including the seed butter composition are disclosed. Method for preparing the edible seed butter composition and food products are also disclosed.

Powderous vitamin e formulation

The present invention relates a powderous formulation comprising vitamin E, which can be produced easily and which can be used in many fields of application, but mainly in beverages.

COMBINATION OF PETROSELINIC ACID AND TAURINE FOR ORAL ADMINISTRATION FOR HAIR AGING CONTROL

The invention relates to the cosmetic use, by oral administration, of a combination of active agents including petroselinic acid and taurine, for improving hair quality and for preventing and controlling the microinflammation of hair follicles, in particular for controlling hair aging in men over the age of 30 or in women. 117-. (canceled)18. A cosmetic method for improving the quality of the head of hair , comprising at least a step consisting in an oral administration of a combination of active agents comprising petroselinic acid and taurine , wherein the improvement in the quality of the hair fiber comprises improving the tensile strength of the hair , and/or the resistance to styling and/or shaping of the hair , and/or preventing and/or combating limp and/or breakable and/or dull and/or split and/or embrittled and/or sensitized and/or dry hair , and/or improving the softness and/or vigor of the hair fibers.19. The method as claimed in claim 18 , for preventing and/or combating aging of the hair in the case of men over 30 years old or in the case of women.20. The method as claimed in claim 18 , for preventing and/or combating low-noise microinflammation of the hair follicles.21Geranium sanguineum. The method as claimed in claim 18 , wherein petroselinic acid is used in the form of umbellifera plant oil or oil.22. The method as claimed in claim 18 , wherein petroselinic acid is used in the form of coriander claim 18 , chervil claim 18 , carrot claim 18 , celery claim 18 , cumin claim 18 , caraway claim 18 , parsley or dill oil.23. The method as claimed in claim 18 , wherein petroselinic acid is used in the form of an oil of coriander seeds.24. The method as claimed in claim 18 , wherein the combination of active agents also comprises zinc gluconate.25. The method as claimed in claim 18 , wherein the combination of active agents also contains vitamin D3.26. The method as claimed in claim 18 , wherein the combination of active agents is used in the form of a food ...

Dissolvable dietary supplement strip and methods for using the same

A strip, which is both edible and dissolvable, is provided comprising a film and a dosage of at least 2% of the reference daily intake (RDI) of at least one dietary supplement for malnutrition or to prevent/treat alcohol induced hangovers. A method for treating malnutrition and/or preventing and treating alcohol-induced hangovers using a dissolvable orally administered strip.

Hemp-Based Infant Formula and Methods of Making Same

The present invention pertains to the field of nutrition and in particular a food product formulation based on protein and other nutrients extracted from oil seeds, such as hemp, for a plurality of uses, including, but not limited to an infant or toddler formula, a beverage, baked goods or a protein supplement. Suitable oil seeds include, but are not limited to hemp, flax, chia, pea and spirulina. Accordingly, the present invention provides a food product formulation for human consumption that can provide a complete source of dietary protein and other nutrients through oil seed protein. The formulation may be prepared in a variety of product forms, including but not limited to, a ready-to-serve liquid form, or a powder form that can be reconstituted prior to human consumption into liquid form, or a powder form that can be added to oilier ingredients to produce a baked product for human consumption, or a protein supplement. 1. An infant formula composition comprising protein , carbohydrates and lipids effective to supply , per 100 calories , between about 1.8 and 4.5 g of protein , between about 3.3 and 6 g of lipids , and between about 9 and 14 g of carbohydrates , the formulation also comprising between about 1 and 100% of a daily recommended intake of vitamins and minerals , wherein said formulation comprises hemp or a hemp derivative as at least one source of protein , carbohydrate , lipids , vitamins or minerals , or a combination thereof.2. The composition of claim 1 , wherein said hemp or a hemp derivative comprises hulled or dehulled hemp seed claim 1 , hemp concentrate claim 1 , hemp protein powder claim 1 , hemp isolate claim 1 , hemp oil claim 1 , hemp liquid or a combination thereof.3aphanizomenflos aquaequinoa. The composition of claim 1 , wherein said composition comprises a protein source in addition to said hemp or a hemp derivative selected from the group consisting of: hemp protein claim 1 , hemp protein isolate claim 1 , hemp milk claim 1 , whey ...

FORMULATION OF TRANSPARENT AND NUTRITIVE MICROEMULSIONS

A clear and nutritive microemulsion comprising an aqueous phase in which at least one liposoluble active ingredient is dispersed, a first surfactant included in the group consisting of non-ionic surfactants with a high HLB and non-ionic surfactants with medium HLBs; and a second surfactant, characterized in that said second surfactant is chosen from the group consisting of anionic surfactants which have an HLB ≧25. 1. Clear and nutritive microemulsion comprising an aqueous phase in which at least one liposoluble active ingredient is dispersed , a first surfactant included in the group consisting of non-ionic surfactants of high HLB and non-ionic surfactants of medium HLB; and a second surfactant , characterised in that said second surfactant is chosen from the group consisting of anionic surfactants having an HLB ≧25.2. Microemulsion according to claim 1 , further comprising a third surfactant from the group consisting of non-ionic surfactants of high HLB when the first surfactant is a non-ionic surfactant of medium HLB claim 1 , or from the group consisting of non-ionic surfactants of medium HLB when the first surfactant is a non-ionic surfactant of high HLB.3. Microemulsion according to claim 1 , wherein said first and/or third non-ionic surfactant of high HLB is chosen from the group consisting of polyoxyethylene sorbitan esters claim 1 , in particular sorbitan monododecanoate poly(oxy-1 claim 1 ,2-ethanediyl) and alkyl polyglucosides (APGs).4. Microemulsion according to claim 1 , wherein said first and/or third non-ionic surfactant of medium HLB is chosen from the group consisting of sorbitan esters claim 1 , in particular sorbitan laurate claim 1 , polyoxyethylene (20) sorbitan monolaurate claim 1 , polyoxyethylene (20) sorbitan monopalmitate claim 1 , polyoxyethylene (20) sorbitan monostearate claim 1 , polyoxyethylene (20) sorbitan monooleate claim 1 , polyoxyethylene glycol sorbitan laurate claim 1 , hexaethylene glycol sorbitan monooleate claim 1 , ...

PRE-PACKAGED MEAL OF FORTIFIED MACARONI AND CHEESE, AND FORTIFIED RICE AND BEANS

A prepackaged, fortified meal provides a substantial portion of the daily recommended requirements, which can be adjusted depending upon the intended consumers for the meals. In a first embodiment, the meal contains macaroni, powdered cheese, soy, vitamins, and minerals. The cheese, vitamins and minerals are contained in a small package, and is added to a larger bag with the macaroni and soy. In a second embodiment, the meal contains rice, beans, soy, dehydrated vegetables, vitamins, minerals and seasoning. The vitamins, minerals and seasoning are contained in a small package, which is added to a larger bag with the rice, beans, soy and vegetables. The meals are cooked in boiling water before consumption. 1. A method of preparing a pre-packaged , fortified meal:opening a first package containing macaroni, soy protein and a second package, wherein the second package contains powdered cheese, vitamins and minerals;boiling the macaroni and soy protein in water to cook the macaroni; and thenafter the macaroni is cooked, adding the contents of the second bag to the cooked macaroni and soy protein.2. The method of wherein the soy protein is selected from a group consisting of textured soy and granulated soy.3. The method of wherein the vitamins are selected from a group consisting of Vitamin A claim 1 , Vitamin B6 claim 1 , Vitamin B12 claim 1 , Vitamin C claim 1 , Vitamin D and Vitamin E claim 1 , biotin claim 1 , folic acid claim 1 , pantothenic acid claim 1 , niacin claim 1 , thiamine claim 1 , and riboflavin.4. The method of wherein the minerals are selected from a group consisting of phosphorus claim 1 , iodine claim 1 , magnesium claim 1 , copper claim 1 , zinc and manganese.5. The method of further comprising retaining the water with the macaroni and soy protein for consumption.6. The method of where in the water is not drained prior to consumption of the macaroni and soy protein.7. A method of preparing a meal of fortified macaroni and cheese claim 1 , comprising: ...

PRE-SPRAY EMULSIONS AND POWDERS CONTAINING NON-POLAR COMPOUNDS

Provided are compositions and methods for producing water-soluble powders that contain additives such as essential fatty acids, including omega-3 fatty acids, omega-6 fatty acids, conjugated fatty acids, and other fatty acids; phytochemicals, including phytosterols; other oils; and coenzymes, including coenzyme Q10, and other oil-based additives. 1. A water-soluble powder , comprising:a polyethylene glycol (PEG) derivative of vitamin E present in an amount of from between 0.1% and 25%, by weight of the powder; the total amount of sugar fatty acid ester and binder is between 5% and 60%, by weight of the powder; and', 'the mixture of sugar fatty acid ester and binder contains at least 5% sugar fatty acid ester;, 'a mixture of sugar fatty acid ester and a binder, whereina non-polar ingredient, other than the PEG derivative of vitamin E, present in an amount of from between 15% and 60%, by weight of the powder; andthe non-polar ingredient is a non-polar compound or contains a mixture of non-polar compounds.2. The powder of claim 1 , wherein the amount of the mixture of sugar fatty acid ester and binder is between 15% and 60% claim 1 , by weight of the powder.3. The powder of claim 1 , wherein the PEG derivative of vitamin E contains a PEG moiety having a molecular weight from between or between about 100 Da and 20 claim 1 ,000 Da.4. The powder of claim 1 , wherein the PEG derivative of vitamin E is selected from among tocopheryl polyethylene glycol succinate claim 1 , tocopheryl polyethylene glycol sebacate claim 1 , tocopheryl polyethylene glycol dodecanodioate claim 1 , tocopheryl polyethylene glycol suberate claim 1 , tocopheryl polyethylene glycol azelaate claim 1 , tocopheryl polyethylene glycol citraconate claim 1 , tocopheryl polyethylene glycol methylcitraconate claim 1 , tocopheryl polyethylene glycol itaconate claim 1 , tocopheryl polyethylene glycol maleate claim 1 , tocopheryl polyethylene glycol glutarate claim 1 , tocopheryl polyethylene glycol glutaconate ...

AQUEOUS, STERILE VITAMIN FORMULATION

The present invention relates to a process for production of a sterile aqueous formulation comprising water-soluble vitamins. Such a formulation is useful as a premix for the production of food, feed and personal care products. Furthermore the invention is also related to such sterile aqueous formulations as well as the use of them in the production of food, feed or personal care products, which are pasteurized. 1. A process for production of a sterile aqueous formulation wherein the aqueous formulation comprises(i) at least 20 g/l of vitamin C, and(ii) at least 10 g/l of at least one further water-soluble vitamin, and(iii) water, and whereinthe process is characterized in that the aqueous formulation is filtered by using a filter with a pore size of ≧0.22 μm.2. Process according to claim 1 , wherein the aqueous formulation comprises 20 g/l to 50 g/l of vitamin C.3. Process according to claim 1 , wherein the aqueous formulation comprises at least 30 g/l-60 g/l of at least one further water-soluble vitamin.4. Process according to claim 1 , wherein the aqueous formulation comprises at least 20 g/l of vitamin C and at least 10 g/l of at least one water-soluble vitamin chosen from the group consisting of vitamin B claim 1 , vitamin B claim 1 , vitamin B claim 1 , vitamin B claim 1 , vitamin B claim 1 , vitamin B claim 1 , vitamin Band vitamin B.5. Process according to claim 1 , wherein the aqueous formulation comprises further ingredients.6. A sterile aqueous formulation wherein the formulation comprises(i) at least 20 g/l of vitamin C, and(ii) at least 10 g/l of at least one further water-soluble vitamin, and(iii) water, and whereinthe formulation only comprises particles with a particle size of less than 0.22 μm.7. A formulation according to claim 6 , wherein the formulation comprises 20 g/l to 50 g/l of vitamin C.8. A formulation according to claim 6 , wherein the formulation comprises at least 10 g/l of at least one water-soluble vitamin chosen from the group ...

Non-Synthetic Emulsion-Based Lipid Formulations and Methods of Use

Saponin (and ) and terpenoid (mono- and di-) botanicals are used for emulsion-based lipids to produce stable nanoparticles of the active nutrients or pharmaceuticals by reducing surfactant usage (less than 5%) and by reducing particle size (less than 600 nm). Non-synthetic emulsion-based formulations enhance bioavailability and mitigate safety concerns. This nanoemulsion technology is suitable for oil-in-water ingredients including vitamin E tocotrienols, CoQ10s, curcuma terpenoids, symmetrical carotenoids, phenolics, lipid-soluble vitamins, and lipid-soluble pharmaceuticals. 1. A method of making a lipid-soluble ingredient nanoemulsion comprising the steps of: a) mixing an active lipid-soluble ingredient and a lipid-soluble co-solvent to produce a lipid solution , b) mixing an emulsifier and an aqueous co-solvent to produce an aqueous solution , c) mixing the lipid solution and the aqueous solution together and homogenizing the two solutions under high pressure to generate emulsified particles of a lipid-soluble ingredient nanoemulsion.2. The method of claim 1 , wherein the emulsified particle is from 50 nm to 600 nm in diameter.3. The method of claim 2 , wherein the emulsified particle is from 100 nm to 400 nm in diameter.4. The method of claim 1 , wherein a zeta potential is calculated for the emulsified particle and the zeta potential is less than −30 mV or more than +30 mV.5. The method of claim 1 , wherein the aqueous solution further comprises a water-soluble natural surfactant.6. The method of claim 1 , wherein the emulsifier is a saponin.7quillaja, yucca. The method of claim 6 , wherein the saponin is selected from the group consisting of claim 6 , and soy.8curcuma. The method of claim 1 , wherein the active lipid-soluble ingredient is selected from the group consisting of vitamin E claim 1 , CoQ10 claim 1 , terpenoid claim 1 , symmetrical carotenoid claim 1 , omega-3 claim 1 , phenolics claim 1 , vitamin A claim 1 , vitamin D claim 1 , vitamin K claim 1 , ...

NUTRACEUTICAL COMPOSITION FOR PDE4 INHIBITION, ENHANCED DOPAMINE METABOLISM AND LONG TERM POTENTIATION

A nutritional supplement for increasing cognitive functioning. The supplement includes a flavonoid such as luteolin and a labdane diterpene such as forskolin. The supplement can also include one or any combination of L-phenylalanine, L-carnitine, acetyl-L-carnitine, and vitamin B6. Artichoke extract can be used as a source of luteolin. Methods of using the nutritional supplements to increase cognitive functioning are also included. 1. A nutritional supplement for increasing cognitive functioning in a human subject , comprising effective amounts of a phosphodiesterase 4 (PDE4) inhibiting flavonoid , a cyclic adenosine monophosphate (cAMP) increasing labdane diterpene , and acetyl-L-carnitine.2. The nutritional supplement of claim 1 , wherein the flavonoid is luteolin.3. The nutritional supplement of claim 1 , wherein the nutritional supplement comprises artichoke extract as a source of the flavonoid.4. The nutritional supplement of claim 1 , wherein the labdane diterpene is forskolin.5. The nutritional supplement of claim 1 , further comprising effective amounts of one or any combination of components selected from the group consisting of L-phenylalanine claim 1 , L-carnitine claim 1 , vitamin B6 claim 1 , and piperine.6. The nutritional supplement of claim 1 , further comprising an effective amount of piperine.7. The nutritional supplement of claim 1 , further comprising an effective amount of L-phenylalanine.8. The nutritional supplement of claim 1 , further comprising an effective amount of vitamin B6.9. The nutritional supplement of claim 1 , comprising in daily dosage form:about 202.5 mg to about 990 mg of artichoke extract standardized to 5% cynarin, as a source of the PDE4 inhibiting flavonoid;about 0.9 mg to about 4.4 mg of forskolin as the labdane diterpene; andabout 180 mg to about 880 mg of acetyl-L-carnitine.10. The nutritional supplement of claim 9 , further comprising one or any combination of components selected from the group consisting of about 112.5 ...

COMPOSITION FOR ENHANCING IMMUNITY

The invention relates to preparations for dietary, food supplement or medical purposes and more specifically to a safe and natural preparation or a composition useful in immunity regulation and/or stimulation and in particular in the building, reinforcement, efficiency, maintenance and regeneration of natural immune defences in a subject. The preparations comprise magnesium, zinc and/or iron, blackcurrent seed oil and/or palm oil, two plant extracts selected from thyme, chickpea and lentil, as well as algae (fucus, wakame, nori), mushroom (shiitake, maitake) and at least one hydrosoluble vitamin and/or vitamin E. 1. A composition for immunity regulation and/or stimulation , per 100 g or 100 ml , comprising the combination of:10 μg to 1000 μg of positively charged minerals consisting of magnesium,10 μg to 1000 μg of metals selected from zinc and iron{'i': Ribes nigrum Oleum Acini', 'Elaeis guineensis Oleum, '7 μg to 700 μg of at least one plant oil selected from (blackcurrant seed oil) and (palm oil),'}{'i': Thymus vulgaris', 'Cicer arietinum', 'Ervum lens, '6 μg to 600 μg of at least two plant extracts selected from (thyme), (chickpea), and (lentil),'}{'i': Fucus vesiculosus', 'Undaria pinnatfida', 'Palmaria palmata', 'Porphyra umbilicalis, '6 μg to 600 μg of at least one alga chosen among (Fucus), (Wakame), (Dulse), and (Nori),'}{'i': Lentinula edodes', 'Grifola frondosa, '7 μg to 700 μg of at least one mushroom chosen among (Shiitake) and (Maitake),'}8 μg to 800 μg of at least one vitamin chosen among vitamins A, B1, B2, B5, B6, B9, C, E, PP(B3);optionally with a suitable excipient.2. The composition for immunity regulation and/or stimulation of claim 1 , wherein vitamin A is between 15% and 100% of the GDA (Guideline Daily Amounts).3. The composition for immunity regulation and/or stimulation of claim 2 , wherein the input weight of vitamin A represents from 120 to 800 μg/100 g of said composition.4. The composition for immunity regulation and/or stimulation of ...

HUNGER MINIMIZED JUICE FASTING SYSTEM

The hunger minimized fasting system relies on providing a blood glucose level at all times in the range of 5 to 10 mM, satisfying glucose needs of the brain and metabolizing blood glucose through anaerobic glycolysis to release ATP at the extramitocontrial portion of the cell. Consuming only solid free nutrient liquids eliminates brain hunger response. Liquids consumed during fasting include solid filtered vegetable soup and clear fruit juices of 8 to 12 ounces taken every 2 to 4 hours having calorie deficiency of 600 to 1400 as compared to minimal daily calorie requirements for an adult. Fat released from storage is metabolized by ATP produced by glycolysis at the extramitocontrial location and enters the interior of the mitochondria, enabling the TCA cycle. Weight loss observed during fasting is about one half to one pound per day. 1) A hunger minimized fasting system , comprising:a) preparing a fasting person for 3 to 5 days prior entering a fasting phase;b) providing liquefied vitamin and mineral supplement on a daily basis enabling production of numerous enzymes for use in glycolysis, the process of conversion blood glucose to pyruvic acid and adenosine triphosphate (ATP) as well as beta oxidation of fats in the TCA (Kreb) cycle;c) providing on a daily basis juices, clear solid free vegetable soup of 8 to 12 ounces every 2 to 4 hours during waking hours representing a caloric intake of only 800 to 1200 calories representing a deficit of 600 to 1400 calories, maintaining blood glucose levels in the range of 5 to 10 mM (90 to 180 mg/dL), preventing the onset of hunger sensing mechanism present in the brain hypothalamus and brain stem preventing or minimizing the hunger sensation of the fasting person;d) said clear solid free vegetable soup formed by lightly cooking vegetables in water at a temperature of about 80° C. to 95° C. to extract vitamins and minerals and micro nutrients and filtering out all solid material;e) the blood glucose entering anaerobic ...

PREPARED FOODS HAVING HIGH EFFICACY OMEGA 6/OMEGA 3 BALANCED POLYUNSATURATED FATTY ACIDS

A composition and method for supplementing food, nutrition, and diet systems with omega-6 to omega-3 balanced oils comprising a synergistic blend of at least two oils. The composition further comprises a synergistic blend of long chain omega-3 oil as a means to further increase the nutritional value. The composition provides an effective increase in therapeutic and pharmacological properties in nutrition and diet systems. 1. A composition for manufacture of a food product , comprising a mixture of omega-6 fatty acids , omega-3 fatty acids , and an antioxidant , wherein the ratio of omega-6 fatty acids to omega-3 fatty acids by weight is from about 0.01:1 to about 4:1; the omega 3 fatty acids comprise a short-chain polyunsaturated fatty acid (“PUFA”) and a long-chain PUFA , where the ratio of short-chain PUFA to long-chain PUFA by weight is from about 0.01:1 to about 5:1; and a standard serving of the food product contains at least 50 mg of long-chain PUFA.2. The composition of claim 1 , wherein the omega-6 fatty acids claim 1 , omega-3 fatty acids claim 1 , and the antioxidant comprise an emulsion.3. The composition of claim 2 , wherein the antioxidant is selected from the group consisting of a sinapyl compound claim 2 , a sulfur containing antioxidant claim 2 , ferulic acid containing antioxidant claim 2 , vitamin E claim 2 , a tocotrienol claim 2 , curcumin claim 2 , inositol claim 2 , and combinations thereof.4. The composition of claim 3 , wherein the antioxidant concentration of the emulsion is between about 5 ppm to 115 ppm.5. The composition of claim 3 , wherein the antioxidant is vitamin E and inositol.6. The composition of claim 1 , wherein the long-chain PUFA is EPA claim 1 , DHA claim 1 , or a combination thereof.7. The composition of claim 1 , wherein the food product is a beverage.8. The composition of claim 7 , wherein the beverage is selected from the group consisting of fruit smoothies claim 7 , flavored beverages claim 7 , orange juice claim 7 , ...

Method for Processing Rosaceous Kernels

A method for processing rosaceous kernels includes the steps of preparing a predetermined amount of rosaceous kernels, heating the rosaceous kernels to a predetermined temperature range for a predetermined time, lowering a temperature of the rosaceous kernels to a normal temperature, and making the rosaceous kernels edible for users to intake Vit B17 contained in the rosaceous kernels. Through the heating process, the beta-glucosidase contained in the rosaceous kernels can be destroyed completely, but the Vit B17 still stays in the rosaceous kernels. 1. A method for processing rosaceous kernels , comprising the steps of:(Step 1) preparing a predetermined amount of rosaceous kernels;(Step 2) heating the rosaceous kernels to a predetermined temperature range for a predetermined time in a non-dipping manner;(Step 3) lowering a temperature of the rosaceous kernels to a normal temperature; and(Step 4) making the rosaceous kernels edible for users to intake Vit B17 contained in the rosaceous kernels;wherein, in the Step 2, beta-glucosidase contained in the rosaceous kernels is completely destroyed, but the Vit B17 therein is stayed.2. The method for processing rosaceous kernels of claim 1 , wherein claim 1 , in the Step 2 claim 1 , the predetermined temperature range is a range of 70° C.˜120° C.3. The method for processing rosaceous kernels of claim 1 , wherein claim 1 , in the Step 2 claim 1 , the predetermined time is at least 5 minutes.4. The method for processing rosaceous kernels of claim 1 , wherein the rosaceous kernels are selected from the group of bitter almond kernels claim 1 , peach seed kernels claim 1 , apple seeds claim 1 , date seed kernels claim 1 , plum seed kernels claim 1 , cherry seed kernels and nectarine seed kernels.5. A method for processing rosaceous kernels claim 1 , comprising the steps of:(Step 1) preparing a predetermined amount of rosaceous kernels;(Step 2) dipping the rosaceous kernels in a water under a normal temperature for a ...

BEVERAGE COMPOSITIONS AND OTHER FORMULATIONS FOR TREATING ALLERGIES AND METHODS FOR MAKING THE SAME

A composition for preventing and/or alleviating an allergy related condition and methods of making such compositions are disclosed herein. A composition in accordance with a particular embodiment can include honey having pollen derived from a known plant species and/or from a known geographic location. The composition can also include a herbal and/or vitamin supplement, wherein the supplement has an anti-inflammatory property. The composition can be in liquid form, such as suitable for drinking, or in a powdered form suitable for reconstitution in liquid. 1. A composition for therapeutically treating an allergy related condition in a human patient , the composition comprising:honey including pollen from a known geographic location, wherein the pollen is associated with the allergy related condition of the patient; anda herbal or vitamin supplement, wherein the supplement has an anti-inflammatory property,wherein the composition comprises 1-5 mL of honey and 50 mg-1 g of supplement wherein the honey and supplement are provided in a ratio that prevents or alleviates the allergy related condition in the patient.2. The composition of wherein the composition is dissolved in water.3. The composition of wherein the composition further includes fruit juice.4. The composition of wherein the supplement includes a ginger root extract.5. The composition of wherein the supplement includes ginseng.6. The composition of claim 1 , further comprising 100-500 mg of vitamin C and 400-1000 IU of vitamin D.7. The composition of claim 1 , further comprising 50-250 mg of cinnamon.8. The composition of wherein the pollen is from a known plant.9. The composition of wherein the composition is a powdered composition.10. The composition of wherein the composition is in a capsule or tablet formulation.11. A beverage composition for therapeutically treating an allergic condition of a human patient claim 1 , the composition comprising:honey including pollen derived from a known plant species, ...

COMPOSITIONS CONTAINING WATER-SOLUBLE DERIVATIVES OF VITAMIN E MIXTURES AND MODIFIED FOOD STARCH

Provided are compositions that contain a modified food starch and one or more non-polar compounds. In some instances, the compositions contain a water-soluble derivative of vitamin E mixture, containing relatively high concentrations of dimer forms of the PEG-derivative of vitamin E. Compositions include concentrates, dilution compositions and compositions for direct consumption. Methods for preparing the compositions also are provided. 1. A composition , comprising:a modified food starch in an amount between 1% or about 1% and 70% or about 70%, by weight, of the composition;a high dimer-containing PEG-derivative of vitamin E mixture in an amount between 1% or about 1% and 98% or about 98%, by weight, of the composition, wherein the PEG-derivative of vitamin E mixture is a PEG-derivative of vitamin E mixture that comprises at least 13 weight % PEG-derivative of vitamin E dimer and up to 87 weight % PEG-derivative of vitamin E monomer; anda non-polar compound or compounds.2. The composition of claim 1 , wherein the PEG-derivative of vitamin E mixture comprises between about 35 weight % and about 55 weight % PEG-derivative of vitamin E dimer.3. The composition of that comprises a polar solvent in an amount between about 1% and about 99% claim 1 , by weight claim 1 , of the composition.4. The composition of claim 3 , wherein the polar solvent is present in an amount up to about 80% claim 3 , by weight claim 3 , of the composition.5. The composition of that is formulated for direct consumption.6. The composition of that is a concentrate.7. The composition of that is an emulsion concentrate.8. The composition of claim 4 , wherein the amount of the non-polar compound(s) is between about 0.001% and about 25% claim 4 , by weight claim 4 , of the composition.9. The composition of claim 1 , comprising a modified food starch in an amount between about 1% and about 30% claim 1 , by weight claim 1 , of the composition.10. The composition of claim 1 , comprising the PEG- ...

COMPOSITIONS, METHODS, AND KITS FOR REGULATING ENERGY METABOLISM

The present invention provides for compositions, methods and kits for regulating energy metabolism. In one aspect, the invention provides for compositions that comprise a combination of (a) branched chain amino acids, such as leucine, and (b) vitamin B6, or any precursors or metabolites of (a) or (b). These combinations may be synergistic and/or effective for reducing weight or adipose volume. In another aspect, the invention provides for methods of regulating energy metabolism by the administration of one or more compositions comprising branched chain amino acids and vitamin B6. The invention also provides for kits comprising compositions of branched chain amino acids and vitamin B6 packaged in an oral dose form with usage instructions. 130.-. (canceled)32. The composition of claim 31 , wherein the composition is packaged as a unit dosage.33. The composition of claim 31 , wherein component (a) is present in an amount of at least about 250 mg claim 31 , and component (b) is present in an amount of at least about 0.1 mg.34. The composition of claim 31 , wherein component (a) is present in an amount of at least about 1130 mg claim 31 , and component (b) is present in an amount of at least about 12 mg.35. The composition of claim 31 , wherein the composition comprises at least about 500 mg of leucine and at least about 5 mg of vitamin B6.36. The composition of claim 31 , wherein the composition comprises less than about 1% of the individual amino acids methionine and tryptophan.37. The composition of claim 31 , wherein the composition comprises less than 0.1% of the individual amino acid glycine.38. The composition of claim 31 , wherein the composition is a dietary supplement packaged as a solid food or a semi-solid food.39. The composition of claim 31 , wherein the composition is formulated as an oral dosage form.40. The composition of claim 31 , wherein the composition is formulated as a tablet claim 31 , capsule claim 31 , or gel capsule.41. The composition of claim ...

COMPOSITION AND METHOD FOR REDUCING FOOD INTAKE

The present invention features a composition and method for reducing food intake. The composition of the invention is composed of yerbe maté extract, guarana extract, and damiana extract in combination with a dietary fiber. 1. A composition for suppressing appetite consisting essentially of about 336 mg of yerba maté leaf extract , about 285 mg of guarana seed extract , about 108 mg of damiana leaf extract , about 5 grams of isolated , fermentable inulin , vitamin B and vitamin C.2. The composition of claim 1 , wherein said composition is formulated as a tablet claim 1 , sachet claim 1 , solid food product claim 1 , dairy product claim 1 , breakfast cereal claim 1 , muesli claim 1 , candy claim 1 , confectionery claim 1 , cookie claim 1 , biscuit claim 1 , cracker claim 1 , chocolate claim 1 , chew claim 1 , chewing-gum claim 1 , dessert or liquid comestible. This application is a continuation-in-part application of U.S. application Ser. No. 12/824,509 filed Jun. 28, 2010, which claims benefit of priority to U.S. Provisional Application Ser. No. 61/222,141, filed Jul. 1, 2009, the contents of which are incorporated herein by reference in their entireties.The necessary condition for the reduction of body mass is a negative energy balance. Energy intake must be consistently lower than energy expenditure in order for weight loss to occur. Therefore, any weight control strategy must address one or both parts of the energy equation; intake or expenditure. With regard to the control of energy intake, two broad strategies can be adopted: the enhancement of the satiety response to food or the blockade of absorption. The physical and chemical properties of various foods can be used to achieve both effects.With specific regard to the modulation of appetite, those processes responsible for the termination of a meal and the suppression of subsequent intake are of particular interest. The within meal processes of satiation and the post-meal end state of satiety are generated by ...

Compositions comprising plant proteins and methods for prevention of metabolic and cardiovascular pathologies in patient with cardiometabolic risk, including hyperglycemia

A composition for oral administration in humans comprising at least one plant protein chosen from pea proteins, rice proteins or a mixture thereof, and: at least one protein of animal origin chosen from calcium caseinate, lactoserum proteins, or a mixture thereof, and/or at least one free amino acid chosen from leucine, glutamine, isoleucine, valine, tryptophan or plant 5HTP, lysine, threonine, arginine and taurine, or any mixture thereof, and/or at least one micronutrient chosen from vitamin D, vitamin B6, vitamin B9, vitamin E, milk calcium, marine magnesium, zinc and chromium, or any mixture thereof, and/or at least one anti-inflammatory and/or antioxidant compound of plant origin chosen from ALA omega-3 fatty acid, purified EPA, protectin in PD1 or PDX form, and curcumin, or any mixture thereof. Methods with these compositions for preventing cardiometabolic risk are also provided.

DIETARY SUPPLEMENT NON-FLUORIDE TOOTHPASTE AND METHODS OF MAKING AND USING THE SAME

Provided herein is a storage stable non-fluoride toothpaste composition enriched with a dietary supplement containing both oil soluble and water soluble vitamins. The dietary supplement is incorporated into the toothpaste, the dietary supplement containing a water soluble vitamin portion including at least one water soluble vitamin and an oil soluble vitamin portion. The oil soluble vitamin portion includes at least one oil soluble vitamin, a carrier oil and an emulsifier. The toothpaste is thereby formulated in a manner such that oral application will result in systemic delivery of at least a portion of the dietary supplement to meet a 2% RDI threshold even when 3 or less serving sizes are orally applied. 127-. (canceled)28. A non-fluoride containing dietary supplement enriched toothpaste suitable for ingestion , said toothpaste comprising:a) a dentally acceptable oral vehicle having a pasty consistency;b) an oil phase containing a carrier oil, an emulsifier and a dietary supplement comprising at least one oil soluble vitamin; andc) an aqueous phase containing water and a dietary supplement comprising at least one water soluble vitamin;wherein a serving size amount of the toothpaste contains at least 2 percent of a reference daily intake (RDI) of the dietary supplement.29. The toothpaste of wherein the serving size amount contains at least about 10% to 80% of the RDI of the dietary supplement.30. The toothpaste of wherein the serving size amount contains at least about 10% to 150% of the RDI of the dietary supplement.31. The toothpaste of wherein the serving size amount contains at least about 50% to about 150% of the RDI of the dietary supplement.32. The toothpaste of wherein the serving size amount contains at least about 50% of the RDI of the dietary supplement.33. The toothpaste of wherein the serving size amount contains at least about 80% of the RDI of the dietary supplement.34. The toothpaste of wherein the serving size amount comprises from about 0.5 to ...

COMPOSITIONS COMPRISING DEHYDRATED MICRO-ORGANISMS, METHOD OF PREPARATION THEREOF, AND USES THEREOF

The invention relates to a composition comprising revivable dehydrated micro-organisms. The invention is characterised in that it further comprises particles at least 50% of which have a mean diameter greater than 250 μm. The invention is applicable, in particular, to human or veterinary pharmaceuticals, to dietetics or to food products. 113-. (canceled)14. A method of preparing a food or medicinal composition , wherein the method comprises:{'i': Lactobacillus plantarum', 'Streptococcus infantarius, 'dehydrating uncoated, revivable micro-organisms, wherein the micro-organisms are a mixture of and ; and'}mixing the dehydrated uncoated, revivable micro-organisms with particles,wherein (i) each of said particles has a mean diameter, (ii) the mean diameters of said particles are distributed almost exclusively in a range of from 50 to 1,000 μm, (iii) about 65% of said particles have a mean diameter greater than 250 μm, and (iv) about 35% of said particles have a mean diameter of at most 250 μm,so as to form a composition comprising about 33% w/w revivable dehydrated micro-organisms, and further comprising about 67% w/w particles, wherein the micro-organisms are mixed with the particles in the composition,wherein the particles are granules comprising an aggregated and granulated mixture of (i) vitamins, trace elements, amino acids, sugars, and minerals or the salts thereof, and (ii) at least one carrier, and wherein the granules are substantially devoid of micro-organisms,wherein the composition has a water activity lower than 0.3, andwherein the micro-organisms in the composition have a revivability such that, after being kept moisture-free and at room temperature for 18 months, the composition comprises at least 20% revivable micro-organisms from amongst 100% revivable micro-organisms initially present in said composition.15. The method of claim 14 , being carried out under controlled moisture conditions ensuring a water activity lower than 0.2 in the composition ...

NEW PARTICLE STABILIZED EMULSIONS AND FOAMS

The present invention relates to a particle stabilized emulsion or foam comprising at least two phases and solid particles, wherein said solid particles are starch granules and said starch granules or a portion thereof are situated at the interface between the two phases providing the particle stabilized emulsion or foam. The invention further relates to the use of said particle stabilized emulsion or foam for encapsulation of substances chosen from biopharmaceuticals, proteins, probiotics, living cells, enzymes and antibodies, sensitive food ingredients, vitamins, and lipids in food products, cosmetic products, skin creams, and pharmaceutical formulations. 1. A particle stabilized emulsion or foam comprising at least two phases and solid particles , wherein said solid particles are starch granules and said starch granules or a portion thereof are situated at the interface between the two phases providing the particle stabilized emulsion or foam.2. A particle stabilized emulsion or foam according to claim 1 , wherein the starch granules have been subjected to physical modification and/or chemical modification to increase the hydrophobicity of the starch granules.3. A particle stabilized emulsion or foam according to claim 2 , wherein the physical modification is performed by dry heating or by other means that partially denature surface proteins.4. A particle stabilized emulsion or foam according to claim 2 , wherein the chemical modification is performed by alkenyl succinyl anhydride treatment or by grafting with other chemicals with a hydrophobic side chain.5. A particle stabilized emulsion or foam according to claim 1 , wherein the starch granules have a small granular size in the range of approximately 0.2-20.6. A particle stabilized emulsion or foam according to claim 1 , wherein the starch granules are obtained from any botanical source.7. A particle stabilized emulsion or foam according to claim 6 , wherein the starch granules are obtained from quinoa claim 6 ...

Method for Prolonging the Life of Animals

A method for increasing the longevity of an old animal comprising administering to the animal a composition comprising one or more antioxidants in a total antioxidant amount sufficient to increase the longevity of the animal. 1. An article of manufacture comprising:a package containing a composition that comprises one or more antioxidants in a total antioxidant amount sufficient, when administered to an old animal, to increase the longevity of the animal; anda means for communicating information about or instructions for administering the composition to an old animal to increase the longevity of the animal, said communicating means being attached to or enclosed in the package.2. A kit comprising:a first package containing a composition that comprises one or more antioxidants in a total antioxidant amount sufficient, when administered to an old animal, to increase the longevity of the animal;a second package containing a food base; anda means for communicating information about or instructions for (i) adding the antioxidant-comprising composition to the food base, and (ii) administering the resulting antioxidant-fortified composition to an old animal to increase the longevity of the animal.3. A means for communicating information about or instructions for administering nun old animal a. composition that comprises one or more antioxidants in a. total antioxidant amount sufficient to increase the longevity of the animal , the means comprising a label , a brochure , an advertisement , a package insert , a computer-readable digital or optical medium , an audio presentation , a visual presentation , or one or more pages on a website , containing the information or instructions. This application claims priority to U.S. Provisional Application Ser. No. 60/699,145 filed Jul. 14, 2005, the disclosure of which is incorporated herein by reference.The invention relates generally to methods for prolonging the life of animals and particularly to the use of antioxidants for ...

Renal function with quercetin-containing compositions

This invention relates to a method of improving renal function by administering to a subject in need thereof an effective amount of a composition containing quercetin, vitamin C, vitamin B3, and folic acid.

ANTI-FATIGUE COMPOSITION AND USE THEREOF

Disclosed is a composition with a sustainable anti-fatigue function and which helps the body to restore the level of high-energy phosphate materials and increases energy, wherein the active ingredients thereof are ribose and caffeine. The composition comprises components with the following weight parts: 1-99.9 parts ribose and 0.1-99 parts coffee or 1-99.99 parts ribose and 0.01-99 parts caffeine. 1. A composition containing ribose and caffeine as effective ingredients , which has a sustainable anti-fatigue effect and helps the body restore the level of high-energy phosphate substances and increase energy.2. The composition according to claim 1 , further comprising the following components in parts by weight: 1-99.9 ribose and 0.1-99 coffee claim 1 , or 1-99.99 ribose and 0.01-99 caffeine.3. The composition according to claim 1 , further comprising one or more selected from the group consisting of: milk powder or fresh milk claim 1 , amino acids claim 1 , sugars claim 1 , sugar alcohols claim 1 , cereals claim 1 , cocoa claim 1 , chocolate claim 1 , non-saccharide and sugar alcohols sweeteners claim 1 , pectin claim 1 , soluble dietary fibers claim 1 , salts claim 1 , other carbohydrates claim 1 , vitamins claim 1 , minerals claim 1 , carbon dioxide or other food additives; wherein claim 1 ,the amino acids comprise one or more of taurine, pyruvic acid, ketoglutaric acid, arginine and citrulline;the sugars comprise one or more of glucose, sucrose or fructose;{'i': 'Momordica grosvenori', 'the non-saccharide and sugar alcohols sweeteners comprise one or more of stevia, aspartame, sucralose, , glycyrrhizin, beet sweetener or saccharin sodium;'}the sugar alcohols comprise one or more of xylitol, erythritol, maltitol, isomalt orsorbitol;the minerals comprise one or more elements of calcium, magnesium, iron and zinc; the salts comprise one or more salts of sodium, potassium and phosphate; said other carbohydrates comprise wheat flour, inulin, oligosaccharides, starch and/ ...

DIETARY SUPPLEMENTS FOR PROMOTION OF GROWTH, REPAIR, AND MAINTENANCE OF BONE AND JOINTS

The present invention provides a dietary supplement that promote the growth, repair, and maintenance of mammalian bone and joint connective tissue. In particular, the dietary supplement comprises a combination of at least one metal chelate and at least one chondroprotective agent. 1. A dietary supplement comprising at least one chondroprotective agent and at least one metal chelate; the metal chelate comprising at least one metal ion and at least one ligand.2. The dietary supplement of claim 1 , further comprising at least one ingredient selected from the group consisting of vitamin claim 1 , mineral claim 1 , amino acid claim 1 , antioxidant claim 1 , yeast culture claim 1 , anti-inflammatory agent claim 1 , and essential fatty acid.3. The dietary supplement of claim 1 , wherein the average ligand to metal ion ratio is from about 1:1 to about 3:1.4. The dietary supplement of claim 1 , wherein the metal ion is selected from the group consisting of zinc ions claim 1 , copper ions claim 1 , manganese ions claim 1 , magnesium ions claim 1 , iron ions claim 1 , chromium ions claim 1 , calcium ions claim 1 , and combinations thereof.5. The dietary supplement of claim 3 , wherein the metal ions are manganese ions claim 3 , zinc ions claim 3 , and copper ions.6. The dietary supplement of claim 1 , wherein the chondroprotective agent is selected from the group consisting of glucosamine claim 1 , chondriotin claim 1 , hyaluronic acid claim 1 , collagen claim 1 , concentrated eggshell membrane claim 1 , and green-lipped mussel.7. The dietary supplement of claim 1 , wherein the ligand is selected from alanine claim 1 , arginine claim 1 , asparagine claim 1 , aspartic acid claim 1 , cysteine claim 1 , glutamine claim 1 , glutamic acid claim 1 , glycine claim 1 , histidine claim 1 , isoleucine claim 1 , leucine claim 1 , lysine claim 1 , methionine claim 1 , phenylalanine claim 1 , proline claim 1 , serine claim 1 , threonine claim 1 , tryptophan claim 1 , tyrosine claim 1 , ...

NUTRITIONAL SUPPLEMENT SYSTEM

A multi-part nutritional supplement system supplies nutrients to a user at advantageous locations in the digestive tract. One type of dosage unit is formulated to release vitamin B12 in the stomach and intestines of the upper GI tract, advantageously in an amount that is greater than or at multiple levels of the DV (Daily Value) of vitamin B12. 1. A nutritional supplement system for human subjects , a daily dose of the nutritional supplement system comprising phosphorus , magnesium , zinc , manganese , boron , copper , chromium , molybdenum , nickel , tin , vanadium , selenium , silicon , calcium , iodine , vitamin A , vitamin B1 , vitamin B2 , vitamin B3 , vitamin B5 , vitamin B6 , vitamin B12 , vitamin C , vitamin D , vitamin E , folic acid , biotin , lutein , lycopene , one or more omega-3 fatty acids , and one or more tocopherols , the daily dose of the nutritional supplement system consisting essentially of four nutritional supplement dosage units , wherein:a first nutritional supplement dosage unit comprises one or more nutrients being selected from phosphorus, magnesium, vitamin C, zinc, vitamin E, manganese, vitamin B3, boron, copper, vitamin A, beta carotene, vitamin B5, chromium, molybdenum, nickel, tin, vanadium, iron, selenium, vitamin K, N-acetyl cysteine, silicon, vitamin B6, vitamin B1, vitamin B2, vitamin B12, vitamin D, folate, folic acid, biotin, iodine and any combination thereof, the first dosage unit being in the form of at least one first dosage element formulated to release one or more nutrients in the stomach of a human subject;a second nutritional supplement dosage unit comprises one or more nutrients being selected from lutein, lycopene, vitamin D, vitamin E, omega-3 fatty acids, gamma tocopherol, beta tocopherol, delta tocopherol, and any combination thereof, the second dosage unit being in the form of at least one second dosage element formulated to release one or more nutrients in the upper intestinal tract of the subject;a third ...

Method for treating metabolic syndrome and diabetes using quercetin and bauhinia forficata extract

This invention relates to a method of treating metabolic syndrome and diabetes using a composition containing quercetin, vitamin B 3 , vitamin C, and a Bauhinia forficata extract.

READY TO EAT COLD VEGETABLE CAKES WITH INGREDIENTS

Cold and ready to eat vegetable cakes, and with a variety of ingredient combinations are suitable for healthy consumption. The vegetable cakes are soft in texture and high in nutrition. People can save the time and energy of preparing and cooking of the food. Serving size can be a single serving, and a six pack of serving. Vegetable cakes are also created as vegetable egg cakes, vegetable plus salt source cakes, vegetable seafood cakes, vegetable meat cakes, vegetable bubbles, vegetables balls, vegetable patties, and vegetable sausages. They can be served as cold and hot food for breakfast, lunch, snack, and dinner. They can also be used as animal food, baby food, for children with less teeth, for old people, and for sick people. Cold and ready to eat vegetable cakes with ingredients offer the consumers an easy and convenient way to obtain an affordable, nutritious, and delicious meal. 1. A ready to eat cold vegetable cake product comprising:a vegetable cake, havingat least one vegetable,at least one liquid ingredient, andat least one binding agent;wherein said vegetable cake is soft in texture, high in nutrition, and suitable for consumption by everybody, including animal, infant, small children, old people, and sick people; andwherein said vegetable cake can be served as breakfast, lunch, snack, and dinner.2. The ready to eat cold vegetable cake product of wherein said vegetable cake with gelatin as said at least one binding agent can be refrigerated to serve cold but not reheated because gelatin from fish and animal congeals below 15 degrees Celsius; and said vegetable cake with said at least one binding agent selected from group consisting of beaten egg claim 1 , egg white claim 1 , and starch component can be served at room temperature claim 1 , refrigerated to serve cold claim 1 , and reheated to serve hot.3. The ready to eat cold vegetable cake product of wherein said at least one vegetable having preparation selected from group consisting of removing outer ...

DIPEPTIDE AND TRIPEPTIDE COMPOSITIONS AND USES

A composition of dipeptides or tripeptides or ester derivatives may be used as a nutritional supplement and to modulate expression of genes associated with healthy maintenance and regulation of muscular and neurological tissue. The compositions include dipeptides and/or tripeptides of branched chain amino acids and optionally include adjuvants, anti-aging compounds and may be provided in a dissolvable powder or liquid form. 1. An orally-administrable nutritional product comprising one or more dipeptides or tripeptides selected from the group consisting of L-Creatyl-L-Leucine , Creatyl-L-Leucine , L-leucyl-L-isoleucine , L-Leucyl-L-leucine , L-Isoleucyl-L-Leucine , L-Isoleucyl-L-isoleucine , L-Leucyl-L-isoleucyl-L-Leucine , L-leucyl-L-leucyl-L-isoleucine and L-Isoleucyl-L-Leucyl-L-leucine.2. The orally-administrable nutritional product of further comprising one or more anti-aging compounds selected from the group consisting of ephedrine claim 1 , caffeine claim 1 , omega-3 fatty acids (fish oil) claim 1 , butein claim 1 , piceatannol claim 1 , fisetin claim 1 , quercetin claim 1 , isoliquiritigenin claim 1 , casokinins and lactokinins claim 1 , casein claim 1 , whey claim 1 , lactotripeptides and creatine.3. The orally-administrable nutritional product of further comprising a nutritional adjuvant selected from the group consisting of flavoring agents claim 1 , colorants claim 1 , viscosity modifiers claim 1 , preservatives claim 1 , chelating agents claim 1 , antioxidants claim 1 , creatine and surface modifiers.4. The orally-administrable nutritional product of further comprising one or more ingredients selected from the group consisting of amino acids claim 1 , vitamins claim 1 , minerals claim 1 , essential fatty acids claim 1 , enzymes claim 1 , mono-glycerides claim 1 , di-glycerides claim 1 , tri-glyceride ester oils claim 1 , emulsifiers claim 1 , hydrolyzed proteins claim 1 , whey protein claim 1 , creatine claim 1 , stabilizers claim 1 , flow modifiers claim ...

INFANT FORMULA MILK POWDER AND PREPARATION METHOD THEREOF

The present invention relates to an infant formula milk powder capable of preventing and alleviating infant iron deficiency anemia and a preparation method thereof. The formula milk powder comprises components such as vegetable oil, fresh milk, whey powder, lactose powder, whey protein powder, oligosaccharides, complex vitamins and complex minerals, wherein the lactoferrin and vitamin C, or alternatively, an iron source (calculated as iron), lactoferrin and vitamin C are maintained in the appropriate mass ratios, and the formula milk powder of the present invention is obtained by performing mixing, homogenizing, cooling, concentrating and spray-drying, packaging or directly using a step-by-step mixing method. The formula milk powder comprises appropriate amounts of vitamin C and lactoferrin, as well as an appropriate amount of iron source as further provided, and the three are combined according to an appropriate proportion, so that the combination of the three kinds of the substances have a synergistic effect, and the absorption and utilization rate of iron are increased dramatically, thereby not only achieving the desirable iron supplementation effect, but also preventing and alleviating the phenomenon of infant iron deficiency anemia. 1. An infant formula milk powder , comprising the following components (parts by weight): 5-20 parts of vegetable oil , 187-427 parts of fresh milk (containing 11.1% of dry matter) , 20-35 parts of whey powder , 12.23-21.753 parts of lactose , 2-4 parts of whey protein powder , 1.5-2.5 parts of oligosaccharides , 0.15-0.2 parts of complex vitamins , 0.35-0.6 parts of complex minerals , 1-1.5 parts of other nutrients , 0.02-0.1 parts of lactoferrin , and vitamin C , wherein the mass ratio of lactoferrin to vitamin C is 1:3 to 1:1.2. An infant formula milk powder , comprising the following components (parts by weight): 25-35 parts of vegetable fat powder , 30-42.5 parts of powdered milk , 21.5-30 parts of whey powder , 1.096-8.93 ...

SOLID, COLOR-STABLE L-ASCORBIC ACID COMPOSITIONS

The present invention relates to solid, color-stable L-ascorbic acid compositions, which are in the form of a powder or granule. These improved compositions have a high amount of vitamin C and they have excellent color stability. 1. Composition in the form of a powder or granules comprising:(a) 75 wt-%-99 wt-%, based on the total weight of the powder or granule, of L-ascorbic acid and/or a salt thereof,(b) 0.1 wt-%-10 wt-%, based on the total weight of the powder or granule, of ascorbyl palmitate or of a mixture of ascorbyl palmitate and at least one compound chosen from the group consisting of hydrogenated vegetable oil, glyceryl behenate, glyceryl monostearate, glyceryl palmitostearate, stearic acid, palmitic acid, myristic acid, talc, sodium lauryl sulfate, waxes, sodium stearyl fumarate, and polyethylene glycol, and(c) 0.9 wt-%-10 wt-%, based on the total weight of the powder or granule, of at least one binder, and(d) optionally adjuvants in quantities within the range of 0.05 wt-%-5 wt-%, based on the total weight of the powder or granule, with the proviso that the composition is essentially free from magnesium stearate.2. Composition according to claim 1 , wherein the salt of L-ascorbic acid is sodium ascorbate.3. Composition according to claim 1 , wherein the binder is chosen from the group consisting saccharides and their derivatives claim 1 , proteins claim 1 , synthetic polymers claim 1 , microcrystalline cellulose claim 1 , silicified microcrystalline cellulose claim 1 , hydroxypropyl cellulose claim 1 , starch claim 1 , lactose claim 1 , dicalcium phosphate claim 1 , sucrose claim 1 , dextrose claim 1 , and sugar alcohols.4. Composition according to claim 1 , which has been produced by fluidized-bed granulation claim 1 , high-shear granulation claim 1 , extrusion claim 1 , spray-drying or wet granulation.5. Use of a composition according to claim 1 , in a dietary supplement claim 1 , food claim 1 , feed or personal care formulation.6. Composition ...

EDIBLE COMPOSITION SUITABLE FOR LOWERING SERUM CHOLESTEROL

The present invention relates to an edible composition comprising plant sterol ester and/or plant stanol ester and triglyceride fat usable for lowering serum LDL cholesterol. The composition further comprises oligosaccharides and sugars. The composition can preferably be used in dietary supplements, fillings and toppings. 1. An edible composition comprising:total fat in an amount of at least 50% by weight, wherein the total fat comprises a mixture of a) plant sterol ester and/or plant stanol ester and b) triglyceride fat, the amount of plant sterol ester and/or plant stanol ester being at least 30% by weight of the composition and the amount of triglyceride fat being at least 10% by weight of the composition, provided that the amount of plant sterol ester and/or plant stanol ester is at least 40% by weight of the total fat,at least one monosaccharide, disaccharide or sugar alcohol in such an amount that the total amount of monosaccharides, disaccharides and sugar alcohols is at most 18% by weight,at least one oligosaccharide in such an amount that the ratio of the total amount of oligosaccharides to the total amount of monosaccharides, disaccharides and sugar alcohols is from 1:0.2 to 1:0.9, andmoisture in an amount of at most 8% by weight.2. The composition according to claim 1 , wherein it is a dietary supplement claim 1 , a filling or a topping claim 1 , preferably a dietary supplement claim 1 , a biscuit filling or a wafer filling claim 1 , more preferably a dietary supplement claim 1 , and most preferably a chewable dietary supplement.3. The composition according to claim 2 , wherein at least 2.0 g claim 2 , preferably at least 2.5 g claim 2 , more preferably at least 3.0 g and most preferably at least 3.4 g plant sterol ester and/or plant stanol ester is provided by one serving of the dietary supplement claim 2 , biscuit or wafer.4. The composition according to claim 1 , wherein the amount of total fat is 50-80% claim 1 , preferably 55-80% claim 1 , more ...

QUICK DISSOLVE NUTRITIONAL POWDER

The present disclosure provides a rapidly disintegrating orally administrable powder. The powder may include an active ingredient such as a dietary supplement. Methods of using the same are also provided herein. 1. A composition comprising a powder including:at least one bulking agent;at least one sweetening ingredient; andat least one active ingredient selected from the group consisting of Vitamin A, Vitamin C, Vitamin D, Vitamin E, Thiamin, Riboflavin, Niacin, Vitamin B6, Folate, Vitamin B12, Pantothenic Acid, Biotin, Chromium, Copper, Iodine, Iron, Manganese, Molybdenum, Selenium, Zinc, Boron, omega-3 fatty acids, coenzyme Q10, calcium, probiotics, and combinations thereof,wherein the powder dissolves in the mouth upon contact with saliva.2. The composition of claim 1 , the powder further comprising a flow agent selected from the group consisting of sodium bicarbonate claim 1 , sodium ferrocyanide claim 1 , postassium ferrocyanide claim 1 , calcium ferrocyanide claim 1 , bone phosphate claim 1 , sodium silicate claim 1 , silicon dioxide claim 1 , calcium silicate claim 1 , magnesium trisilicate claim 1 , talcum powder claim 1 , sodium aluminosilicate claim 1 , potassium aluminum silicate claim 1 , calcium aluminosilicate claim 1 , bentonite claim 1 , aluminum silicate claim 1 , stearic acid claim 1 , polydimethylsiloxane claim 1 , and combinations thereof.3. The composition of claim 1 , wherein the at least one bulking agent is selected from the group consisting of polyols claim 1 , sucrose claim 1 , maltodextrin claim 1 , and combinations thereof.4. The composition of claim 3 , wherein the polyol is selected from the group consisting of mannitol claim 3 , xylitol claim 3 , sorbitol claim 3 , maltitol claim 3 , erythritol claim 3 , isomalt claim 3 , lactitol claim 3 , polyglycitol claim 3 , and combinations thereof.5. The composition of claim 1 , wherein the sweetening ingredient is selected from the group consisting of stevia claim 1 , sucralose claim 1 , ...

DIETARY SUPPLEMENT CONTAINING PHOSPHOLIPID-DHA DERIVED FROM EGGS

Described herein are manufactured dietary supplements that contain a phospholipid extract, folic acid, vitamin D, vitamin B, vitamin B, Vitamin E, Vitamin C, iodine, iron, and magnesium. 1. A composition , comprising: 'an effective amount of stabilizer that improves shelf life.', 'a phospholipid extract at a concentration ranging from 50 mg to 600 mg, the phospholipid extract having phosphatidylcholine-docosahexaenoic acid and phosphatidylethanolamine-docosahexaenoic acid at a ratio ranging from about 1:1 to about 2:1, wherein the amount of phospholipid-docosahexaenoic acid comprises about 10% the amount of phospholipids in the supplement, and'}2. The composition of claim 1 , additionally comprising: an amount of Vitamin D between 100 IU and 2000 IU,', {'sub': '6', 'an amount of Vitamin Bbetween 0.5 mg and 5 mg,'}, {'sub': '12', 'an amount of Vitamin Bbetween 10 mcg and 1 mg,'}, 'an amount of Vitamin E between 10 IU and 100 IU,', 'an amount of Vitamin C between 50 mg and 150 mg,', 'an amount of Iodine between 50 mcg and 300 mcg,', 'an amount of Iron between 10 mg and 30 mg, and', 'an amount of Magnesium between 5 mg and 30 mg., 'an amount of folic acid between 400 mcg and 800 mcg,'}3. The composition of claim 1 , wherein the amount of phospholipid extract is about 150 mg.4. The composition of claim 1 , wherein the amount of phospholipid-DHA is about 15 mg.5. The composition of claim 2 , wherein the amount of phospholipid extract is about 89 mg.6. The composition of claim 2 , wherein the amount of phospholipid-DHA is about 9 mg.7. The composition of claim 2 , wherein the amount of Vitamin D is about 1000 IU,', {'sub': '6', 'the amount of Vitamin Bis about 5 mg,'}, {'sub': '12', 'the amount of Vitamin Bis about 1.9 mg,'}, 'the amount of Vitamin E is about 20 IU,', 'the amount of Vitamin C is about 100 mg,', 'the amount of Iodine is about 1500 mcg,', 'the amount of Iron is about 27 mg, and', 'the amount of Magnesium is about 7.5 mg., 'the amount of folic acid is about ...

Additives and supplements

Disclosed are ingestible additives and ingestible supplements that are capable of promoting liver function, promoting liver health, or reducing alcoholic hepatopathy in a subject. The ingestible additive or supplement can include at least one essential amino acid, at least non-essential amino acid, at least one antioxidant, at least one lipotropic compound, at least one water-soluble vitamin, or at least one plant or extract thereof.

FORTIFIED MICRONUTRIENT SALT FORMULATIONS

Salt formulations, which are resistant to moisture and cooking conditions, are described herein. The formulations provide particles of micronutrients and vitamins encapsulated within heat resistant pH-sensitive water-insoluble polymers, which are packaged within a salt shell. The pH-sensitive, water-insoluble, thermally stable materials stabilize the micronutrients, particularly at high temperatures, such as during food preparation and cooking, and release the micronutrients at the desired locations such as the stomach, small intestine, etc. Preferred pH-sensitive polymers release at a low pH, less than the pH present in the stomach. The particles can be used to deliver daily-recommended doses of micronutrients simultaneously with salt, eliminating the need for vitamin pills. This is particularly important in populations suffering from severe malnutrition. 1. A salt formulation comprising:particles comprising one or more therapeutic agents, prophylactic agents, nutraceutical agents, diagnostic agents, or combinations thereofa matrix formed of inert excipient having the particles dispersed therein,a pH-sensitive polymer coating on the outer surface of, or surrounding, the matrix, wherein the polymer coating is resistant to permeation of water into the matrix and provides release of the particles upon exposure to a defined pH, anda coating of one or more salts on the pH-sensitive polymer coating,wherein the formulation is stable up to one hour at 100° C.2. The formulation of claim 1 , wherein the particles comprise vitamins claim 1 , trace minerals claim 1 , micronutrients claim 1 , or combinations thereof.3. The formulation of claim 1 , wherein the matrix is partially of wholly formed of materials selected from the group consisting of salts claim 1 , sugars claim 1 , carbohydrates claim 1 , oils claim 1 , fats claim 1 , waxes claim 1 , proteins claim 1 , and combinations thereof.4. The formulation of claim 1 , wherein the matrix is partially or wholly formed of a ...

NOVEL COATING SYSTEM

The present patent application relates to a novel coating system, coated compositions with such a coating system, as well as to the use of such compositions in the production food, feed, dietary supplements and/or pharmaceutical products, as well as to food, feed, dietary supplements and/or pharmaceutical products comprising such compositions. 2. Coating system according to claim 1 , wherein the mass median diameter of the lipid compound is less than 0.8 μm.3. Coating system according to claims claim 1 , wherein the lipid compound is a saturated fatty acid as well as salts thereof.4. Coating system according to claim 1 , wherein the gum having emulsifying properties is chosen from the groups consisting of gum acacia claim 1 , gum ghatti and tic gums.5. Coating system according to claim 1 , wherein the film forming compound is a hydrocolloid claim 1 , preferably alginates claim 1 , pectins claim 1 , guar gum claim 1 , caroube gum claim 1 , xanthan gum claim 1 , starches claim 1 , modified starches claim 1 , cellulose and cellulose derivates (such as carboxymethylcellulose or hydroxypropylmethylcellulose).6. Coating system according to claim 1 , wherein the emulsifier is chosen from the group consisting of sucrose ester claim 1 , ascorbyl palmitate and polyoxyethylene-sorbitan-fatty acid esters.7. Coating system according to claim 1 , wherein the coating system comprises at least one plasticizer.8. Coating system according to comprising 10 to 50 wt-% of at least one lipid compound claim 1 , preferably claim 1 , 20 to 40 wt-% claim 1 , based on the total weight of the coating system.9. Coating system according to comprising 5 to 30 wt-% of at least one gum having emulsifying properties claim 1 , preferably 10 to 25 wt-% claim 1 , based on the total weight of the coating system.10. Coating system according to comprising 40 to 80 wt-% claim 1 , preferably 45 to 70 wt-% of at least one film forming compound and/or at least one emulsifier claim 1 , based on the total ...

IMPROVED POWDEROUS FORMULATIONS OF ORGANIC ACID AMIDES HAVING AN AROMATIC RING SYSTEM

The present invention relates to improved powderous formulations comprising organic acid amides having an aromatic ring system as well as to the production of such formulations. 2. Powderous formulations according to claim 1 , wherein{'sup': '1', 'sub': 3', '2', '3', '2', '2', '3', '2', '3', '3, 'Rin the definition of formula (I) is H, CH, CHCH, (CH)CHand (CH)CH, and'}{'sup': '2', 'sub': 3', '2', '3', '2', '2', '3', '2', '3', '3, 'Rin the definition of formula (I) is H, CH, CHCH, (CH)CHand (CH)CH, and X is N.'}3. Powderous formulations according to claim 1 , wherein{'sub': 2', '3, 'Ris H or CH, and'}{'sub': 1', '3., 'Ris H or CH'}6. Powderous formulations according to claim 1 , wherein the auxiliary compound has an average particle size (d 0.5) of 10 μm-100 μm.7. Powderous formulations according to claim 1 , having MIE values of 10-100 mJ (determined by the method of EN 13821:2002).8. Powderous formulations according to claim 1 , wherein 0-5 wt-% claim 1 , based on the total weight of the formulation claim 1 , of water is present.9. Powderous formulations according to claim 1 , optionally comprising a carrier material chosen from the group consisting of synthetically produced precipitated silica or formiate (such as calcium formiate) claim 1 , proteins claim 1 , starches claim 1 , lignosulfonates and gums.10. Powderous formulations according to claim 1 , comprising(ii) 5-35 wt-%, (preferably 10-30 wt-%), based on the total weight of the formulation, of at least one compound selected from the group consisting of ammonium dihydrogen phosphate, (purified) diatomaceous earth, potassium hydrogen carbonate, potassium sulphate, potassium carbonate, sodium chloride and sodium hydrogen carbonate.12. Use of at least one formulation according to in food products claim 1 , feed products and personal care products.13. Food products claim 1 , feed products and personal care products comprising at least one formulation according to . The present invention relates to improved ...

IMPROVED POWDEROUS FORMULATIONS OF ORGANIC ACIDS OR ESTERS HAVING AN AROMATIC RING SYSTEM

The present invention relates to improved powderous formulations comprising a high amount of at least one organic acids or esters having an aromatic ring system, as well as to the production of such formulations. 3. A powderous formulation according to claim 1 , wherein the auxiliary compounds have an average particle size (d 0.5) (in the powder formulation) of 10 μm-100 μm.4. A powderous formulation according to claim 1 , wherein the formulations have MIE values of 10-1000 mJ.5. A powderous formulation according to claim 1 , wherein the formulations have MIE values of more than 1000 mJ.6. A powderous formulation according to claim 1 , comprising 0-5 wt-% claim 1 , based on the total weight of the formulation claim 1 , of water.7. A powderous formulation according to claim 1 , wherein the formulations comprise(ii) 10-30 wt-%, based on the total weight of the formulation, of at least one compound selected from the group consisting of ammonium dihydrogen phosphate, (purified) diatomaceous earth, potassium hydrogen carbonate, potassium sulphate, potassium carbonate, sodium chloride and sodium hydrogen carbonate.8. A powderous formulation according to claim 1 , wherein the formulations comprise(iii) up to 40 wt-%, based on the total weight of the formulation, of at least one carrier material chosen from the group consisting of synthetically produced precipitated silica, formiate (such as calcium formiate), proteins, starches, lignosulfonates and gums.10. Use of at least one formulation according to in food products claim 1 , feed products and personal care products.11. Food products claim 1 , feed products and personal care products comprising at least one formulation according to . The present invention relates to improved powderous formulations as well as to the production of such formulations.Powderous formulations of organic acids or esters having an aromatic ring system are very common and useful formulations.Examples of such organic acids or esters are niacin and ...

Glyceride Composition

A composition for use in developing and/or improving brain function comprises a glyceride having a palmitoyl group at the 2-position wherein at least 40% by weight of the palmitic acid content of the composition is present as palmitoyl groups bonded at the 2-position of a glyceride. 1. Composition comprising a glyceride having a palmitoyl group at the 2-position wherein at least 40% by weight of the palmitic acid content of the composition is present as palmitoyl groups bonded at the 2-position of a glyceride , for use in developing and/or improving brain function.2. Composition as claimed in claim 1 , for use in developing and/or improving brain function by increasing the level of oleoylethanolamide.3. Composition as claimed in claim 1 , wherein the glyceride having a palmitoyl group is a triglyceride.4. Composition as claimed in claim 1 , wherein the glyceride having a palmitoyl group is 1 claim 1 ,3-dioleoyl-2-palmitoyl glyceride (OPO).5. Composition as claimed in claim 1 , wherein the glyceride having a palmitoyl group is derived from a vegetable source.6. Composition as claimed in claim 1 , wherein the glyceride having a palmitoyl group is produced by the reaction of palm oil stearin with oleic acid or an ester thereof in the presence of a lipase.7. Composition as claimed in claim 1 , which comprises alpha-linolenic acid or a derivative thereof in an amount of greater than 1% by weight alpha-linoleic acid based on total free and bound Cto Cfatty acids and/or linoleic acid or a glyceride thereof claim 1 , and wherein the weight ratio of total free and bound linoleic acid to total free and bound alpha-linolenic acid is preferably 15:1 or less.8. Composition as claimed in which is a blend comprising (i) a composition comprising alpha-linolenic acid or a glyceride thereof and (ii) a triglyceride composition comprising OPO in an amount of at least 20% by weight claim 1 , and wherein the composition comprising alpha-linolenic acid or a glyceride thereof is preferably ...

NUTRITIONAL COMPOSITION FOR PROMOTING MUSCULOSKELETAL HEALTH IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE (IBD)

A nutritional composition for promoting musculoskeletal health in patients with inflammatory bowel disease is disclosed. The nutritional composition comprises casein protein, vitamin K in a ratio of vitamin K1:vitamin K2 being between 3:1 to 1:3 and the vitamin K providing between 3.5-20 μg/100 kcal of the nutritional composition, vitamin D and alpha-linolenic acid. A pharmaceutical formulation, a nutritional formulation, a tube-feed formulation, a dietary supplement, a functional food, a beverage product or a combination thereof comprising the nutritional composition is also disclosed. A method for improving musculoskeletal health is also disclosed. 1. A nutritional composition comprising:acid casein protein;vitamin K at a ratio of vitamin K1:K2 of between 3:1 to 1:3 and the vitamin K present in an amount of between 17.5 to 100 μg/100 g of the nutritional composition;vitamin D present in an amount of between 2.5 to 75 μg/100 g of the nutritional composition; andn6/n3 fatty acids at a ratio of n6:n3 fatty acids of between 5:1 to 1:5 and mixtures thereof.2. The nutritional composition of claim 1 , wherein the n6 claim 1 , omega-6-fatty acids are selected from the group consisting of linolenic acid (LA) C18:2 claim 1 , gamma-linolenic acid (GLA) C18:3 claim 1 , eicosadienoic acid C20:2 claim 1 , dihomo-gamma-linolenic acid (DGLA) C20:3 claim 1 , arachidonic acid (AA) C20:4 claim 1 , docosadienoic acid C22:2 claim 1 , adrenic acid C22:4 claim 1 , docosapentaenoic acid C22:5 claim 1 , tetracosatetraenoic acid C24:4 claim 1 , tetracosapentaenoic acid C24:5 and Calendic acid C18:3 and mixtures thereof.3. The nutritional composition of claim 1 , wherein the n3 claim 1 , omega-3-fatty acid are selected from the group consisting hexadecatrienoic acid (HTA) C16:3 claim 1 , alpha-linolenic acid (ALA) C18:3 claim 1 , stearidonic acid (SDA) C18:4 claim 1 , eicosatrienoic acid (ETE) C20:3 claim 1 , eicosatetraenoic acid (ETA) C20:4 claim 1 , eicosapentaenoic acid (EPA) C20:5 ...

NUTRITIONAL SUPPLEMENT CONTAINING PHOSPHOLIPID-DHA DERIVED FROM EGGS

Described herein are manufactured dietary supplements that contain a phospholipid extract derived from eggs, where the extract contains phospholipid-docosahexanoic acid derived from eggs, folate, vitamin D, vitamin B6, vitamin B12, vitamin C, calcium, iron, N-Acytl-L-Cysteine, iodine, and magnesium. 1. A manufactured dietary supplement , comprising:an amount of phospholipid extract derived from eggs, wherein the extract comprises an amount of phospholipid-docosahexanoic acid derived from eggs,an amount of folate,an amount of Vitamin D,an amount of Vitamin B6,an amount of Vitamin B12,an amount of Vitamin C,an amount of Calcium,an amount of Iron,an amount of Iodine, andan amount of Magnesium.2. The manufactured dietary supplement of claim 1 , whereinthe amount of phospholipid extract is about 200 mg and the amount of phospholipid-docosahexanoic acid derived from eggs is between about 20 mg,the amount of folate is between about 400 mcg and about 1 mg,the amount of Vitamin D is about 1000 IU,the amount of Vitamin B6 is about 26 mg,the amount of Vitamin B12 is about 12 mcg,the amount of Vitamin C is about 70 mg,the amount of Calcium is about 15 mg,the amount of Iron is between about 5 mg and about 30 mg,the amount of Iodine is about 150 mcg, andthe amount of Magnesium is about 20 mg.3. The manufactured dietary supplement of claim 1 , wherein the phospholipid extract comprises phosphatidylcholine.4. The manufactured dietary supplement of claim 1 , wherein the phospholipid extract comprises phosphatidylethanolamine.5. The manufactured dietary supplement of claim 1 , wherein the phospholipid-docosahexanoic acid is phosphatidylcholine-docosahexanoic acid6. The manufactured dietary supplement of claim 1 , wherein the phospholipid-docosahexanoic acid is phosphatidylethanolamine-docosahexanoic acid.7. (canceled)8. The manufactured dietary supplement of claim 1 , wherein the phospholipid extract contains less than 5% free triglycerides.9. The manufactured dietary supplement of ...

BRAIN FUNCTION-IMPROVING COMPOSITION

Provided is a brain function-improving composition which can inhibit binding of homocysteic acid to a receptor (NMDA receptor) and, at the same time, decrease the binding ability of homocysteic acid per se to the receptor to thereby improve reduction in the brain function caused by the toxicity of homocysteic acid. The brain function-improving composition comprises 0.3-0.5 part by weight of a cinnamic acid derivative compound and 0.5-0.7 part by weight of a calcium hydride powder. Also, the brain function-improving composition is characterized by further comprising 0.4-0.6 part by weight of a green tea powder, 0.4-0.6 part by weight of a cocoa powder, 0.25-0.35 part by weight of a hydroxysilica powder, and 0.9-1.1 parts by weight of a dry Makino powder. 1. A brain function-improving composition which comprises 0.3-0.5 part by weight of cinnamic acid derivative compound and 0.5-0.7 part by weight of calcium hydride powder.2. The brain function-improving composition according to claim 1 , characterized by comprising 0.3-0.5 part by weight of ascorbic acid and/or 0.3-0.5 part by weight of lycopene.3Angelica shikokiana. The brain function-improving composition according to claim 1 , characterized by further comprising 0.4-0.6 part by weight of green tea powder claim 1 , 0.4-0.6 part by weight of cocoa powder claim 1 , 0.25-0.35 part by weight of hydroxysilica powder claim 1 , and 0.9-1.1 parts by weight of dry Makino powder.4. The brain function-improving composition according to claim 1 , characterized in that said cinnamic acid derivative compound is any one selected from ferulic acid claim 1 , caffeic acid claim 1 , sinapoic acid or the mixture thereof.5. A supplementary food claim 1 , which comprises the brain function-improving composition according to .6. A brain function-improving agent claim 1 , which comprises the brain function-improving composition according to .7Angelica shikokiana. The brain function-improving composition according to claim 2 , ...

KITS AND METHODS FOR NUTRITION SUPPLEMENTATION

The present invention relates to methods of co-administration of various vitamin and mineral compositions, and in a specific embodiment, said methods comprise co-administering one composition comprising vitamin A, beta carotene, B-complex vitamins, vitamin C, vitamin D, vitamin E, iron, magnesium and zinc, and a second composition comprising omega-3 fatty acids such as DHA, to supplement the nutritional needs of individuals within physiologically stressful states; and kits provided for co-administration of various vitamin and mineral compositions, and in a specific embodiment, said kits comprise one composition comprising vitamin A, beta carotene, B-complex vitamins, vitamin C, vitamin D, vitamin E, iron, magnesium and zinc, and a second composition comprising omega-3 fatty acids such as DHA, to supplement the nutritional needs of individuals within physiologically stressful states. 1. A kit comprising:{'sub': 1', '2', '3', '6', '9', '12', '3, 'a first flavored and chewable composition comprising vitamins and minerals and one or more pharmaceutically-acceptable carriers, wherein the vitamins and minerals being one or more selected from the group consisting of: vitamin A, beta carotene, vitamin B, vitamin B, vitamin B, vitamin B, vitamin B, vitamin B, vitamin C, vitamin D, vitamin E, iron, magnesium and zinc, and wherein the one or more pharmaceutically-acceptable carriers; and'}a second flavored soft gel composition comprising omega-3 fatty acids and one or more pharmaceutically-acceptable carriers.2. The kit of claim 1 , wherein the one or more pharmaceutically-acceptable carriers for the first composition comprises one or both of a flavorant and a sweetener.3. The kit of claim 2 , wherein the flavorant is one or more selected from the group consisting of: natural flavor oils claim 2 , synthetic flavor oils claim 2 , flavoring aromatics claim 2 , extracts from plants claim 2 , extracts from leaves claim 2 , extracts from flowers claim 2 , extracts from fruits claim ...

COMPOSITIONS COMPRISING VITAMIN K DERIVATIVES AND SALTS

This application relates to new formulations of vitamin K1 and K2 provitamins. These formulations can be used as nutraceuticals, e.g. for the fortification of foods or simply in supplements or can be used in pharmaceuticals for the treatment of a variety of conditions known to benefit from the administration of vitamin K1 and K2. 2. A unit dosage form comprising:{'claim-ref': {'@idref': 'CLM-00001', 'claim 1'}, '(A) 10 to 500 microg of the compound of formula (I) or (I′) as defined in ; and'}(B) 10 wt % or more, such as 20 wt % or more of at least one Li, Na, Mg, K, Ca, V, Cr, Mn, Fe, Co, Ni, Cu, Zn, Mo, or Se salt.3. A composition as claimed in any preceding claim wherein the composition comprises 25 to 200 microg of the compound of formula (I) or (I′).4. A composition as claimed in any preceding claim wherein the composition is a tablet.5. A composition as claimed in any preceding claim wherein the composition is a tablet formed by direct compression.6. A composition as claimed in any preceding claim wherein there is at least 40 wt % of calcium salt present in the composition.9. A composition as claimed in any preceding claim wherein the calcium salt is calcium carbonate.10. A composition as claimed in any preceding claim wherein neither R is hydrogen.11. A composition as claimed in any preceding claim wherein both R groups are identical.12. A composition as claimed in any preceding claim wherein both R groups are COCHor are not COCH.13. A composition as claimed in any preceding claim wherein one R is a —COCalkyl group or COAr group where Ar is an optionally substituted phenyl or naphthyl group , said substitutent being a C1-6 alkyl CHalH , CHalH , CHal , OH , OC1-6-alkyl , COOR; and Ris H or C1-6 alkyl.15. A process for the fortification of a food or drink comprising adding to said food or drink a compound of formula (I) or (I′) as hereinbefore defined; andat least one Li, Na, Mg, K, Ca, V, Cr, Mn, Fe, Co, Ni, Cu, Zn, Mo, or Se salt.16. A composition as claimed ...

Liquids and Foodstuffs Containing beta-hydroxy-beta-methylbutyrate (HMB) in the Free Acid Form and Methods of Manufacturing or Producing the Same

Liquids, substantially clear liquids and foodstuffs are described that contain free acid HMB. The liquids, substantially clear liquids and foodstuffs are substantially free of crude fat and may contain soluble proteins, carbohydrates, vitamins, minerals, amino acids, flavorings and other components. The products are shelf-stable and are substantially free of separation, gelation, sedimentation and coagulation. 1. A substantially clear , non-emulsified liquid composition comprising beta-hydroxy-beta-methylbutyric acid (HMB-acid) between about 0.5 grams of HMB-acid to about 30 grams of HMB-acid.2. The composition of claim 1 , wherein the composition further comprises soluble protein.3. The composition of claim 1 , wherein the composition further comprises calcium.4. The composition of claim 1 , wherein the composition further comprises vitamins and minerals.5. The composition of claim 1 , wherein the substantially clear claim 1 , non-emulsified liquid is shelf stable.6. The composition of claim 1 , wherein the substantially clear claim 1 , non-emulsified liquid is selected from the group consisting of nutritional liquids claim 1 , sports drinks claim 1 , fruit juice claim 1 , and carbonated beverages.7. The composition of claim 1 , wherein the substantially clear claim 1 , non-emulsified liquid has a pH of about 2.0 to about 4.7.8. The composition of claim 1 , wherein the substantially clear claim 1 , non-emulsified liquid has a pH of about 2.0 to about 2.8.9. The composition of claim 8 , wherein the substantially clear claim 8 , non-emulsified liquid has a pH of about 2.0 to about 2.75.10. A process for preparing a substantially clear claim 8 , non-emulsified liquid composition comprising HMB-acid claim 8 , wherein the HMB-acid is added to the nutritional composition at any time during the manufacturing process.11. A concentrate comprising HMB-acid between about 0.5 grams of HMB-acid to about 30 grams of HMB-acid.12. The concentrate of claim 11 , wherein the ...

Biologically Active Food Supplement

A biologically active food additive comprises an ecdysteroid medicinal herb, such as (5-70 wt. %), drone brood (1-70 wt. %), ascorbic acid (3.6-70 wt. %), vitamin E (0.05-30 wt. %), and vehicles, such as calcium stearate, talc, lactose (the balance). The additive contributes to increasing the muscle weight in athletes, maintaining testosterone level, and demonstrates anabolic, anticatabolic and potency enhancing effects. 1{'i': 'Rhaponticum carthamoides;', 'a medicinal herb comprising ecdysteroid such as'}Drone brood;Ascorbic acid;Vitamin E; andVehicles, such as calcium stearate, talc, lactose;the additive ingredients being in the following ratio (wt. %):Drone brood: 1-70;{'i': 'Rhaponticum carthamoides', '(or another medicinal herb containing ecdysteroids): 5-70;'}Ascorbic acid: 3.6-70;Vitamin E: 0.05-30;Vehicles—the balance,whereby increasing the muscle weight in athletes, maintaining testosterone level, and anabolic, anticatabolic and potency enhancing effects are achieved.. A biologically active food additive comprising the following ingredients: This application is a continuation in part of U.S. application Ser. No. 14/138,875 filed on Dec. 23, 2013, which is a continuation in part of U.S. application Ser. No. 13/256,237 filed on Sep. 13, 2011, which is a U.S. National Stage application of International application PCT/RU2010/000098 filed on Mar. 3, 2010, which claims priority of Russian Federation application RU 2009109273 filed on Mar. 13, 2009, all of the above applications being incorporated herein by reference in their entirety.The invention relates to food industry, and specifically, to biologically active food additives, and is intended for increasing muscle weight in athletes and maintaining testosterone level, while providing anabolic, anticatabolic and potency enhancing effect.The best biostimulators and energetically rich products are the preparations developed from bee hive products. The preparation “Tonus” is known, which was developed from pollen ...

COMPOSITIONS CONTAINING NON-POLAR COMPOUNDS

Provided are compositions and methods for clear and stable beverages that contain additives such as essential fatty acids, including omega-3 fatty acids, omega-6 fatty acids, conjugated fatty acids, and other fatty acids; phytochemicals, including phytosterols; other oils; and coenzymes, including Coenzyme Q10, and other oil-based additives. 1. A liquid nanoemulsion concentrate , comprising:a) one sucrose fatty acid ester or a mixture of sucrose fatty acid esters, wherein:the total amount of sucrose fatty acid esters is between about 16% and about 30%, by weight, of the concentrate; andb) a polar solvent in an amount between about 60% and about 79%, by weight, of the concentrate, wherein the polar solvent is selected from among water, glycerin, propylene glycol, ethylene glycol, tetraethylene glycol, triethylene glycol and trimethylene glycol; andc) a non-polar active ingredient selected from among any one or more of polyunsaturated fatty acids, omega-3 fatty acids, omega-6 fatty acids, conjugated fatty acids, Coenzyme Q10 compounds, vitamin D3 and phytosterols in an amount between about 5% and about 10%, by weight, of the concentrate.2. The liquid nanoemulsion concentrate of claim 1 , wherein the concentrate contains between about 17% and about 29% claim 1 , by weight claim 1 , sucrose fatty acid ester or mixture thereof.3. The liquid nanoemulsion concentrate of claim 1 , wherein the sucrose fatty acid ester or mixture thereof in the composition has an HLB value of between about 14 and about 20.4. The liquid nanoemulsion concentrate of claim 1 , wherein the sucrose fatty acid ester or mixture thereof comprises a sucrose fatty acid monoester.5. The liquid nanoemulsion concentrate of claim 1 , wherein the sucrose fatty acid ester or mixture thereof contains sucrose stearate claim 1 , sucrose laurate claim 1 , sucrose palmitate claim 1 , sucrose oleate claim 1 , sucrose caprylate claim 1 , sucrose decanoate claim 1 , sucrose myristate claim 1 , sucrose pelargonate ...

MULTI-SUPPLEMENT COMPOSITIONS

This document provides dietary supplement compositions. For example, multi-supplement compositions having combinations of dietary supplement formulations useful for human or animal consumption are provided. 1. A multi-supplement composition comprising:(a) a probiotic supplement;(b) a multivitamin and mineral supplement;(c) an antioxidant supplement; and(d) an anti-inflammatory supplement.2. The composition of claim 1 , further comprising a fish oil supplement.3. The composition of claim 1 , wherein the probiotic supplement comprises:{'i': Lactobacillus acidophilus, Lactobacillus plantarum, Lactobacillus casei, Lactobacillus rhamnosus, Bifidobacterium longum, Bifidobacterium lactis', 'Bifidobacterium bifidum, '(i) from about 5 billion to about 15 billion cfu of a mixture of , and ; and'}(ii) a filler having a water activity less than 0.2.4. The composition of claim 1 , wherein the probiotic supplement comprises a capsule or a tablet.5Lactobacillus acidophilus, Lactobacillus plantarum, Lactobacillus casei, Lactobacillus rhamnosus, Bifidobacterium longum, Bifidobacterium lactisBifidobacterium bifidum. The composition of claim 1 , wherein said dietary supplement of a Supplement Formulation A releases said claim 1 , and within an intestine of a mammal following oral administration to said mammal;6. A multi-supplement composition comprising: [{'i': Lactobacillus acidophilus, Lactobacillus plantarum, Lactobacillus casei, Lactobacillus rhamnosus, Bifidobacterium longum, Bifidobacterium lactis', 'Bifidobacterium bifidum,, '(i) from about 5 billion to about 15 billion cfu of a mixture of , and'}, '(ii) a filler having a water activity less than 0.2, and', '(iii) a capsule,, '(a) a dietary supplement of a Supplement Formulation A comprising{'i': Lactobacillus acidophilus, Lactobacillus plantarum, Lactobacillus casei, Lactobacillus rhamnosus, Bifidobacterium longum, Bifidobacterium lactis', 'Bifidobacterium bifidum, 'wherein said dietary supplement of a Supplement Formulation A ...

Edible Energy Composition with Low Caffeine

An energy composition includes a methylated xanthine, a choline derivative, and at least one flavorant in a sufficient amount to render the energy composition palatable. The energy composition may also include vitamins, amino acids, enzymes, preservatives, and the like. 1. An edible energy composition comprising:caffeine in an amount less than 0.00045 g/ml;a choline derivative in an amount from about 0.0004 g/ml to about 0.009 g/ml; andat least one flavorant.2. The energy composition of wherein the caffeine is present in an amount from about 0.00008 g/ml to about 0.004 g/ml.3. The energy composition of wherein the caffeine is present in an amount from about 0.0001 g/ml to about 0.0003 g/ml.4. The energy composition of wherein the choline derivative is present in an amount from about 0.0008 g/ml to about 0.007 g/ml.5. The energy composition of wherein the choline derivative is present in an amount from about 0.001 g/ml to about 0.005 g/ml.6. The energy composition of wherein the choline derivative comprises citicoline.7. The energy composition of further comprising at least one amino acid or amino acid derivative.8. The energy composition of wherein the amino acids or amino acid derivatives are present in an amount from about 0.005 to about 0.05 g/ml.9. The energy composition of wherein the amino acids comprise a component selected from the group consisting of N-acetyl L-tyrosine claim 7 , L-phenylalanine claim 7 , taurine claim 7 , and combinations thereof.10. The energy composition of further comprising N-acetyl L-tyrosine in an amount from about 0.001 to about 0.01 g/ml.12. The energy composition of further comprising L-phenylalanine in an amount from about 0.001 to about 0.008 g/ml.13. The energy composition of further comprising taurine in an amount from about 0.002 to about 0.016 g/ml.14. The energy composition of further comprising vitamins in an amount from about 0.0003 g/ml to about 0.01 g/ml.15. The energy composition of further comprising a vitamin ...

Nutritional formulation for weight control

A nutritional formulation or dietary regime for improving animal health. The nutritional formulation includes effective and dietary acceptable amounts of glucose tolerance factor (GTF) chromium and L-Glutamine that are beneficial in controlling animal weight and reducing blood sugar levels.

LIQUID CONCENTRATED HUMAN MILK FORTIFIER CONTAINING HYPOALLERGENIC PROTEIN AND LUTEIN

The present invention is directed to concentrated liquid human milk fortifiers using extensively hydrolyzed casein as a protein source, a stabilizer system comprising octenyl succinic anhydride modified corn starch in combination with a low acyl gellan gum, and the carotenoid lutein. 1. A concentrated liquid human milk fortifier comprising from about 5% to about 50% by weight extensively hydrolyzed casein protein , on a dry weight basis , lutein , and a stabilizer system comprising an octenyl succinic anhydride modified corn starch and a low acyl gellan gum.2. The concentrated liquid human milk fortifier of claim 1 , comprising from about 20% to about 40% by weight extensively hydrolyzed casein claim 1 , on a dry weight basis.3. The concentrated liquid human milk fortifier of claim 1 , wherein the lutein concentration is at least about 50 mcg/liter claim 1 , based on an as-fed basis.4. The concentrated liquid human milk fortifier of claim 3 , wherein the concentrated human milk fortifier further comprises at least about 30 mg/liter docosahexaenoic acid claim 3 , based on an as-fed basis claim 3 , wherein the weight ratio of lutein (mcg) to docosahexaenoic acid (mg) is from about 1:2 to about 10:1.5. The concentrated liquid human milk fortifier of claim 4 , wherein the concentrated human milk fortifier comprises from about 54 to about 360 mg/liter docosahexaenoic acid claim 4 , based on an as-fed basis claim 4 , wherein the weight ratio of lutein (mcg) to docosahexaenoic acid (mg) is from about 1:2 to about 10:1.6. The concentrated liquid human milk fortifier of claim 4 , wherein the octenyl succinic anhydride modified corn starch is present in an amount of from about 0.1% to about 3.5% by weight of the concentrated liquid human milk fortifier.7. (canceled)8. The concentrated liquid human milk fortifier of claim 4 , wherein the low acyl gellan gum is present in an amount of from greater than 125 to about 800 ppm.9. (canceled)10. The concentrated liquid human milk ...

Nutritional Formulas Comprising Medium Chain Fatty Acids or Esters Thereof and Methods Related Thereto

This disclosure relates to nutritional formulas and uses for treating or preventing a gastrointestinal condition and/or motor-planning speech and/or coordinator difficulties. In certain embodiments, this disclosure relates to a nutritional formula comprising medium 5 chain fatty acids, or esters thereof (such as and tri-, di-, mono-glycerides, or alkyl esters), unsaturated fatty acids, and a vitamin E and optionally other nutrients. In certain embodiments, any of the compounds or nutrients may be in alternative salt forms. 1. A dietary formulation comprising:a) medium chain fatty acid, glycerol ester, or alkyl ester thereof ester thereof,b) an omega-3 fatty acid, glycerol ester, or alkyl ester thereof, andc) a vitamin E isomer, wherein the vitamin E isomer is in an amount of from 100 mg to 10,000 mg.2. The dietary formula of claim 1 , wherein the medium chain fatty acid glycerol ester is selected from glycerol tricaprate claim 1 , glycerol claim 1 , dicaprate claim 1 , glycerol monocaprate claim 1 , glycerol tricaprylate claim 1 , glycerol dicaprylate claim 1 , glycerol monocaprylate claim 1 , and glycerol trihexanoate claim 1 , or combinations thereof.3. The dietary formula of claim 1 , wherein the medium chain fatty acid or alkyl ester thereof is selected from capric acid claim 1 , ethyl caprate claim 1 , caprylic acid claim 1 , ethyl caprylate claim 1 , hexanoic acid claim 1 , and ethyl hexanoate claim 1 , or combinations thereof.4. The dietary formula of further comprising a vitamin K.5. The dietary formula of further comprising a vitamin A claim 1 , vitamin D claim 1 , and vitamin K.6. The dietary formula of claim 1 , wherein the omega-3 fatty acid or alkyl ester thereof is selected from alpha-linolenic acid claim 1 , eicosapentaenoic acid claim 1 , docosahexaenoic acid claim 1 , ethyl linolenate claim 1 , ethyl eicosapentaenoate claim 1 , and ethyl docosahexaenoate or combinations thereof.7. The dietary formula of comprising eicosapentaenoic acid and ...

Oral Delivery Product

This invention provides a nutritional supplement composition which is a vitamin mint that can be taken anytime or anywhere without water or other liquid which is usually required for swallowing a tablet. The present invention is a nutritional supplement composition which is a convenient, flavorful and enjoyable vitamin mint which can be ingested without water. 1. A composition for oral delivery to a subject comprising vitamins or minerals , wherein the composition can dissolve in the subject's mouth or can be chewed and swallowed by the subject.2. The composition of wherein the vitamins are selected from Vitamin C claim 1 , Vitamin E claim 1 , folic acid claim 1 , Vitamin K claim 1 , biotin claim 1 , Vitamin D claim 1 , betacarotene claim 1 , Vitamin A claim 1 , niacin claim 1 , Vitamin B1 claim 1 , Vitamin B6 claim 1 , Vitamin B12 and pantothenic acid.3. The composition of wherein the minerals are selected from calcium claim 1 , iron claim 1 , phosphorous claim 1 , iodine claim 1 , magnesium claim 1 , zinc claim 1 , selenium claim 1 , copper claim 1 , manganese claim 1 , chromium claim 1 , molybdenum claim 1 , chloride claim 1 , potassium claim 1 , boron claim 1 , nickel claim 1 , silicon claim 1 , tin and vanadium.4. The composition of wherein the minerals are selected from zinc claim 3 , manganese claim 3 , iodine claim 3 , selenium claim 3 , molybdenum and chromium.5. The composition of further comprising binders selected from sorbitol claim 1 , xylitol claim 1 , mannitol claim 1 , lactitol claim 1 , maltitol claim 1 , erythritol and isomalt.6. The composition of further comprising sweetening agents selected from acesulfame potassium claim 1 , aspartame claim 1 , sucralose and stevia.7. The composition of wherein the caloric content of the composition is about calories.8. The composition of wherein the hardness of the composition is 17 kp to 40 kP.9. The composition of further comprising one or more flavorings.10. The composition of wherein the flavorings are ...

COMPOSITIONS AND METHODS FOR ENHANCING BRAIN FUNCTION

A nutritional supplement composition enhances cognitive function and includes huperzine A, vinpocetine, acetyl-L-carnitine, and rhodiola. The composition is formulated for oral administration. The huperzine A, vinpocetine, acetyl-L-carnitine, and rhodiola are in a ratio a:b:c:d: respectively such that a as the huperzine A is between about 0.8 and 1.2, b as vinpocetine is between about 80 and 120, c as rhodiola is about 1,600 and 2,400, and d as the acetyl-L-carnitine is between about 8,000 and 12,000. 1. A nutritional supplement composition for enhancing cognitive function , comprising:huperzine A;at least one of vinpocetine and rhodiola;acetyl-L-carnitine;a vitamin B complex; anda green tea and guarana extract;wherein the composition is formulated for oral administration and one of at least the vinpocetine is present in an amount from about 10 mg to 30 mg and the rhodiola is present in an amount from about 200 mg to 400 mg and the acetyl-L-carnitine is present in an amount from about 1,250 mg to 2000 mg, and the huperzine A, acetyl-L-carnitine, and at least one of the vinpocetine and rhodiola together account for at least 80 wt % of a dosage unit of the composition.2. The nutritional supplement composition of claim 1 , wherein the huperzine A is present in an amount from about 50 mcg to 200 mcg.3. The nutritional supplement composition of claim 1 , wherein the vitamin B complex is present in an amount from about 125 mg to 175 mg.4. The nutritional supplement composition of claim 1 , wherein the huperzine A claim 1 , at least one of vinpocetine and rhodiola claim 1 , acetyl-L-carnitine claim 1 , the Vitamin B complex claim 1 , and the green tea and guarana extract are in a ratio of a:b:c:d:e:f respectively such that a as the huperzine A is between about 0.8 and 1.2 claim 1 , b as the vinpocetine is between about 80 and 120 claim 1 , c as the rhodiola is between about 1600 and 2400 claim 1 , d as the acetyl-L-carnitine is between about 8 claim 1 ,000 and 12 claim 1 , ...

METHODS FOR TREATING NEUROLOGICAL DISORDERS USING NUTRIENT COMPOSITIONS

Nutrient compositions comprising botanical extracts and an omega 3 fatty acid as well as methods of their use for treating, inter alia, autism or apraxia and/or ameliorating one or more symptoms thereof are disclosed. The use of such compositions for enhancing cognitive function and/or one or more aspects thereof, or for treating stroke or seizures and/or ameliorating one or more symptoms thereof are also disclosed. 1. A nutrient composition comprising:{'i': gymnema sylvestre, commiphora mukul, curcuma longa, camellia sinensis, emblica officinalis,', 'terminalis chebula;, 'an effective amount of a mixture or purified mixture thereof comprising three or more botanical extracts selected from the group of botanicals consisting of and and'}an effective amount of an omega 3 fatty acid or pharmaceutically acceptable or food grade acceptable derivative thereof.2. A method for treating apraxia , autism , speech impairments , traumatic brain injury , seizure disorders , epilepsy , global delays , Alzheimer's Disease , or ADHD , comprising administering to a patient in need thereof:{'i': gymnema sylvestre, commiphora mukul, curcuma longa, camellia sinensis, emblica officinalis,', 'terminalis chebula;, "a nutrient composition that ameliorates one or more symptoms of apraxia, autism, speech impairments, traumatic brain injury, seizure disorders, epilepsy, global delays, Alzheimer's Disease, or ADHD, said nutrient composition comprising an effective amount of a mixture or purified mixture thereof comprising three or more botanical extracts selected from the group of botanicals consisting of and and"}an effective amount of an omega 3 fatty acid or pharmaceutically acceptable or food grade acceptable derivative thereof.3gymnema sylvestre, commiphora mukul, curcuma longa, camellia sinensis, emblica officinalis,terminalis chebula.. A nutrient composition according to claim 1 , wherein the nutrient composition comprises a mixture or purified mixture thereof comprising botanical ...